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Previous reports have indicated a dichotomy in the actions of TCDD on humoral 
immunity, both in vivo and in vitro, in which enhancements and suppression have been 
identified. The latter effect has been correlated with induction of liver P4501Al enzyme 
activity, a response which is regulated by the Ah-gene locus. Additionally, the primary 
alteration in suppression of antibody responses is in the differentiation of the B cell. 
Therefore, the current investigation was undertaken to determine the relationship between 
these dual actions of TCDD on humoral immunity as related to its direct actions on B 
lymphocyte function. Specific emphasis was placed on determining the potential role of 
the Ah-gene locus in the modulation of the B cell and in vitro antibody responses. 
Initial observations determined that: 1) the degree of suppression of in...Yili:Q antibody 
responses in B6C3Fl mouse (an Ah-high responder strain) splenocytes is dependent on 
both the lot, concentration, and type (i.e., fetal bovine versus newborn bovine) of serum 
used in culture; and 2) there is a similarity in the actions of TCDD and Staphylococcus 
aureus Cowan strain I (SAC); a polyclonal B cell activator. These observations prompted 
the study of the direct effects of TCDD on B cells in different stages of in vivo activation 
X IX 
and in the presence of different serum environments for which SAC has been reported to 
have opposing actions. TCDD was found to increase background levels of proliferation 
and differentiation in resting B cells (Go); thereby suggesting that resting B cells are a 
primary target in enhancement of immune responses by TCDD. However, no effect was 
seen on either response when the cells were stimulated with lipopolysaccharide (LPS). In 
cycling B cells (G 1), TCDD caused suppression of both background and LPS-stimulated 
proliferation and differentiation and demonstrated a serum dependency that paralleled its 
actions in whole lymphocyte antibody responses; thereby demonstrating that it is the 
cycling B cell that is the primary target in suppression of antibody responses by TCDD and 
that both proliferation and differentiation are affected. 
The modulatory role of serum was also determined in primary hepatocyte cultures 
using P4501Al enzyme induction as the endpoint. Sera which supported either no effect 
or enhancements in both whole lymphocyte and purified B cell responses did not support 
induction of P4501A 1 activity above BSA, a protein control. Conversely, sera which 
supported a consistent and dose-related suppression of in vitro antibody responses were 
found to enhance the induction of P4501A l activity. More importantly, normal mouse 
serum was found to allow for the full expression of the Ah-dependent phenomena in vitro, 
where primary hepatocytes and splenocytes from Ah-high responder (B6C3Fl )  and Ah­
low responder (DBN2) mouse strains were affected by TCDD in a manner that parallels 
the effects seen in the two strains following in vivo exposures. The latter results using 
mouse sera are consistent with a role by the Ah-gene locus in the direct effects of TCDD on 
whole lymphocyte and purified B cell antibody responses. However, the results with 
other, more traditional sources of sera, indicate that the ultimate expression of the TCDD­
induced responses can be modulated by serum factors, which are at present unidentified. 
Furthermore, the results of this investigation indicate that the susceptibility of the cell, as 
related to its stage in the cell cycle, can contribute to the complex effects that are seen in the 
alteration of antibody responses following TCDD exposure. 
I. INTRODUCTION 
One of the primary focuses of this laboratory has been to investigate the mechanism 
by which 2,3,7,8-tetrachlorodibenzo-p-dioxin ( TCDD) induces the suppression of 
humoral immunity. Specifically, this investigation has centered around the effects of 
TCDD on the T-dependent antibody response, a highly sensitive target for toxicity by 
TCDD and other members of the halogenated aromatic hydrocarbons [ Thomas and 
Hinsdill, 1979; Hinsdill, et aI., 1980; Clark, et al., 1981; Thomas and Faith, 1985]. It has 
been well documented that many of the toxicities induced by TCDD in vivo are mediated 
through binding to a specific steroid-like cytosolic protein known as the Ah-receptor. As 
modeled in the hepatocyte, this TCDD/Ah-receptor complex has been further shown to 
translocate to the nucleus and bind to specific "dioxin-responsive-elements" (DRE) of the 
DNA and to induce the transciptional activation of a number of genes, including those 
which code for the P4501Al and l A2 cytochrome P450 enzymes. [Poland, et aI., 1974; 
Poland and Glover, 1975; Poland and Glover, 1980; Poland and Knutson, 1982]. 
Similarly, the impairment of immune cell and organ functions by TCDD have also been 
implicated as being regulated via the Ah-receptor and its associated gene locus [Vecchi, et 
aI., 1983; Nagarkatti, et aI., 1984; Blank, et aI., 1987]. However, work from this 
laboratory has demonstrated that suppression of the T-dependent antibody response by 
TCDD has a component which is at least partially independent of effects mediated through 
the Ah-gene locus. This conclusion is based on two specific lines of evidence. The first 
is the report by Holsapple, et aI. (1986) which demonstrated that splenocytes derived from 
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B6C3Fl (Ah-high responder) and DBN2 (Ah-low responder) mice had comparable dose­
response curves for the TCDD-induced suppression of LPS-stimulated in vitro antibody 
responses when compared under identical culture conditions [Holsapple, et aI., 1986a]. 
The second was the report by Holsapple, et al. (1986) which demonstrated that subchronic 
exposure of B6C3Fl mice to 2,7-DCDD, a low-affinity Ah-receptor ligand, caused 
suppression of the in vivo T-dependent antibody response which was comparable to that 
produced by TCDD [Holsapple, et al., 1986b]. Therefore, it appears that both Ah- and 
non-Ah-receptor mediated processes are involved in the effects of TCDD on humoral 
immunity, the relative contributions of these two actions to the overall effects on immune 
cell function however, are still unresolved. 
In terms of the specific effects of TCDD on the T-dependent antibody response, 
previous studies have demonstrated that the primary target for suppression is the B 
lymphocyte [Tucker, et al., 1986; Dooley and Holsapple, 1988]. Uniquely, the effects of 
TCDD on this cell have been characterized as immunomodulatory, in which TCDD 
exposure selectively alters the normal function and differentiation of these cells during the 
antibody response without any sign of overt toxicity [Tucker, et aI., 1986; Holsapple, et 
aI., 1986a; Kramer, et aI., 1987; Dooley and Holsapple, 1988; Luster, et aI., 1988b]. 
Additionally, TCDD was shown to cause no detectable alteration in mitogenically-induced 
proliferation of lymphocytes, and it was concluded that the ultimate effect of TCDD was to 
cause a specific alteration in the differentiation of the B cell during normal progression 
through the cell cycle [Tucker, et aI., 1986; Dooley and Holsapple, 1988; Luster, et al., 
1988b]. This conclusion is consistent with the work in other tissue systems in which 
alterations in differentiation have been reported [Poland and Knutson, 1982; Hudson, et 
al., 1985; Hudson, et al., 1986]. In contrast, several lines of evidence still suggest that 
activation and/or proliferation in the B cell can be altered by TCDD exposure. First, 
although TCDD seems to manifest its effects by arresting the differentiation of the B 
lymphocyte following antigen stimulation, it was recognized by several investigators that 
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this compound must be present during the flrst 24 hours of a T-dependent antibody 
response to S RBC (or within the flrst 3 hours of an LPS-induced polyclonal antibody 
response) to produce it's suppressive effects [Tucker, et aI., 1986; Holsapple, et aI., 
1986a]. This is an important observation since all of the B cells that are committed to 
differentiation during an in vitro antibody response to S RBC have been determined to be 
activated and proliferating within 27 hours of culture, whereas T cell help is not needed 
until 48 hours [Dutton, 1975]. Secondly, addition of TCDD to naive (unsensitized) 
splenocytes was found to increase the basal antibody forming cell (AFC) response, which 
peaked on day 3 of culture [Kramer, et aI., 1987]. This finding is in agreement with 
earlier work which demonstrated that in vivo exposure of naive animals to low doses of 
TCDD caused an increase in the level of serum antibodies and background antibody 
forming cell responses in the absence of antigen stimulation [Sharma and Gehring, 1979; 
Clark, et aI., 1981]. It was further noted in the work by Clark, et al. (1981) that TCDD 
also increased the number of spleen colony-forming cells in bone marrow by 25-39%, an 
additional indication that under selective exposure conditions, TCDD can act at speciflc 
site (s) within hematopoietic cells to initiate an "activation-like" signal. Moreover, in the 
report by Kramer, et ai. (1987), it was determined that addition of TCDD to purifled B 
cells produced an increase in the level of basal kinase activity, produced after only 30 
minutes of incubation. This kinase activity was further shown not to involve PK-C; a 
kinase which has been shown to be functionally activated during antigen stimulation 
through the immunoglobulin receptor of the B cell [Kramer, et aI., 1986]. However, 
many growth factor receptors have associated kinase activity (tyrosine kinases in 
particular), suggesting the possible alteration in B cell growth at the level of a growth 
factor receptor. This hypothesis is supported by the previous work of Hudson, et al. 
(1986) which demonstrated an alteration in the EGF receptor on epidermal cells following 
exposure to TCDD [Hudson, et aI., 1986]. Lastly, it has recently been established by our 
laboratory that the pleiotropic cytokine, gamma-interferon (G-IFN), can inhibit the TCDD-
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induced suppression of the T-dependent antibody response, the TCDD-induced kinase 
activation in purified B cells and the TCDD-induced E ROD activity in primary hepatocytes 
(Dooley, Yang, Snyder and Holsapple; unpublished observations). Most interesting about 
this fmding was the fact that this cytokine, although it can affect many different cell types, 
had to be added early into culture to reverse the effects of TCDD on the in vitro antibody 
response (ftrst 18 hours of culture) which correlated precisely with the time of TCDD 
addition that was needed to produce suppression. Moreover, G-I FN (or immune 
interferon) has been shown by a number of investigators to enhance both B cell activation 
and proliferation, as well as differentiation, to a number of activating stimuli; thereby 
suggesting a direct interaction between this cytokine and TCDD at the molecular level of 
the B cell during early activation by antigen [Defrance, et al., 1986; Romagnani, et al., 
1986; Boyd, et al., 1987; Karray, et al., 1987; Morikawa, et al., 1987; Xia and Choi, 
1988; Punnonen and Viljanen, 1989a; Punnonen and Viljanen, 1989b]. 
Collectively, these observations have suggested that early activation events in the B 
lymphocyte are targeted by TCDD and that both enhancements and/or suppression can 
result depending on the conditions of exposure. Therefore, the primary objective of this 
investigation was to determine the relationship between the immune enhancing and 
immunosuppressive effects of TCDD on humoral immunity and to determine whether these 
two opposing actions of TCDD on in vitro antibody responses is the result of differential 
effects on separate B lymphocyte subpopulations within the spleen (i.e., dense resting and 
cycling B cells). In addition, studies were conducted to determine if these two opposing 
actions of TCDD are correlated with responses mediated by the Ah-receptor and the Ah­
gene locus. 
Results of the current investigation demonstrate that TCDD has a differential pattern 
of effects on the B lymphocyte depending on their state of in vivo activation - potentiation 
of resting (Go) and a generalized suppression of cycling (primarily G 1) B cell function; 
where suppression of cycling B cell responses was found to result from effects on both 
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proliferation and differentiation into antibody secreting cells. Furthermore, these two 
opposing actions of TCDD on the B cell were found to be modulated by the presence of 
either serum-derived growth factors (and/or hormones) and T cell-derived cytokines which 
were found to potentiate the direct effects of TCDD on the B cell to either increase or 
decrease the enhancements or suppression in B cell function seen in vitro. Moreover, it 
was determined that the effects of TCDD on both in vitro antibody responses and 
modulation of B cell function correlate with responses mediated by the Ah-receptor and 
associated gene locus. This effect was most apparent when lymphocytes and primary 
hepatocytes from both Ah-low (DBA/2) and Ah-high (B6C3Fl) responsive mouse strains 
were exposed to TCDD in the presence of normal mouse sera; serum conditions which QQ 
!1Qt appear to alter the genotypic expression of Ah-receptor-mediated responses to TCDD in 
the lymphocyte and which are normally encountered in vivo. Additionally, it was 
determined that suppression of in vivo antibody responses by TCDD in DBA/2 (Ah-low 
responsive) mice can be enhanced following subchronic (14 day repetitive) exposures to 
TCDD. This enhanced suppression of the antibody response was accompanied by an 
increase in splenic, but not liver, P450 activity and a coordinate loss in a non-B/non-T cell 
population within the spleen; indicating that the effects of TCDD on lymphocyte function in 
vivo is a dynamic process that can be altered by changes in the conditions of TCDD 
exposure. 
II. LITERA TURE REVIEW 
A .  Review of Immunology and the Humoral I mmune Response: 
Although a generalized overview of the immune system and effector mechanisms will 
be described, this review of the immunology literature will focus primarily on humoral, or 
antibody-mediated immunity, and the role of T cells in this response. A more detailed 
characterization of other T cell-mediated mechanisms of immunity, while being equally 
important, is beyond the scope of this discussion and the current work for which it 
precedes. However, because of the potential cooperativity that may occur between T cells 
and B cells during humoral as well as other immune responses to infectious agents, a more 
detailed description of the effects of TCDD on both cell-mediated and humoral immunity 
will be included in the following section. 
1 . General Concepts of I mmunity: 
The essential function of the immune system is to defend against infection. As such, 
it comprises all of the physiological mechanisms which enables an animal (or host) to 
recognize materials as foreign to itself and to neutralize, eliminate or metabolize them with 
or without injury to its own tissues [Paul, 1984; Roitt, et aI., 1985]. Lower animal forms 
possess innate immune mechanisms which protect them against infecting organisms. 
Higher animal forms have evolved to possess, in addition to innate immunity, 
6 
7 
acquired immune mechanisms which provide a more customized, specific and efficient 
defense against infectious agents. 
Innate immunity represents the first line of defense during infections and is 
characterized as being non-specific (or non-selective) and as not having immunological 
memory (i.e., the resistance is not improved upon secondary challenge or repeated 
infection). The mechanisms involved in innate immunity are comprised of specialized 
physical and biochemical barriers outside or within the body (i.e., skin, cilia lining the 
trachea, stomach acid, sebaceous gland secretions, lysozymes and mucous), commensal 
organisms of the gut, non-specific soluble factors (i.e., the complement proteins, acute 
phase proteins and interferons) and specialized leukocytes (i.e., neutrophils, 
monocytes/macrophages, natural killer cells, Kupffer cells and synovial A cells). The 
latter patrol the tissues of the body, non-specifically recognize a foreign substance (via cell 
surface receptors for complement proteins and antibodies bound to the surface of the 
infectious agent) and then phagocytize or secrete soluble factors such as lysozyme which 
destroys the organism. Other mechanisms of innate immunity include inflammation, fever 
and bodily reflexes such as coughing and sneezing [Paul, 1984; Roitt, et al., 1985]. 
Acquired or adaptive immunity is the second line of defense, and is activated if innate 
immune mechanisms fail to rid the body of the infection. This line of defense is 
characterized as producing a specific reaction to each infectious agent (i.e., specific 
recognition of self versus non-self via specialized cell surface molecules encoded in the 
major histocompatibility gene complex) and as producing immunological memory of the 
experience which improves the resistance of the host to that agent upon secondary 
challenge. The cellular mediators of this response are the T and B lymphocytes which 
form two divisions of acquired immunity known as cell mediated (CM!) and humoral ( HI) 
immunity, respectively. CM I is acquired immunity that is dependent upon T cells which, 
upon activation, differentiate into distinct subsets of T effector cells that function to attack 
and rid the body of a wide spectrum of infectious agents. HI is acquired immunity which 
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is dependent on the B cells which, upon activation, differentiate into effector B cells (also 
called plasma cells) that secrete specific antibodies that can bind to and either neutralize or 
mediate the destruction of microorganisms. Although the two arms of acquired immunity 
can act independent of one another, there is considerable interaction between them, and it is 
this cooperativity that enables the immune system to develop a very diversified reaction to 
most infectious agents [Paul, 1984; Roitt, et al., 1985]. 
2 .  Specificity of the Immune Response: Self Versus Non-Self. 
In order to mount an immune response against any infectious agent, the immune 
system must be able to distinguish between "self' and "non-self'. "Self' to the immune 
system, as the term implies, comprises all of the tissues within the body, including normal 
flora. Privileged sites are the exception (i.e., cornea of the eye, testes and brain) which are 
considered to be outside the bodies realm of surveillance. 
In innate immune mechanisms (i.e, phagocytosis), "non-self' recognition is mediated 
by way of cell surface receptors on the phagocyte that are specific for a number of various 
immune factors (i.e., complement and antibodies) that are activated or secreted during an 
immune response. These factors bind to the surface of an infectious agent and mediate 
their recognition and subsequent engulfment and/or destruction by the phagocyte. In 
acquired immune mechanisms, specialized molecules on the surface of all nucleated cells of 
the body help to distinguish "self' from "non-self'. These molecules are cell surface 
proteins that are encoded by the major histocompatibility gene complex (MHC) and are 
known as the MHC antigens [Paul, 1984; Roitt, et ai., 1985]. This region of the genome 
in the mouse is referred to as the H-2 complex (located on chromosome 17) or in the 
human as the HLA gene cluster (located on chromosome 6). Two classes of MHC 
molecules exist and are distinguished from one another by structure, function and cellular 
distribution. Class I antigens consist of 2 polypeptides, a larger protein which is encoded 
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by the H-2 complex, and a smaller protein , known as B2-microglobulin , which is encoded 
outside the H -2 complex. Class I antigens are found on all nucleated cells and platelets and 
function to present endogenously produced foreign antigens (i.e., such as viral gene 
products) at the cell surface. Class I I  antigens consist of 2 polypeptide chains (a and B), 
both of H-2 complex origin, and are expressed on specific types of immune cells - B cells, 
macrophages, monocytes, dendritic and Langerhans cells, epithelial cells and activated T 
cells (identified in the human only). These molecules function in immune responses to 
mediate the presentation of exogenously encountered antigens on the surface of antigen 
presenting cells (APC) following internal processing. It is the latter system that allows for 
more specific immune responses to occur and is further governed by antigen specific T 
cells that recognize foreign antigens only when bound to or in context with the MHC 
antigen on the surface of APC [Paul, 1984; Roitt, et al., 1985]. 
3 . Cells of the Immune Response: 
The cells of the immune system are a diversified group, each having specialized 
functions that enables them to attack and rid the host of a multitude of organisms and 
transformed cells (i.e., virally infected or tumor cells). These cells include, among others, 
the lymphocytes, monocytes/macrophages, neutrophils, dendritic and Langerhans cells and 
specialized epithelial cells such as those formed within the thymus. These cells occur in 
organized tissues and organ systems including the spleen, lymph nodes, Peyer's patches, 
tonsils, thymus and bone marrow. In addition, a trafficking population of these cells are 
found in blood and lymph. 
All cells of the immune system share a common precursor known as the pleuripotent 
stem cell. This cell undergoes hematopoietic differentiation down two distinct pathways 
within the primary immune organs (i.e., fetal liver, fetal spleen and fetal bone marrow or 
bone marrow of adult mammals) to give rise to two generalized populations of cells [Paul, 
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1984; Roitt, et aI. ,  1985] .  The first is the myeloid pathway which begins with the 
development of a myeloid progenitor cell. The myeloid progenitor then undergoes 
hematopoietic differentiation to produce the mononuclear p hagocytes (i.e . ,  
monocytes/macrophages), the polymorphonuclear granulocytes (i.e . , neutrophils, 
basophils and eosinophils), mast cells and megakaryocytes (i.e . ,  which produce and 
release the blood platelets upon maturity). The second pathway consists of the lymphoid 
lineage and begins with the development of the lymphoid progenitor. These cells undergo 
further differentiation to form the various populations of immature lymphocytes (i.e. ,  the 
pre-T and pre-B cells). Lymphocytes undergo additional development within a second set 
of primary immune organs, the thymus and Bursa of Fabricius (and/or Bursa-equivalent). 
Pre-T cells develop into mature T cells within the thymus whereas pre-B cells develop 
within a specialized organ known as the Bursa of Fabricius (in birds) or in the bone 
marrow or Bursal-equivalent of mammals. It is the developmental origin within these two 
tissues from which their names are derived. Both pathways (i.e. ,  myeloid and lymphoid) 
give rise to mature immune cells which then migrate to secondary immune organs, such as 
the spleen and lymph nodes (i.e., lymphocytes), or to sites surrounding all tissues of the 
body (i.e., monocytes/macrophages and neutrophils), where they can survey the tissues 
and secretions of the body for infectious agents. 
Functionally, the mononuclear phagocytes have two important tasks, phagocytosis 
and antigen presentation, each carried out by distinctly different forms of the same cell 
[Paul, 1984; Roitt, et al. ,  1985]. Phagocytic macrophages are dispersed throughout the 
body and play a key role in the engulfment and destruction of particulate antigens. 
Destruction takes place within the cell when phagosomes containing the microorganism are 
fused with degradative enzyme containing lysosomes. APC are found primarily in the 
skin, lymph nodes, spleen and thymus and include, in addition to the mononuclear 
phagocytes [Mosier, 1967], the Langerhans cells [Stingl, et al . ,  1978], dendritic cells 
[ Inaba, et al. ,  1983] and B cells [Chestnut, et aI . ,  1982]. APCs are especially rich in Class 
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II MHC antigens, and following incorporation by phagocytosis and/or pinocytosis (i.e., 
macrophages) or receptor-mediated endocytosis (i.e., B cells), process and present soluble 
antigens to antigen-responsive lymphocytes. 
Polymorphonuclear granulocytes act non-specifically, and together with other soluble 
factors play an important role in acute inflammation and protection against microoganisms 
[Paul, 1 984; Roitt, et aI . ,  1985]. Their predominant function, l ike the macrophage, i s  
phagocytosis, where ingested microbes contained within the phagosomes are fused with 
granules that contain degradative enzymes. Eosinophils, basophils and mast cells make up 
a group of specialized granulocytes which play a more specific role during helminth 
infections and more selective forms of infammation. Another myeloid lineage cell, the 
megakaryocyte, does not leave the bone marrow upon maturation, but rather functions to 
produce and release platelets into the circulatory system of the host. Platelets are important 
in blood clotting and inflammatory responses. They not only release factors that can 
increase the permeability of the vascular system, thus allowing for entry of immune cells 
into infected areas, but release other factors such as PDGF, EGF and TGF which can 
locally modulate immune responses mediated by other immune cells in the area. 
Lymphocytes are comprised of subsets of cells that are morphologically very similar 
but functionally very distinct. They can be distinguished from one another by cell surface 
proteins or surface markers, many of which are important in their responses to infectious 
agents. For example, T cells and B cells can be distinguished via their antigen receptor 
complexes, T cells possessing the CD3 signalling complex of the T cell receptor (TCR) 
and B cells the surface immunoglobulin (sIg) receptor. Whereas B cells primarily function 
to produce specific antibodies during HI responses, T cells are additionally separated into 4 
functionally distinct subsets - helper cells (Th), cytotoxic cells (Tc), suppressor cells (Ts) 
and delayed type hypersensitivity helper cells (T dth). Th cells, of which there are two 
subtypes based on their spectrum of lymphokine release (i.e., Th l and Th2) [Mosmann, et 
aI. , 198 6] , are distinguished by the mouse cell surface marker L3T4 (or CD4 in the 
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human) and function in providing help to B cells during HI responses and to other effector 
T cells during CMI responses. Thl cells predominantly secrete IL-2 and G-IFN whereas 
Th2 cells have been shown to secrete IL-4, IL-5 and IL-6 [Mosmann and Coffman, 1987]. 
T dth cells are a specific type of helper cell that resides in the skin and aids in immune 
responses during dermal attack by pathogens. Ts cells, are distinguished in the mouse by 
possessing the Lyt-2 surface marker (or CD8 in the human) and play an active role in 
controlling the immune response once the antigen has been successfully destroyed or in 
immune tolerance to the hosts own tissues. Tc (or CTL) also possess the Lyt-2 or CD8 
marker but function primarily in the attack against intracellular parasites (i .e., viruses) and 
against transformed tumor cells. NK cells, which possess characteristics of both T and B 
lymphocytes, fulfill a similar function to the CTL, but act in a more non-selective, as 
opposed to specific, manner. 
4 .  The T-Dependent Humoral Immune Response: 
The work of Mishell and Dutton (1967) [Mishell and Dutton, 1967] was key in 
establishing the cells and events necessary to produce specific antibodies to an antigen. 
This was accomplished by the development of an in vitro culture system which models the 
events during a HI response. In this system, mouse splenocytes were cultured in the 
presence of a red blood cell (RBC) antigen (i.e., a particulate T-dependent antigen). Under 
controlled atmospheric conditions, these cells gave rise to specific antibodies to the antigen 
that could be detected by a plaque formation technique developed by Jerne and Nordin 
(1963) [Jerne and Nordin, 1963]. Using this technique, Mosier and co-workers (1967) 
[Mosier, 1967] later separated spleen cel ls  into 2 main populations, adherent 
(monocyte/macrophages) and non-adherent (lymphocytes), and determined that both 
populations were required for maximal antibody formation in vitro. Therefore, the T­
dependent antibody response, so named for its dependence on thymus-derived or T cells as 
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ear lier determined by Claman, et al. ( 1966) [Claman, et al., 1966], requires the cooperative 
interaction of 3 major immune ce ll types - i.e., the B ce ll , the T cell and the macrophage 
(or APC). Additionally, Melchers and Andersson ( 1986) [Melchers and Andersson, 1986] 
further deter mined that the interaction of these cells in production of specific antibodies to 
an antigen can be divided into 3 distinct phases. As reviewed elsewhere [Vitetta, et al., 
1989], the first phase is the specific recognition and endocytosis of the antigen by the 
APC, processing of the antigen and presentation of the antigen on the cel l surface for 
recognition by antigen-speci fic T h  ce lls. Si mu ltaneous ly to these events, APC secrete 
so lub le factors, such as IL-l [ Vitetta, et aI., 1989], that aid in the initiation of T cell 
activation and growth [Duru m, et aI., 1985]. In the second phase, B cel ls become 
activated and, in co mbination with solub le factors secreted by the he lper T cel l (i.e., IL-4 
or BSF- l), wou ld move into the ce ll cycle [Mos mann and Coff man, 1987]. The third 
phase is the specific regu lation of B cel l growth and differentiation by T cell factors (i.e., 
IL-2, G- IFN, IL-4, IL-5 and IL-6) which control both proliferation and differentiation of 
the B cell into an antibody secreting cel l [Mosmann and Coffman, 1987]; the Th2 cell clone 
being the most important T h  cell involved in the promotion of growth and differentiation of 
T-dependent antigen-stimulated B cells .  
5 .  T -Independent Antigens: 
As opposed to T-dependent antigens (i.e., S RBC, soluble proteins and hapten-carrier 
co mplexes) which require T ce ll help, T-independent antigens can cause the direct 
activation of B ce lls without the apparent need for T cells. Most T-independent antigens 
are high molecular weight polymers with repeating subunits that enable the m to cross-link 
cell surface receptors on the B cell. T-independent antigens have been classified according 
to two types - Type I ( TI- l) and Type I I  ( TI-2). This classification is based on the ability 
of a T I  antigen to activate B ce lls fro m the CBA/N mouse strain which has the xid gene 
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mutation [Mosier and Subbarao, 1982] and lacks the Lyb 5 subset of mature B cells. TI-1 
antigens, such as TNP-LPS and TNP-B. abortus, can effectively stimulate CBA/N B cells 
[Mond, et al. ,  1978] whereas TI-2 antigens, such as TNP-Ficoll and TNP-dextran, can 
not. Moreover, TI- 1 antigens such as LPS have the ability to polyclonally activate B cells 
to differentiate into antibody forming cells with a wide spectrum of specificities whereas 
TI-2 antigens generally do not. TI antigens have also demonstrated differences in 
accessory cell help, where both can be modulated by the presence of either macrophages or 
T cells. TI-2-stimulated B cells have been shown to require either macrophage-like 
adherent accessory cell help or T cell factors to produce an optimal response whereas TI- 1  
antigens seem to be less dependent on these accessory cells [Mond, et al., 1980; Mond, et 
al., 1983]. 
6 . B Cell Activation and Lymphocyte Signalling: 
The activation of resting B cells results in clonal expansion and subsequent 
differentiation into antibody producing cells. This process is regulated in a complicated 
manner by exogenous molecules such as antigens and bacterial cell wall products, as well 
as by cytokines that are produced by the T lymphocyte and macrophage APC [Kishimoto, 
1985; Melchers and Andersson, 1986]. In developing an understanding of this process, 
various agents have been used to determine the mechanisms of signal transduction that are 
important in cell-surface-receptor-mediated responses of the B cell (or T cell), and it is this 
collection of signals which transduces information from the external environment to the cell 
interior and ultimately produces the functional response. 
As described in later sections of the dissertation, the TI antigen LPS can be used as 
an excellent tool in the study of B cell activation. This is in light of the direct activating 
potential of LPS on B cells in the absence of either T cells, macrophage accessory cells or 
their respective secretory factors. However, although a great deal is known about the 
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cellular effects of LPS on B cells, the molecular mechanisms associated with activation of 
B cells by LPS is still unresolved. In as much, LPS has been shown to activate a class of 
membrane signalling components known as G proteins [DeFranco, et aI., 1987]. As 
activation of these components is associated with a number of receptors for hormones and 
neurotransmitters, it is therefore likely that LPS also utilizes a specific cell surface receptor 
[Dziarski, 1989]. Furthermore, signal transduction mediated by LPS has been shown to 
be somewhat different with respect to signals mediated through the sIg receptor, 
demonstrating a distinction between these two types of cell surface "antigen" receptors in 
the activation of the B cell. As opposed to the sIg signalling cascade, LPS has been shown 
to cause the translocation of protein kinase-C (PK-C) [Chen, et aI., 1986] , without the 
activation of PL-C or the release of IF3 [Wrightman and Raetz, 1984; Bijsterbosch, et aI. , 
1985]. Consistent with these findings, LPS has been further shown to induce the influx of 
extracellular calcium through membrane calcium channels [Freedman, 1979; Arnigorena, et 
aI., 1990a]. This latter effect has been further correlated with the proliferative capacity of 
B cells activated by LPS and may be the key second messenger signal in the activation 
process induced by LPS. Other signals that have been identified as early events following 
LPS stimulation include membrane depolarization [Kiefer, et al., 1980], the activation of a 
voltage-dependent K+ channel [Freedman, 1979; Arnigorena, et aI., 1990a; Amigorena, et 
al., 1990b], the activation of a Na+JH+ exchange operation at the membrane [Gaidano, et 
aI., 1989] and a decrease in intracellular cAMP [Cambier and Ransom, 1987; Defranco, 
1987]. 
As opposed to the more "traditional" T-independent antigens as described above, a 
second class of T-independent antigens have been selectively used to study the cellular 
events which occur during T-dependent antigen stimulation of the B cell. These agents are 
the sIg-cross-linking agents and include anti-IgM and anti-IgD antibodies and 
Staphylococcus aureus Cowan strain I (SAC). At low concentrations, anti-Ig (::;; 5 llg/m1) 
has been found to transmit signals to the B cell which mimic the activation by antigen 
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[Cambier and Ransom, 1987; Imboden, 1988]. This signal induces the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) by PL-C [Coggeshall and Cambier, 1984], 
which subsequently results in the release of both diacylglycerol (DAG) and inositol 1 ,4,5-
trisphosphate (IP3). DAG, in combination with Ca++ and phospholipids, is able to 
activate PK-C [Nishizuka, 1984], whereas IP3 is responsible for the release of Ca++ from 
intracellular stores (Ca++j). These two second messengers therefore interact to transmit the 
antigen signal from the membrane to the nucleus. However, this signal is inefficient to 
produce DNA synthesis and proliferation of these cells. Entry of these cells into active cell 
cycle requires an additional signal which has been shown to be provided by IL-4 (BSF- l)  
[Kishimoto, 1985]. Additionally, these independent signals can be mimicked in the B 
cell by the addition of a phorbol ester, such as PMA (i.e. , direct PK-C activator), and a 
calcium ionophore, such as ionomycin [Cambier and Ransom, 1987]. This combination, 
much like antigen and IL-4, can induce proliferation but not immunoglobulin secretion. 
Additional factors, secreted by the T cell, are required for differentiation of these cells into 
antibody producing cells [Mosmann and Coffman, 1987]. 
Conversely to the cellular events that occur following cross-linking of sIg on the B 
cell by low concentrations of anti-Ig, a secondary effect has been identified when B cells 
are exposed to higher concentrations of anti-Ig (:?: 25 Ilglml) or SAC. SAC has been 
described as a T cell-independent polyclonal B cell activator, in that it can bind to (by way 
of protein A immunoglobulin binding molecules on the bacterial cell surface) and cause the 
direct activation and proliferation of resting B cells [Kehrl, et al., 1984] ; the bacterial cell 
wall acting as a support or catalyst in transmitting a much greater intracellular signal to the 
B cell than is achieved by low concentrations of anti-Ig. However, although proliferation 
is induced, the signal is still inefficient in causing the differentiation of these cells in the 
absence of T cell-derived growth and differentiation factors. In this respect, activation by 
SAC (and high concentrations of anti-Ig) is unique, in that it can stimulate the expression 
of the high-affinity IL-2 receptor on the surface of resting B cells [Tanaka, et aI., 1988], 
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and it is IL-2, as opposed to IL-4, which is the primary B cell growth factor for B cells 
activated in this manner. More importantly, proliferation of SAC activated B cells is 
modulated by serum-derived growth factors, which can increase or decrease the ability of 
these cells to proliferate and/or differentiate [Choi and Xia, 1987]. In fact, it has been 
speculated that it is the activation of B cells in an IL-2 dependent manner, as compared to 
IL-4, which may render these cells susceptible to modulation by the serum-derived factors. 
Moreover, G-IFN and TNF-alpha, as opposed. to IL-4, IL-5, and IL-6, have been shown 
to be important modulators of SAC-induced proliferation and differentiation of B cells; 
where both have been shown to augment the effects of IL-2 [Karray, et al. ,  1987; Kehrl, et 
aI., 1987]. It is therefore apparent that B cells can be activated and modulated by several 
different pathways, and thus demonstrates another level of diversity in the immune 
response which occurs at the molecular level of the B lymphocyte. 
Analogous to the events occurring in the T-dependent antigen-stimulated B cell, 
antigen-specific T cells recognize antigen (in conjunction with class II MHC molecules on 
the APC) through specific binding to the T cell receptor (TCR). The TCR is a 
heterodimeric glycoprotein made up of an a and B chain held together by disulfide bonds. 
Signals are transduced by this receptor through associated proteins known as the CD3 
complex [Clevers, et aI. , 1988]. Much like the cross-linking of sIg on the B cell, 
triggering of this receptor in vitro (i.e., cross-linking antibodies to the TCR complex) leads 
to the activation of PL-C and hydrolysis of PIP2 to IP3 and DAG. IP3 and DAG in turn, 
cause the release of Ca++j and the activation of PK-C, respectively [Imboden, et al. ,  1987; 
Weiss and Imboden, 1987]. These events subsequently lead to the specific activation of 
the T cell and the expression of cell surface receptors and lymphokine secretion which are 
important in autocrine growth and in co-activation of the B cell [Isakov, et al. ,  1986]. 
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B .  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and Immunotoxicology: 
As opposed to the r eview of the immuno logy literatur e, this s ection of the literature 
r eview wi ll give a broad overvi ew o f  th e effects o f  TCDD on both cell-mediat ed and 
humoral immunity. This is to give the reader a fu ll understanding of the effects o f  TCDD 
on both T cell and B cell functional responses and on the cooperativity that oc curs between 
th es e  two cells during th e process o f  an immune r esponse. Additionally, it is design ed to 
demonstrat e the pot ential for syn ergism b etween the effects on th ese  two populations of  
cel ls in  suppr ession o f  T-d ependent antibody r espons es, as  w ell as  oth er immune 
r esponses mediated by the various lymphocyte effector cells which are r esponsibl e for host 
r esistance to in fection. 
1 . General Mechanism of TCDD Action : 
Whi le the overall focus of this section of th e r eview is on the immunotoxi cologi cal 
effects o f  TCDD and r elated compounds, it is important to emphasize that exposure to 
th ese  ch emi cals produ ces a wide spectrum o f  toxic responses (for a comprehensive r eview 
s ee Po land and Knutson, 198 2 ( [ Poland and Knutson, 198 2]) .  B esid es 
immunosuppr ession, thes e  r espons es includ e a g en eraliz ed wasting syndrome, 
pan cytopenia, hepatom egaly and hepatotoxicity, chloracne and hyperkeratosis, gastric 
l esions, urinary tra ct hyp erp lasia, ed ema, tumor promotion, t eratog enicity and 
embryotoxicity, decr eased spermatogenesis and lymphoid invo lution ( esp ecially of the 
thymus). The spectrum of toxicity observed following TCDD exposure is characterized by 
wide variations in pot en cy among di fferent sp eci es o f  laboratory animals. For exampl e, 
the LD50 varies approximat ely 5000-fo ld between the most s ensitive species, guinea pigs 
(0.6 - 2 Ilg/kg), and the l east sensitive sp eci es, hamsters (5 mg/kg). Moreov er, th e 
speci fi c  features o f  the spectrum of toxi city can vary markedly b etween sp ecies. On th e 
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other hand, certain toxic effects, including the generalized wasting syndrome, thymic 
involution, immunosuppression and hepatomegaly, have been observed as correlates to 
exposure in almost all species tested. 
As described below, it was the ability of this chemical to cause lymphoid 
involution, which prompted the original interest in determining the effects of TCDD on 
immune function. However, it was the effects on the liver, most notably the induction of 
drug metabolizing enzymes, especially the P4501a isozyme, while not a toxic response in 
itself, which led to the most accepted and best supported model for the mechanism of 
action associated with exposure to HAH [Safe, 1986; Goldstein and Safe, 1989]. This 
model is centered around the binding of TCDD to a cytosolic receptor and has many 
similarities to the classical steroid receptor model. Early work demonstrated that the 
expression of this receptor is controlled by the Ah-gene locus and that various mouse 
strains differ in their expression of the receptor (i.e., there are highly responsive mouse 
strains, such as C57BL/6 mice, and less responsive mouse strains, such as DBA/2 mice). 
TCDD is thought to bind to this Ah-gene locus encoded cytosolic receptor (Ah-R), and the 
bound ligand-receptor complex then translocates to the nucleus where it binds to specific 
"dioxin regulatory elements" (DRE). It is this latter interaction which is thought to 
precipitate a pleiotrophic gene response which culminates in a measurable increase in 
mRNA specific for the various enzymes whose levels are controlled at the gene level by the 
Ah-gene locus [Whitlock, 1987; Nebert, 1989; Whitlock, 1990]. Differences in potency 
among different HAH congeners are explained by structure-activity-relationships (SAR) 
and differences in affinity for the Ah-R, where a strong correlation has been shown 
between receptor binding affinity and enzyme induction for all HAH families [Goldstein 
and Safe, 1989]. The SAR established for the PCDD indicates that maximal activity 
occurs when only the 4 lateral ring positions of the dibenzo-p-dioxin molecule are 
halogenated. This point is demonstrated in Figure 1, where the most active congener of 
the PCDD, TCDD, has 4 chlorines which are substituted at the 2, 3, 7, and 8 positions of 
2 0  
the parent ring structure. Active congeners must also have at least 3 of the 4 lateral 
positions occupied, with at least 1 position adjacent to the lateral positions remaining 
unsubstituted. Deviations from this structure are associated with decreased activity. 
Investigations with other families of HAH, especially PCB and PCDF, have demonstrated 
a parallel SAR for the same measured endpoints, although with decreased activity relative 
to the analogous PCDD congeners. In the case of PCB and PBB, the active congeners 
must be able to achieve the planar conformation which exists for PCDD and PCDF 
[Sillcworth and Grabstein, 1982]. Therefore, the model centered around a role by the Ah­
R is well established for enzyme induction, and either a parallel SAR or a correlation with 
A h-R functionality in responsive and non-responsive strains, or both, have been 
demonstrated. 
CI CI  
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Figure 1.  Chemical Structure of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD). 
While differences in potency and the spectrum of toxic effects between species have 
been putatively explained by differences in gene activation and the presence, distribution 
and functional capacity of the cytosolic Ah-R, the association between the Ah-R and 
toxicity is not conclusive. Most importantly, a causal relationship between specific genes 
activated by Ah-R binding and the manifestation of toxic symptoms following TCDD 
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exposure has not been directly established. The most extensively used approaches to 
determining a role for the A h -R in the profile of toxicity of TCDD, including 
immunotoxicity, have been somewhat indirect. These approaches have capitalized on 
either the defmite S AR associated with HAH binding to the Ah-R, or on the genetics 
associated with the expression of the Ah-R. The possible mechanisms of action of TCDD 
on immunocompetence have been recently reviewed [Holsapple, et aI . ,  1 99 1 a] .  In 
particular, this review discusses a number of reports in which the same kinds of indirect 
approaches have been used as described above, and present conflicting data that are not 
readily explained by Ah-R-based mechanisms. Therefore, while the ultimate mechanism 
has not yet been elucidated, this earlier review extensively discusses the possibility that 
both A h-R-dependent and A h-R-independent processes may be involved. Because 
possible mechanism(s) have been extensively discussed elsewhere, the focus of this 
review will be to present an update on the profile of immunological effects by TCDD and 
related compounds. 
2 . A p p roaches to TCDD-Induced Immunotoxicity: 
As discussed above, an immune response is mediated by the specific cooperative 
interaction of immunocompetent cells and the non-specific soluble factors produced by 
these cells. The effector systems are interrelated, complementary, and possess 
considerable redundancy. An infected host is able to marshall one or more of a number of 
defenses against a particular parasite or pathogen. The redundancy of effect and the fact 
that there are overlapping effector processes have contributed to the complexity associated 
with the evaluation of xenobiotic-induced changes in immunocompetence. As described 
by Luster, et al. ( 1988) [Luster, et al. ,  1988a] ,  there are well characterized assays which 
can be applied to assess the responsiveness and functionality of immunocompetent cells, 
the effective cooperative interactions of these cells to produce CMI or HI, and the general 
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immunocompetence of the host when challenged by infectious agents or pathogens (i.e., 
host resistance capabilities). One of the most important conclusions reached in this paper 
is that when the immunological protocols are standardized, there can be excellent 
agreement between several laboratories regarding the effects of specific chemicals. In 
actuality, this type of standardization in immunotoxicology is rare. A given immune 
parameter can be elicited with several different antigens and/or protocols. More 
importantly, the precise experimental conditions regarding the length of chemical exposure 
and the frequency of chemical administration (i.e., daily or weekly), can vary markedly 
from one study to the next. A second factor which contributes to the problems in 
comparing results from several labs is that the immune response is not an event which can 
be approached with a discrete time point. Rather, it is an orchestrated series of distinct 
events which may have differential sensitivity to a given xenobiotic. Therefore, results 
from studies in which the xenobiotic is administered before antigen may be different from 
studies in which the xenobiotic and antigen are administered simultaneously, which in turn 
may be different from studies in which the xenobiotic is administered after the antigen. 
The consequence is that sometimes it is difficult to compare the results of two or more 
studies. This difficulty is particularly apparent regarding the immunological actions of 
TCDD, especially as it relates to attempts to compare the sensitivity of the various animal 
species in which it has been evaluated. As discussed briefly above and more extensively in 
several reviews [Poland and Knutson, 1982; Safe, 1 986; Goldstein and Safe, 1 989; 
Nebert, 1 989], the acute toxicity (i.e., LDSO values) and liver enzyme induction (i.e., also 
generally measured by a standardized protocol after acute exposure) have been compared in 
several species by a number of laboratories. These results indicate a distinct species­
specificity regarding sensitivity to these effects of acute exposure to TCDD and related 
compounds, with guinea pigs especially sensitive and hamsters much more resistant. Such 
comparisons of the immunotoxicity by TCDD are difficult, partially because individual 
laboratories have used a variety of immunological protocols, and no single laboratory has 
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made comparisons between several species using a single standardized immunological 
parameter. In one report where the effects of TCDD on the immunocompetence of multiple 
species were determined, Vos, et al. ( 1 973) did not measure a comparable immune 
parameter in each of the three species studied [Vos, et al., 1973]. Their results did indicate 
a suppression of a tuberculin DHR in Hartley guinea pigs (i.e., at doses as low as 0.04 
Ilglkglweek for 8 weeks) but not in randomly bred CD rats (i .e. ,  at doses up to 5 
Ilg/kglweek for 6 weeks). A DHR was not measured in C57BU6 mice in this study, but 
they did show that a graft-vs-host reaction was decreased (i.e., at doses as low as 1 .0 
Ilglkglweek for 4 weeks). Humoral immunity was only assessed in the guinea pigs as 
both a primary and a secondary antibody titer in response to tetanus toxin. Exposure to 
low doses (0.008-0.04 Ilglkglweek for 5 weeks) significantly enhanced the primary 
antibody response; but slightly reduced the secondary antibody response (i.e., 7 week 
exposure). Exposure to the high dose (0.2 Ilglkglweek) had no effect on the primary 
response (i.e., 5 week exposure) and significantly reduced the secondary response (i.e., 7 
week exposure). Surprisingly, this early study by Vos and co-workers represents the only 
report of the immunological effects by TCDD in guinea pigs, historically, the most 
sensitive species, and there are no studies on the effects of TCDO on immune function in 
hamsters, historically, the most resistant species. As discussed at several places in this 
review, the most effective comparisons in animal sensitivity to the immunological effects 
of TCDO have been made within one species, between highly responsive and low 
responsive mouse strains. 
Overview: Immunotoxicity in animal models. Immunotoxicity testing with 
TCDO was initially undertaken to extend the findings of general toxicity studies. These 
earlier investigations were important in demonstrating that exposure of animals to TCDD 
produced a prominant lymphoid involution, especially of the thymus. Since the thymus 
represents the central organ for maturation of T lymphocytes, initial immunotoxicity 
studies concentrated on T cell-mediated immunity. Among the different species tested, 
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suppression of CMl was shown to be dependent upon the age at which the animal was 
exposed. Exposures in younger animals produced a more extensive and longer lasting 
suppression, where in utero exposures during organogenesis were required to induce 
maximal effects in some species. Consistent with these fmdings, it has been reported that 
TCDD induces the terminal differentiation of thymic epithelial cells, thus indirectly 
preventing the maturation of thymocytes to mature T cells because of the absence of the 
proper microenvironment within the thymus [Greenlee, et aI . ,  1 984b; Greenlee, et aI., 
1 985]. Because of the prominant effect by TCDD on the thymus, it was assumed that CMI 
would be much more sensitive than HI, and that immune responses which are mediated by 
antibody would be largely unaffected in perinatally exposed animals. In actuality, antibody 
responses were not consistently measured in these early studies which were centered 
around perinatal or in utero exposure. In one study where both CMI and HI were 
measured in 5-week old offspring from mice fed chow containing TCDD, Thomas and 
Hinsdill showed that the anti-SRBC PFC response (HI) was significantly reduced at both 
2 .5  ppb and 5 .0 ppb, while the contact hypersensitivity response (CMI) to 
dinitrofluorobenzene was only significantly reduced at 5.0 ppb. Moreover, as discussed 
below in the section on lymphocyte development and homing, effects on both B- and T 
cells have been described. Therefore, it is not surprising that both HI and CMI are targeted 
when exposure occurs in younger animals. In contrast with these studies, several 
laboratories have shown that exposure in adult animals produces a profound suppression 
of antibody responses under conditions where T cell-mediated immunity appears to be less 
affected. As described below, TCDD-induced suppression of humoral immune responses 
appears, at least in part, to be a direct effect on the B lymphocyte. Although the functional 
deficit has not been identified, studies suggest that the differentiative processes of these 
cells are altered. Thus, current data suggests that TCDD either indirectly (i.e., in the case 
of T cells) or directly (i.e., in the case of B cells) affects the maturational or differentiative 
processes of immunocompetent cells, and that such cells are sensitive to the effects of this 
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xenobiotic during periods of activity associated with these events. This observation is 
consistent with findings in other cell systems in which the basis for the actions of TCDD 
were reported to be the consequence of altered differentiation or growth [Greenlee, et al . ,  
1 984b; Greenlee, et al. ,  1 985]. 
Overview: Immunotoxicity in humans. To what extent significant human 
health effects are associated with environmental levels of exposure to TCDD is 
controversial. The only adverse human health effects which have been conclusively 
associated with dioxin exposure are chloracne and hyperkeratosis, which are oftentimes 
accepted as hallmarks for human exposure to TCDD and related HAH. Various cancers, 
embryotoxic and teratogenic effects, and immune dysfunction are alleged to result from 
both environmental and occupational exposure. As noted, these toxic effects have been 
demonstrated in various animal species following exposure to TCDD. In the animal 
species studied, atrophy of lymphoid tissue, especially the thymus, and suppressed 
immune function are among the earliest and most sensitive indicators of HAH toxicity, and 
significant suppression of both T cell- and B cell-mediated immune function occurs with 
doses which do not produce overt signs of toxicity. It is reasonable, therefore, to assume 
that the chronic, low level human exposures associated with HAH contamination, might 
adversely affect immune function . Studies in exposed human populations and in non­
human primates have shown that HAH do produce measurable alterations in immune 
parameters associated with both innate and acquired immunity. Significant deficits in 
immunocompetence, however, have not been conclusively associated with these changes 
and the interpretation of these data is difficult. For further review of the effects of TCDD 
on human and non-human primate immunity, please refer to the recent reviews by 
Holsapple, et al. ( 1990) [Holsapple, et al., 1 99 1 a; Holsapple, et al . ,  1 99 1 c] .  
3 .  Immunotoxicity Studies of 2,3,7,8·TCDD in Animal Models: 
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Immune dysfunction is an early and sensitive indicator of exposure to TCDD and is 
manifested to some extent in every species in which it has been measured. Figure 2 
illustrates that the effects of a xenobiotic on immunocompetence can be approached in 
animal studies by three separate but related protocols which differ in regards to chemical 
exposure and antigen sensitization. Approach #1 is the most "real world" approach 
because both the chemical and the antigen are given to the animal. This is the approach 
most often employed in irnmunotoxicological studies. However, as described above, there 
are several ways in which these two components of a protocol can be integrated. The 
ultimate effects associated with Approach #1  are due to a combination of direct actions on 
immunocompetent cells and any of a number of indirect effects - for example, a change in 
an endocrine system of an animal which results in a change in the immune status. 
Approach #3 is an important mechanistic approach in which both the chemical and the 
antigen are added to cultured cells derived from naive (i.e. ,  previously unexposed and 
unimmunized) animals. This approach is the most definitive way to assess the direct 
effects of a chemical on immunocompetent cells in the absence of other systems which can 
affect immune status in the whole animal. Approach #2 is another important mechanistic 
approach in which antigen is added to cultured cells derived from animals previously 
exposed to the chemical. Thi s approach is an i ntegral component of 
separation/reconstitution studies which are employed to identify the primary cellular targets 
affected by a given xenobiotic. The ultimate effects associated with Approach #2 would 
indicate that exposure to a chemical can precede exposure to the antigen in order to produce 
the defect. The results summarized in this review indicate that all three approaches have 
been used successfully to study TCDD, which is yet another reason why this xenobiotic is 
unique in immunotoxicology. 
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Figure 2. Mechanistic Approaches to Study Drug/Chemical-Induced Modulation 
of the Immune Response. 
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In this section, the effects of TCDD on various specific or selective immune 
parameters reflecting cell-mediated immunity , humoral immunity, myelotoxicity, 
lymphocyte development and homing, and innate immunity will be described. Effects on 
more holistic indicators of immunocompetence, as measured in host resistance models, 
will also be presented. 
4 .  Effects of 2,3,7,8-TCDD on Cell -Mediated Immunity : 
One of the first indications of immunotoxicity observed in an animal model was 
described by Buu-Hoi and co-workers ( 1 972), in which exposure to TCDD caused a 
dramatic involution of the thymus [Buu-Hoi, et al . ,  1972] . This acute effect by dioxin was 
later confmned by numerous investigators and was shown to occur in all animal species 
tested, including the rat, mouse, guinea pig, hamster, cow, chicken, and monkey [Harris, 
et al., 1972; Gupta, et al., 1 973 ;  Vos, et aI . ,  1 973;  Vos and Moore, 1974a; Vos, et aI., 
1 974b; Kociba, et aI., 1976; Moore and Faith, 1976; Vos, 1 977; Vos, et aI., 1 980; Clark, 
et al . ,  1 98 1 ;  Poland and Knutson, 1 982] . This observation was extended by several 
laboratories to show that TCDD and other HAH could cause the involution of the spleen 
and, to a lesser degree, the lymph nodes of rats, mice, and guinea pigs [Harris, et aI., 
1 972; Gupta, et aI., 1973; Vos, et al., 1 973] .  Lymphoid involution was shown to be even 
more pronounced if the animals were exposed either peri- or postnatally, suggesting that 
TCDD could have a more selective effect on the developing immune system than on that of 
the adult animal [Vos and Moore, 1 974a] . These effects were further shown to occur in 
the absence of any major pathological changes in the liver; although a pronounced wasting 
syndrome was observed. 
In light of the dramatic effects on the thymus and other lymphoid organs, 
numerous investigators began to characterize the functional consequences associated with 
the TCDD-induced atrophy of lymphoid tissue by defining the acute and chronic effects on 
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the two divisions of acquired immunity. The earliest studies focused primarily on cell­
mediated immunity, in which thymus-derived cells (i.e., T cells) play an integral role in 
tumor surveillance and the defense against infecting microorganisms. In addition to the 
severe thymic atrophy and lymphoid involution, mitogenic responses of splenic and thymic 
lymphocytes of young mice and rats to PHA and Con A [Vos and Moore, 1 974a; Faith and 
Luster, 1979; Luster and Faith, 1 979a; Luster, et al., 1979b] , graft vs host reactions [Vos, 
et al . ,  1 973 ;  Vos and Moore, 1 974a] , delayed type hypersensitivity responses (DHR) 
[Moore and Faith, 1976; Faith, et al . ,  1978; Faith and Luster, 1979; Luster and Faith, 
1 979a; Luster, et aI. , 1 979b] , and prolongation of allograft rejection [V os, et aI., 1 973;  
Vos and Moore, 1 974a] have all been described as being decreased following exposure to 
TCDD; although the suppression of mitogenic responses has generally been the least 
consistently observed, and was the smallest in terms of magnitude. These effects have 
been further shown to exclude specific alterations in helper T cell function [Faith, et al . ,  
1 978] , to be especially pronounced in either peri- or postnatally exposed animals (as 
previously noted) [Vos and Moore, 1974a; Faith, et aI., 1 978;  Luster and Faith, 1 979a; 
Luster, et al. ,  1 979b] and to be prevalent for an extended period of time following initial 
exposure [Faith and Moore, 1 977; Faith, et aI., 1978; Luster and Faith, 1 979a; Luster, et 
aI., 1 979b] . More recently, Lundberg, et ai. ( 1 990) [Lundberg, et al . ,  1 990a] described a 
slightly different effect on thymocytes taken from I S-day-old mice (CS7BL/6) which were 
pretreated with TCDD (50 �g/kg; i.p.) 4 days prior to sacrifice. When placed in culture, 
these cells demonstrated a heightened response to Con A stimulation which was 
characterized by an earlier onset of response and a higher maximal cell proliferation. 
Levels of IL-2 were coordinately reduced on day 2 of culture but were postulated to be due 
to an increased cellular IL-2 consumption. An increase in cells of the CD8+ subpopulation 
was also observed on days 2, 3 and 4 of these cultures. 
A structure-activity-relationship was revealed for the effects on the thymus in a 
comparison study between 9 week old CS7Bl/6 male mice and 3 to 4 week old Hartley 
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male guinea pigs. In looking at the acute effects of a single oral dose of a series of PCDD, 
it was determined that the most potent congener was TCDD, causing an extensive atrophy 
of the thymus in both species [McConnell, et aI., 1 978 ;  Vos, et al., 1980; Poland and 
Knutson, 1 982] . It is interesting to note however, that whereas the CS7Bl/6 mice showed 
a higher LDSO value for TCDD than the guinea pig, they displayed a greater sensitivity to 
the thymic involution, indicating the potential for this compound to produce a complex 
proflle of toxicity. In this same report [McConnell, et al. ,  1978] , it was determined that 
the thymic involution was the direct result of the loss of thymocytes from the cortical 
region of the thymus, thus confmning the earlier flndings of Vos and Moore ( 1 974) and 
that of Kociba and co-workers ( 1 976), in which both peri- or postnatal exposure of rats 
and mice produced an effect on the thymus which resulted in an almost complete loss of 
the cortical-derived thymocytes [Vos and Moore, 1 974a; Kociba, et aI . ,  1 976].  In 
addition, it was further recognized that these effects were not directly correlated with 
changes in peripheral lymphocyte and monocyte counts [Vos and Moore, 1 974a] ; although 
an earlier study by Zinkl, et al. ( 1973) [Zinkl, et al., 1973] had demonstrated that exposure 
to TCDD could result in a reduction in the numbers of peripheral lymphocytes in both 
guinea pigs and mice. No apparent effect was seen in the rat. 
Extending these and other observations, it was later determined that the mechanism 
for the effect of TCDD on the cortical thymocytes was not due to a decrease in food intake 
[van-Logten, et aI., 1 980] , to lymphocyte destruction [Vos, 1 977] ,  to stress-induced 
release of glucocorticoids [van-Logten, et al . ,  1980] , to a reduction in growth hormone 
levels [van-Logten, et al ., 1980], to an increase in serum alpha-fetoprotein levels [Vos, 
1 977],  to decreased thymosin activity [V os, 1 977] ,  to a reduction in serum zinc levels 
[Vos, et al. ,  1 978] ,  or to an increase in the release of pituitary hormones (as evidenced by 
studies in hypophysectomized animals which had in fact increased the involution produced 
by TCDD exposure) [van-Logten, et al . ,  1 980]. In addition, Greenlee and co-workers 
have since demonstrated that the thymic atrophy is due primarily to a direct action on the 
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thymic epithelium [Greenlee, et aI., 1 985] . These investigators have reported that 
exposure to TCDD can cause a "push" in the thymic epithelial cell population toward 
terminal differentiation so that the necessary factors which are critical for lymphocyte 
maturation can no longer be produced by these cells. This finding is also consistent with a 
recent report by Kerkvliet and Brauner ( 1 990) in which acute exposures to an 
immunosuppressive dose of TCDD (i.e., 0.74 1lg!kg) in C57BL/6 mice caused significant 
reductions in both the percentage and absolute number of the most immature CD4+CD8+ 
double-positive cell population of the thymus [Kerkvliet and Brauner, 1 990d] .  The 
absolute numbers of CD4-CD8-, CD4+CD8- and CD4-CD8+ cells were not significantly 
altered. 
Perhaps the most frequently studied alteration in CMI induced by TCDD exposure, 
and possibly the most sensitive, is the specific reduction in the generation of cytolytic T 
lymphocytes (CTLs). Clark and co-workers have reported that TCDD at doses ranging 
from 0.004 to 40 Ilg!kg could significantly affect the generation of CTLs in C57Bl/6 mice, 
in the abscence of any significant alteration in cellularity of the spleen or lymph nodes or a 
suppression of the DHR (�4 Ilglkg) [Clark, et aI. ,  1 98 1 ;  Clark, et aI. ,  1 984] . The 
antibody responses to SRBC and TNP-Brucella abortus (TNP-BA) were also reduced in a 
dose-related manner on days 3 (TNP-BA; 0.4 and 40 Ilg!kg) and 4 (SRBC; 0.4-40 Ilg!kg) 
after sensitization of the exposed animals. However, the lowest doses tested in these 
antibody responses (i.e., 0.4 and 4 Ilg!kg) did not appear to produce a consistent, or time­
dependent, suppression of the antibody response to either antigen whereas the CTL 
response was shown to be consistently affected at doses as low as 0.04 Ilg!kg. It was 
therefore concluded that the CTL response is more sensitive to the effects of TCDD than 
the antibody response; although doses of TCDD below 0.4 Ilg!kg were not shown to have 
been tested for effects on the antibody response in either of these reports. It was further 
shown by limiting dilution analysis that TCDD did not deplete the number of CTL 
precursors but induced a population of suppressor cells which prevented the generation of 
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functional CfLs in...Yit;rQ. T-helper cell function, as assessed by the ability to secrete IL-2, 
appeared nonnal [Clark, et al. ,  1983].  
Several laboratories have further studied the role of the Ah-gene locus, and its 
associated receptor, in the suppression of the CTL response by TCDD. Using different 
strains of mice (C57B1/6 and DBA(2) and bone marrow chimeras, Clark, et al. ( 1983) have 
demonstrated that the effects of TCDD and related PCDD on CTL generation segregates 
with the A h-gene locus and the sensitivity to induction of ethoxyresorufin-o-deethylase 
(EROD) activity [Clark, et aI., 1983; Nagarkatti, et aI . ,  1984] . Additionally, it was found 
that 3,3',4,4'-TCB and Aroclor 1 254, PCB congeners which have also been found to bind 
to the Ah-R, suppress the CTL response, whereas 2,2',4,4',6,6'-HCB, which has a much 
lower affinity for the Ah-R, did not [Clark, et al., 1983] .  More recently, Kerkvliet, et al. 
[Kerkvliet, et al., 1 990b] presented additional support for the specific role of the Ah-gene 
locus in the direct modulation of the effects of TCDD on the CTL response. They 
demonstrated that the potency of HxCB congeners - specifically, 3,4,5,3' ,4' ,5'-HxCB, 
2,3,4,5,3',4'-HxCB and 2,4,5,2',4',5'-HxCB - and TCDD for suppression of the CTL 
response, as well as their effects on spleen cellularity, thymic atrophy and elevation of 
serum corticosterone levels, was directly correlated with the binding affinities of these 
congeners for the Ah-R. In addition, Ah-nonresponsive (Ahdd) C57BL/6 congenic mice 
were significantly more resistant to alterations induced by either 3,4,5,3 ',4',5'-HxCB or 
TCDD when compared to Ah-responsive (Ahbb) C57BL/6 con genic mice. Another recent 
study has further demonstrated that the TCDD-induced effects on Con A stimulated 
proliferation of splenic lymphocytes were more pronounced in the C57BL/6 mouse than in 
the DBN2 mouse [Pavlyak, et al . ,  1989] . Phenobarbital did not modify the effects of 
TCDD, suggesting that suppression of these responses were mediated via specific binding 
to the Ah-R. 
5 .  Effects of 2,3,7,8·TCDD on Humoral Immunity: 
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The other division of acquired immunity is humoral immunity and is defined as the 
production of specific antibody (Ab) to a specific antigen challenge. Because of the 
dramatic effect seen on the thymus and cell-mediated immunity as previously noted, the 
effects of TCDD on T-dependent humoral immune responses requiring T cell help, were 
first determined. Although some agreement in terms of deficits in cellular function are 
evident, understanding the specific mechanism involved in the suppression of humoral 
responsiveness has met with some discrepancies, especially with regards to effects in the 
whole animal versus effects in vitro, as related to differences in the biological activity of 
specific dioxin congeners and the genotypic differences between various mouse strains. 
The first studies were centered around the effects of pre- or postnatal exposure to 
TCDD on humoral immune responsiveness. Thomas and Hinsdill ( 1 979) found that 
young Swiss-Webster mice from mothers exposed to 1 , 2.5, 5, 10 or 20 ppb TCDD in 
feed (from 4 weeks prior to conception to 3 weeks after birth) had significantly suppressed 
humoral responses [Thomas and Hinsdill, 1979] . Mice from mothers fed 2.5 and 5 ppb 
TCDD had atrophy of the thymus and a significantly reduced splenic plaque forming cell 
(PFC) response to sheep erythrocytes (SRBC). Serum anti-SRBC antibody titers and 
lymphocyte responses to Con A and LPS were not affected at these doses. Similar results 
were obtained in a comparison study between juvenile (4 week old) and adult (7 week old) 
female Swiss-Webster mice [Hinsdill, et aI., 1 980] . Animals exposed to � 10 ppb TCDD 
in the feed had significantly suppressed primary and secondary humoral responses to both 
tetanus toxoid and SRBCs, as well as a decrease in circulating IgG levels and tetanus 
toxoid-induced IgE production in the exposed animal (i.e., at 10 and 1 00  ppb TCDD in 
feed). This effect was further noted to be dose-related and more extensive in the younger 
animals. The suppression of humoral PFC formation was further characterized as an effect 
on the production of all immunoglobulin classes including IgM, IgG, and IgA [Clark, et 
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al., 1 98 1 ] .  More recently, House .. et aI. ( 1 990) demonstrated in B6C3F 1 mice that a 
single exposure to TCDD caused a dose-related suppression (0. 1 - 1 0  Ilg/kg) in the numbers 
of IgM and IgG PFC in response to SRBC [House, et al. ,  1 990] . 
Vecchi and co-workers ( 1983) were the first to describe a differential sensitivity to 
the suppression of humoral antibody production in strains of mice which differ with 
respect to induction of aryl hydrocarbon hydroxylase (AIlli) activity by TCDD [Vecchi, et 
al., 1 983].  Using an acute exposure regimen and Approach #1 as described in Figure 2, 
they reported that the C57BL/6 and C3H/HeN mouse strains were highly susceptible 
strains to both the enzyme induction and immunosuppression, and that the DBA/2 and 
AKR strains were less sensitive, in that greater concentrations of TCDD were required to 
produce only moderate effects in these animals. Longer exposures (i.e., once per week for 
8 weeks) did not increase the sensitivity of the DBA/2 strain and established a correlate to 
humoral toxicity with the degree of binding of TCDD to the cytosolic A h-R. This 
observation was later extended to show that other inducers of AHH (3-MC and BNF) 
could cause an additive effect on the suppression of both humoral antibody production and 
responsiveness to Con A, but not PHA or LPS, when combined with TCDD [Vecchi, et 
aI., 1 986] . However, subchronic exposure (i.e., once per day for 14 consecutive days) of 
mice to 2,7-DCDD, which has no or weak binding capacity for the Ah-R, caused a 
suppression of in vivo antibody responses, which was comparable to that observed with 
TCDD [Holsapple, et al., 1986b]. More recently, we have compared acute and subchronic 
(i.e., again once per day for 1 4  consecutive days) exposures to identical total doses of 
TCDD in B6C3F 1 mice and DBA/2 mice [Holsapple, et aI., 1 99 1  b] . Following acute 
single exposure to TCDD at doses of 4.2, 14.0 and 42.0 Ilg/kg, we confmned the results 
of earlier studies by demonstrating a greater suppression in the responsive strain. 
However, fol lowing subchronic exposure to doses of 0.3, 1 .0 and 3.0 Ilg/kglday for 14 
consecutive days, there was at least a 10-fold shift in the sensitivity of the DBA/2 mice, 
which resulted in a comparable suppression of the antibody response in responsive and 
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non-responsive mice. Taken together, the available results indicate that the length - i.e., 
acute � subchronic - and conditions - i.e., repeated weekly � repeated daily - of exposure 
can affect the suppression of the antibody response by TCDD, and that repeated weekly 
exposures appears to produce the same profile as that observed after an acute single 
exposure. Moreover, these results may be indicative of a bifunctional effect of these 
compounds on the immune response as related to the length of exposure and the role 
played by the Ah-R. 
Holsapple and co-workers [Holsapple, et al. ,  1 984] were the fIrst to report that IDlY 
dioxin congener could suppress in vitro humoral immunity by demonstrating that direct 
addition of 1 ,2,3,6,7,8-HCDD suppressed several models of the antibody response (i.e., 
Approach #3 as described in Figure 2). S ubsequent studies by Holsapple, et al. ( 1986) 
and Tucker, et al. ( 1 986) suggested that the primary defect elicited by direct exposure to 
TCDD is the selective inhibition of B lymphocyte differentiation into antibody producing 
cells [Tucker, et al. ,  1 986; Holsapple, et al., 1986a] . This conclusion was based primarily 
on the fInding that the humoral response to both SRBCs (T-dependent antigen) and LPS 
(T-independent) were suppressed at doses which caused neither cellularity changes nor 
effects on mitogen-induced proliferation. Time of addition studies have further 
demonstrated that TCDD must be present early in culture (within 24 hours of a T­
dependent response [Tucker, et ai . ,  1 986] and within 3 hours of an LPS response 
[Holsapple, et ai. ,  1986a]) to suppress these PFC responses. 
Studies comparing the direct effects of TCDD on various mouse strains using 
Approach #3 (Figure 2) and a limited number of Ah-R antagonists and dioxin congeners 
over a narrow concentration range, have also suggested that the suppression of the in..yij;rQ 
humoral immune response was correlated with binding to the Ah-R [Tucker, et ai., 1986; 
B lank, et ai., 1987] . However, these results are in contrast with the work of Holsapple, et 
al. ( 1986) [Holsapple, et al . ,  1986a] and more recently, Davis and Safe ( 1990) [Davis and 
Safe, 1990] , which indicated that the direct suppression of the in vitro antibody response 
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did not segregate with the A h-R. Both of these studies demonstrated the lack of 
segregation with the Ah-R by showing that congeners with weak binding affinity were 
suppressive, and by showing that comparable suppression could be obtained in both 
responsive and non-responsive mouse strains. Of particular importance to a consideration 
of the structure-activity relationship are the results from the earlier study which 
demonstrated the suppression by direct addition of 2,7-DCDD [Holsapple, et al., 1 986a] , 
the congener with weak binding affinity which was also shown to be effective in vivo 
when administered daily for 1 4  days [Holsapple, et al. ,  1 986b]. Of particular importance 
to a consideration of the comparison between various mouse strains is a recent report from 
Nemoto, et al. ( 1990) which apparently represented the first comparative study of the P450 
gene expression and AHH inducibility in adult primary hepatocytes from responsive and 
non-responsive mice [Nemoto, et aI., 1 990] . The results indicated that although AHH 
induction was genetically determined, appreciable activity could be induced in hepatocytes 
of non-responsive, as well as responsive mouse strains by treatment with TCDD and 
several polyaromatic hydrocarbons (i.e., including benz(a)anthracene, benzo(a)pyrene and 
3-methylcholanthrene) following transfer of the cells to primary culture. Additional studies 
are required to more fully characterize the nature of the Ah-R in the suppression of the 
antibody response by TCDD and the basis for the non-Ah-R-dependent component. The 
available results suggest that the effects of direct addition of TCDD and related compounds 
to cultured cells may be similar to the profile of activity associated in vivo with repeated 
daily exposures to these chemicals in that both types of studies demonstrated a dissociation 
from an exclusive role by the Ah-R. 
Utilizing Approach #2 (Figure 2), Dooley and Holsapple ( 1 988) and Chastain and 
Pazdernik ( 1985) have provided convincing evidence that the B lymphocyte is the primary 
target for suppression of the T-dependent humoral immune response by demonstrating that 
the suppression of several humoral responses: the polyclonal response to LPS [Dooley 
and Holsapple, 1988] ,  the T-independent response to TNP-LPS [Chastain-Jr. and 
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Pazdemik, 1 985] ,  the T-independent response to DNP-Ficoll [Dooley and Holsapple, 
1988] ,  and the T -dependent response to SRBCs [Dooley and Holsapple, 1988] are 
characterized by comparable dose-response-effect curves that are approximately parallel. 
Dooley and Holsapple subsequently used separation/reconstitution assay techniques (i.e., 
Approach #2; Figure 2) to show that the suppression of antibody responses by TCDO is 
the predominant result of a specific effect on the functional capabilities of the B cell and not 
to effects on the functionality of either the adherent macrophage population or the T cell 
[Dooley and Holsapple, 1 988] .  The absence of cellularity changes following acute 
exposures to TCDD has been recently confIrmed by flow cytometry studies which showed 
that splenic Ig+, Thy 1 .2+ and CD4+ lymphocyte populations remain unaltered in either the 
absence or presence of an antigen challenge to the animal [Kerkvliet and Brauner, 1 990d] . 
The lack of effect by TCOD on macrophage antigen-presenting cells has also been 
confIrmed in a preliminary study by Kerkvliet, et al. ( 1990) [Kerkvliet and Brauner, 
1 990a] . Moreover, Chastain and Pazdemik ( 1985) compared the functional defIcits of 
both bone marrow-derived (immature) or splenic-derived (mature) B cells to fInd that 
TCDD had a selectively greater effect on immature B cells than on the more mature B cells 
of the exposed animal [Chastain-Jr. and Pazdemik, 1985].  This fInding, as in the case 
with immature T cells (i .e . ,  thymocytes), further suggests that susceptibility of 
lymphocytes to the effects of TCDD is related to the early stages of development either 
within the bone marrow or thymus or as a consequence of antigen stimulation. 
The most recent report by Dooley and co-workers [Dooley, et al. ,  1 990] has also 
confIrmed earlier reports that effects of TCDD on the T-dependent humoral immune 
response does not appear to be due to an alteration in helper T cell function [Faith, et al . ,  
1 978;  Clark, et al . ,  1 983] .  These results were derived from experiments in which T­
dependent antibody responses were measured using cultured T cells from TCOD-treated 
mice that were titrated into B cells from vehicle-treated controls, and on experiments which 
demonstrated the absence of an effect on IL-2 release following mitogen stimulation of 
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spleen cell suspensions and isolated T cells derived from TCDD-treated mice. Additional 
support for a lack of effect by in vivo exposure to TCDD on T-helper cell function comes 
from the results by House, et aI. ( 1 990) which demonstrated a comparable dose-related 
suppression of both the T-dependent antibody response to SRBC and the T-independent 
antibody response to D NP-Ficoll [House, et aI., 1 990] . The report by Dooley, et al . 
( 1990) also demonstrated that the effects of TCDD on humoral responsiveness, specifically 
the effects on the B cell, were ll.Q1 mediated by the activation of a suppressor T cell 
[Dooley, et aI., 1 990] . Therefore, these results differ from the earlier report by Clark, et 
aI. ( 1 983)  [Clark, et aI . ,  1 983] in which the suppression of the CTL response was 
attributed to the induction of a T-suppressor cell, and support the interpretation for a 
separation in the mechanisms for the functional suppression of these two cellular targets of 
dioxin toxicity. 
Additional support for an effect on B cells comes from the results of Luster, et aI. 
( 1988) who used an in vitro model of B cell activation to assess the direct effects of TCDD 
on the proliferation and differentiation of isolated B lymphocytes [Luster, et al. ,  1 988b]. 
In this report, TCDD caused the specific suppression of IgM secretion in B cells that were 
activated by anti-Ig and T cell replacing factor (TRF), but had no effect on proliferation; 
further suggesting a selective effect on B cell differentiation. This conclusion was further 
supported by the finding that neither the expression of Ia nor the proliferative marker, 7D4, 
were affected, whereas the expression of the plasma cell specific marker, PC.2, was 
significantly reduced. Collectively, it has been concluded by this and other laboratories, 
that TCDD causes an alteration in the cellular programming, either prior to or during 
antigen stimulation, which results in a specific alteration in the capacity of activated B cells 
to differentiate into antibody producing cells [Tucker, et aI . ,  1986; Holsapple, et al., 
1 986a; Luster, et aI., 1988b]. 
However, while several laboratories have ruled out that T-helper cells are targeted by 
TeDD [Faith, et al. ,  1 978; Clark, et al., 1983; Dooley, et al . ,  1990; House, et aI . ,  1 990] , 
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there are at least two reports that have indicated an effect on T cell regulation of immune 
responses. In the first report, Kerkvliet, et al. ( 1 987) demonstrated that 1 ,2,3,4,6,7,8-
HpCDD can suppress the antibody response to both T-dependent (SRBC) and T­
independent (TNP-LPS and DNP-Ficoll) antigens, but there was a significantly higher 
degree of suppression in the response to SRBC [Kerkvliet and Brauner, 1 987] .  In 
addition, nu/nu mice were shown to be significantly more resistant to the 
immunosuppressive effects of HpCDD to DNP-Ficoll (at doses of $; 100 Ilg/kg) as 
compared with their nu/+ littermates, an observation which further indicates a primary 
immunological defect by this compound on regulatory T cells. In the second report, 
Kerkvliet, et ai. ( 1 990) [Kerkvliet, et al. ,  1 990c] described an apparent biphasic dose­
response curve for TCDD-induced suppression of the in vivo T-dependent antibody 
response in Ahdd con genic C57BL/6 mice which was not seen in Ahbb congenics, and have 
suggested that these data represent an A h-independent component of the observed 
suppression. The authors suggest that the T -helper cell is the likely target for A h­
independent toxicity induced by low levels of TCDD because they observed linear, 
approximately parallel dose-response curves, showing an approximately 4-fold difference 
in sensitivity between AfLdd and Ahbb congenics for the suppression of the in vivo antibody 
response to TNP-LPS. However, an influential role by thymic-derived hormones in the 
suppression of humoral immune responses has not been ruled out by these studies. 
Thymic humoral factor(s) (THF) have been documented to modulate both T- and B cell 
responses both in vitro and in vivo [Trainin, et aI . ,  1 985 ;  Kouttab, et aI . ,  1 988] . 
Moreover, Greenlee and co-workers [Greenlee, et al. ,  1 985] have shown that the primary 
cellular targets responsible for thymic atrophy following TCDD exposure were the thymic 
epithelial cells and not the thymocytes, which were shown to lack sensitivity to the direct 
effects of TCDD. 
In addition to demonstrating that exposure to TCDD has an effect on the antibody 
response to specific antigens, a number of laboratories have reported effects on serum 
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immunoglobulins. However, whereas the specific antibody responses were suppressed, 
in general, the results have indicated that exposure to TCDD elevates serum 
immunoglobulin levels. Sharma and Gehring ( 1 979) have reported increases in total 
serum immunoglobulins at both two and four weeks following exposure of mice to doses 
of 0.0 1 - 1 .0 Ilg/kg TCDD [Sharma and Gehring, 1979] ; a significant decrease was noted at 
higher doses (i.e. ,  1 0  Ilg/kg). Sharma, et al. ( 1 984) showed that a similar effect occurred 
in New Zealand rabbits - almost a 2-fold enhancement in total serum IgG levels at 8 weeks 
of exposure to 0.01 and O. I Ilg/kg/week; and a 50% decrease in total serum IgG levels at 8 
weeks of exposure to 1 0.0 Ilg/kg/week [Sharma, et aI . ,  1 984]. A more recent paper by 
Moran and co-workers showed in rats that a single exposure to 30 Ilg/kg caused an 
increase in total serum IgA with no effect on total serum IgG [Moran, et al . ,  1986] .  While 
they suggested that the increase in serum IgA levels in exposed rats was attributable to 
generalized TCDD-induced liver damage, the possible contribution by the ability of TCDD 
to cause an aberrant lymphocyte activation, as described below, cannot be discounted. 
6 . Myelotoxicity and Effects on Lymphocyte Development and 
Homing:  
As previously mentioned, TCDD has been shown to alter the immunocompetence of 
rodents more effectively when administered during pre- or postnatal life, a time during the 
maturational development of the immune system. These results have suggested that TCDO 
could be acting to alter normal maturational processes involved in lymphocyte development 
and has led several investigators to determine if exposure can alter hematopoietic stem cell 
function or lymphocyte homing so as to indirectly affect the proper immunological 
development and subsequent immunocompetence of the animal. 
One report [Luster, et al ., 1980] has demonstrated that exposure to female C57BV6N 
mice (crossed with male C3H mice) on day 14 of gestation and days 1 ,  7 and 14 post 
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parturition at doses of 1 ,  5 ,  and 1 5  Ilg/kg, resulted in severe alterations in fetal 
development of immunocompetence as measured in the 3-week old neonates. In addition 
to general toxicity changes (decreased body weight and thymic atrophy), maternal 
exposure to 1 5  Ilg/kg showed significant hematological changes which included decreased 
red blood cell counts, hematocrits, hemoglobin levels, and absolute numbers of 
lymphocytes. Platelets were also decreased at all exposure levels. In contrast, there was a 
slight increase in white blood cell counts and neutrophils and an absence of effect on the 
number of circulating monocytes. When bone marrow was examined, there was a 
decrease in cellularity which occurred at both 5 and 1 5  Ilg/kg, in which the latter was 
accompanied by a significant decrease in CFU-GM. Exposures to 1 and 5 Ilg/kg gave a 
small increase in the CFU-GM. In addition, exposure to TCDD reduced the proliferative 
capacity of pluripotent stem cells in the bone marrow at both 5 and 1 5  Ilg/kg, as measured 
by a decrease in CFU-S formation in these animals. 
Of relevance to this latter finding are the results of the effects of TCDD on 
lymphocyte homing patterns following pre- or postnatal exposure in the rat [Faith and 
Luster, 1979].  When inbred Fisher rats were exposed to TCDD via maternal dosing (5 
Ilg/kg) on gestational day 1 8  and on days 0, 7 and 14 postpartum, significant effects were 
detected in the homing patterns of splenic-, thymic-, and bone marrow-derived 
lymphocytes obtained from 45 day old rats. These effects were hallmarked by differences 
in the patterns of homing of exposed thymus cells to both the spleen and thymus of 
unexposed animals and of unexposed cells to the spleen or thymus of exposed animals. 
Additional studies were initiated to determine if acute exposure of young adult mice 
(6 to 8 weeks old) could cause a similar pattern of myelotoxicity and alterations in stem cell 
function as that seen in the pre- and postnatally exposed animal [Luster, et al . ,  1985].  In 
addition, a comparison was made between B6C3Fl and DBA/2 mice to determine if 
differences existed in terms of their sensitivity to the myelotoxic effects of dioxin as related 
to differences in their susceptibility to the induction of aryl hydrocarbon hydroxylase 
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activity. Mice were exposed to a single dose of 0.2, 1 , 2, 5  or 1 0  Ilg/kg TCDD and their 
bone marrow was removed and examined on day 5 for cellularity and stem cell alterations. 
In the B6C3 F l  strain, bone marrow cellularity was significantly decreased only in the 10 
Ilg/kg dosage group. Likewise, CFU-S (a  measure of stem cell proliferative capacity) was 
only moderately decreased over this dose range. However, CFU-GM was decreased at 
doses of � 1 Ilg/kg, a dose 5-fold below that producing thymic involution, and seemed to 
be a more sensitive indicator of the myelotoxic effects in these animals .  Kinetic studies 
were performed using the 1 0  Ilg/kg acute dose to disclose that the effects on cellularity and 
CFU-GM had occurred within 24 hours after exposure. During a 10 day observation 
period however, cellularity changes had recovered within 96 hours of exposure whereas 
CFU-GM did not recover until day 10. In comparison, the DBA/2 strain remained 
insensitive to the effects on CFU-GM even at doses as high as 50 Ilg/kg. In addition, 
Chastain and Pazdernik [Chastain-Jr. and Pazdernik, 1985] have also demonstrated a 
significant reduction in the number of B lymphocyte colony forming units in culture (BL­
CFU-C) derived from femoral bone marrow cells of TCDD exposed animals (acute doses 
of 30- 1 20 Ilg/kg). 
In vitro experimentation was utilized to further investigate the myelotoxic effects of 
dioxin as a function of the direct effects on progenitor cell function [Luster, et al., 1 985] . 
Using a sensitive (B6C3F l )  and a less-sensitive (DBA/2) strain of mouse, it was 
determined that CFU-GM and CFU-E colony formation was significantly suppressed in 
the bone marrow cells derived from the B6C3Fl  strain, at concentrations as low as 5 X l O­
W M. Cells derived from the DBA/2 strain were only affected at the highest concentration 
tested, 1 0-7 M. In further characterizing the effects on the B6C3F l -derived cel ls, a 
significant effect on DNA synthesis was observed in cells stimulated with mouse lung 
conditioned medium in the presence of 10-9 to 1 0-7 M TCDD, thus exposing an effect on 
these progenitor cells which either selectively affects cells already in S phase or prevents 
them from entering S phase. It is important to note that these effects were determined to be 
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more a function of the direct effects of TCDD on the nonadherent progenitor cells than an 
effect on the feeder cells; although some suppression was acquired by exposure to feeder 
cells alone. In this same report [Luster, et al . ,  1985],  these investigators further studied 
the relationship between the myelotoxicity and the A h-R. Using B6D2F l/J mice, 
heterozygous at the Ah-gene locus (AhbAhd), it was determined that the heterozygous 
responsive mice were more sensitive to the myelotoxic effects of TCDD (as measured by 
suppression of CFU-GM colony formation) than were the homozygous nonresponsive 
mice; suggesting that these effects segregate with the Ah-gene locus. This finding was 
further supported by the observation that congeners with low affinities for the Ah-R such 
as OCDD and 2,8-DCDD did not inhibit progenitor cell proliferation whereas those that 
bound with at least moderate affinities, 2,3,7,8-TCDF and 2,3,7-TCDD, directly 
suppressed this activity. 
Fine, et aI. ( 1 988 and 1 990) [Fine, et aI . ,  1988;  Fine, et aI. ,  1 990] have also 
examined the acute effects of TCDD on lymphocyte stem cell function in young adult 
BALB/c mice following either direct or perinatal exposures to determine if alterations in the 
early events of T cell lymphopoiesis can contribute to the TCDD-induced thymic atrophy. 
Following perinatal exposures to 10 Ilg/kg TCDD on gestational day (gd) 14, lymphocyte 
stem cell populations in the fetus and neonate were examined for alterations. In both the 
fetus and the neonates, significant reductions were found in both the biosynthesis and 
mRNA level s  of the lymphocyte stem cell-specific DNA polymerase terminal 
deoxyribonucleotidal transferase (TdT). In contrast, thymic TdT biosynthesis appeared 
relatively unaffected at this dose; even though an extensive involution of the thymus was 
produced. A slight reduction in the Lyt-2+L3T4+ immature thymocyte population was also 
noted [Fine, et al. ,  1 988] .  In young BALB/c mice, direct exposures to doses of 5 to 120 
Ilg/kg TCDD caused a dose-dependent decrease in thymic weight which closely correlated 
with a dose-dependent suppression in both the biosynthesis and mRNA levels of TdT in 
the bone marrow and thymus [Fine, et al . ,  1 990] .  The absolute number of thymocyte 
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subpopulations were only reduced at doses � 30 �g/kg TCDD. The relative percentage of 
CD4+/CD8+ and IL-2 receptor expressing cells were also altered on a cell-to-cell basis and 
led to the conclusion that thymocytes are more refractory to the actions of TCDD than are 
pre-T cells. Additionally, prothymocytes were removed from the bone marrow of exposed 
animals and analyzed for their ability to replenish the thymus of irradiated recipients. This 
activity by prothymocytes was severely impaired by exposure and occurred at low tissue 
levels of TCDD. They found no change in the number of granulocyte/monocyte colony 
forming units (CFU-GM) and only moderate effects on the number of stem cell colony 
forming units (CFU-S) at doses which significantly affected prothymocyte function. 
These studies suggest that thymic atrophy induced by TCDD is partially due to a decreased 
seeding of the thymus by prothymocytes emigrating from the bone marrow. 
d'Argy, et al. ( 1989) [d'Argy, et aI., 1 989] have described the use of fetal thymus 
organ cultures (day 14 of gestation) to characterize the effects of TCDD and a number of 
polycyclic hydrocarbons on lymphoid development. In this assay system, TCDD was 
shown to exhibit an EC50 of -5 x lO- lOM for decreased thymocyte development whereas 
polycyclic hyd,rocarbons were shown to have relatively low toxicities (i.e., EC50 values of 
1 0-5 to lOAM). It was further noted in this report that 3H-thymidine incorporation into the 
thymuses of TCDD-treated mice was almost completely suppressed at 48 hours after 
exposure, suggesting that TCDD can impair cellular proliferation in the thymus. A similar 
report has been documented by Lundberg, et al. ( 1990) [Lundberg, et al ., 1 990a] in which 
2 to 4-week old mice and fetal thymus cultures were exposed to TCDD (5, 25 and 50 
�g/kg and 1 O-9M, respectively) and used to monitor thymocyte subpopulations with 
respect to their differentiation antigens (i.e., CD4 and CD8). They found that cell numbers 
of all thymocyte populations, except CD8 single positive (CD8+), were significantly 
decreased as compared to controls. Following in vivo exposure, the most marked decrease 
occurred in the CD4-/CD8- (double negative) and the CD4+/CD8+ (double positive) 
populations [Lundberg, et aI., 1990b] . In addition, proliferation in the thymus was 
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decreased at 24, 48 and 72 hours after exposure, but returned to near normal levels at 96 
hours. Marked enhancements were seen on days 7 and 8. Fol lowing in vitro exposure, 
the C04+/C08+ population was the most severely affected (i.e., decreased), although cell 
numbers of all populations recovered from the fetal thymus cultures were decreased. 
Nikolaidis, et al. ( 1990) [Nikolaidis, et aI., 1 990] have described similar effects of 
TCOO on the support of B cell development by the Bursa of Fabricious. Bursae of 10-
day-old chick embryos were cultured in the presence of TCOO for 24 hours and were then 
transplanted into the chorioallantoic membrane of l O-day-old eggs of the same strain or of 
a strain expressing a different B cell surface alloantigen. After 5 days, the number of B 
cells were determined and the grafts were sectioned for immunocytochemistries. Lower 
numbers of lymphoid cells were observed in the TCOO-treated transplants as compared to 
controls, with a 40-50% decrease noted at 1 O-9M. Bursal epithelium showed relatively 
normal development, even in cases of impaired B cell development. Because lymphoid 
cells recovered from grafted bursae originated from the embryo of the host egg, these 
findings suggest that TCOO and related congeners have a direct effect on the bursa which 
leads to an inhibition of lymphoid development. It was specifically concluded that the 
result of such actions by these compounds was an alteration in the microenvironment of the 
bursal tissue which resulted in a decrease in the attraction of stem cells and/or in the 
capacity of the affected tissue to induce proliferation of the colonizing cells. These 
fmdings are consistent with those of Greenlee and co-workers [G reenlee, et al., 1 985], in 
relation to the effects of TCOO on thymic epithelial cells and the ultimate alterations in the 
development of mature T cells in the thymuses of exposed mice, as discussed in an earlier 
section of this review. 
7 .  Effects of TCDD on Innate Immunity: 
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The results presented in the previous sections have indicated that exposure to TCOO 
can affect the antigen-driven processes associated with lymphocytes involved in acquired 
immunocompetence. There is a limited number of studies which have evaluated the effects 
of TCDD on components of innate immunocompetence. Using peritoneal macrophages, 
Mantovani, et al. ( 1 980) [Mantovani, et al. ,  1 980] reported that TCDO did Il.Q1 affect 
spontaneous macrophage-mediated cytotoxicity per unit number of effector cells or the 
endotoxin-stimulated increase in cytolytic and cytostatic activities. In the same report, they 
showed that TCDD also did !lQ1 affect NK cell-mediated lysis of YAC- l lymphoma cells 
when calculated based on the number of effector cells. However, because there were 
lower numbers of peritoneal macrophages and splenocytes recovered from exposed mice, 
the total number of lytic units recovered from animals exposed to TCDD was lower than 
controls, and they concluded that these changes were enough to contribute to a potential 
decrease in resistance. More recently, House, et al. ( 1 990) reported no significant 
alterations by TCOD in splenic NK-cell activity; in the numbers of resident or elicited 
macrophages obtained from the peritoneal cavity; or in a number of assays reflecting the 
functional capabilities of thioglycollate-elicited macrophages including; cytostasis, 
cytolysis, phagocytosis, IL- l production or H202 production [House, et al., 1 990] . In 
contrast, Ackermann, et aI. ( 1989) [Ackermann, et aI. ,  1989] have reported that exposure 
to TCDO did reduce the cytolytic and cytostatic activity of activated polymorphonuclear 
neutrophils (PMNs) taken from the peritoneal cavity, but had no effect on the production 
of superoxide or hydrogen peroxide, or on degranulation. As these effects were greater in 
B6C3Fl mice than DBN2 mice, the authors concluded that this action segregated with the 
Ah-R. Because examination of bone marrow stem cells revealed that granulocytic, but not 
monocytic colonies, were reduced after exposure, the authors speculated that TCOO may 
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affect PMNs at the level of hematopoiesis, an effect which is  consistent with the 
myelotoxicity discussed in the preceding section. 
Luster and co-workers have also investigated the effects of TCDD on the fixed cells 
associated with the reticuloendothelial system (RES). Rosenthal, et al. ( 1989) [Rosenthal, 
et aI., 1 989] demonstrated that the clearance of endotoxin by the liver was decreased by 
exposure to TCDD, an effect which could contribute to the TCDD-induced hypersensitivity 
to endotoxin reported by others [Vos, et al. ,  1 978] .  Taylor, et al. (1 990) [Taylor, et al . ,  
1 990] have also speculated that an increase in the sensitivity to LPS may be due to an 
increase in the release of tumor-necrosis factor by Kupffer cells isolated from exposed rats. 
Therefore, exposure to TCDD seems to produce a complex profile of activity on fixed cells 
of the RES, with both a decrease in the uptake of bacterial fragments and an increase in the 
release of cytokines in response to bacterial stimuli. 
Results by White and co-workers have demonstrated that exposure to TCDD and 
related PCDD suppressed the complement pathway indicating that soluble mediators 
associated with innate immunity are also targeted by the dioxins. White and Anderson 
( 1 985)  [White and Anderson, 1985b] initially demonstrated that technical grade 
pentachlorophenol (PCP), but not pure PCP, suppressed the classical complement 
pathway, the spontaneous C 1  autoactivation, the alternate pathway and the levels of 
complement component, C3. Confirmation that the PCDD's, which contaminated the 
PCP, principally 1 ,2,3,6,7 ,8-HCDD, were responsible for the actions on the complement 
system, was provided in a subsequent report [White, et al. ,  1986]. TCDD was included as 
a comparative control in these studies (i.e . ,  TCDD is not a major contaminant of PCP). 
Recovery studies demonstrated that complement activity in mice treated with TCDD ( 1  
�g/kg) and the high dose of 1 ,2,3,6,7,8-HCDD ( 10  �g/kg) was suppressed until 50  days 
post-treatment. Interestingly, treatment with the lower doses of 1 ,2,3,6,7,8-HCDD (0. 1  
and 1 .0 �g/kg) produced an elevation in complement activity. In contrast with these 
results with complement, House, et al. ( 1 990) have reported that exposure to TCDD had 
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no effect on a second type of soluble mediator, serum interferon, as triggered by the 
administration of poly I :C [House, et al. ,  1 990]. 
The effects of TCDD on innate immunity, although limited, are important from a 
number of perspectives. First, they demonstrate that the effects on immunocompetence are 
complex and are not restricted to a given cell type. Second, they provide an important 
perspective for the discussion in the following section, in that innate immune processes are 
an important component of the repertoire of host resistance. Finally, the effects on innate 
immunity observed in animal studies have been corroborated in some human studies, as 
discussed below. This latter point is particularly true in regards to changes in the 
complement system. 
8 .  Effects of TCDD on Host Resistance Models: 
In response to studies which had demonstrated that exposure to TCDD could induce 
thymic atrophy and suppress cell-mediated immunity in laboratory animals, Thigpen, et aI. 
( 1 975) investigated whether or not mice exposed to TCDD were more susceptible to 
Salmonella bern (S. bern) and Herpesvirus suis, or pseudorabies virus [Thigpen, et aI., 
1 975] .  Following exposures a s  low as 1 Ilg/kg administered once per week for 4 
consecutive weeks beginning at 4 weeks of age, an exposure which did not produce any 
clinical or pathological evidence of toxicity, male C57BV6 mice infected with S. bern had a 
significantly higher rate of mortality and significantly shorter time to death when compared 
to control mice. In contrast to the findings with S. bern, TCDD exposure did not increase 
mortality following pseudorabies virus infection at any of the dose levels tested. 
Subsequent studies by Vos, et al. ( 1978) and Thomas and Hinsdill ( 1 979) indicated that 
the increased susceptibility to Salmonella infection is likely due to the endotoxin content of 
the bacteria [Vos, et al ., 1 978;  Thomas and Hinsdill, 1979] . Using an exposure regimen 
similar to that which was used by Thigpen and co-workers [Thigpen, et al. ,  1975], both 
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male Swiss mice [Vos, et al . ,  1978] and the offspring of female Swiss-Webster mice, fed 
TCDD-containing chow prior to mating, during gestation, and between partuition and 
weaning [Thomas and Hinsdill ,  1979] , demonstrated increased mortality following 
bacterial endotoxin (E. coli and S. typhimurium LPS, respectively) administration relative 
to controls. In neither case was resistance to Listeria monocytogenes (L. monocytogenes), 
a gram-positive bacteria lacking endotoxin, affected by TCDD exposure. Because the 
phagocytic activity of peritoneal macrophages was not affected, Vos, et al. ( 1 978) [Vos, et 
al. ,  1978] concluded that a suppression of CM! was not mediated by a combined effect on 
T cells and macrophages. However, as noted by Thigpen, et al. ( 1 975) [Thigpen, et al . ,  
1975] , studies which have dealt with circulating macrophages do not address the potential 
effects on tissue (i.e., fixed) macrophages. Moreover, as discussed in the preceding 
section, changes in cells of the RES induced by TCDD tend to at least partially explain the 
increase in endotoxin sensitivity observed in animal models (i.e., this point is further 
discussed below) .  
Support for the lack of  effect on  L.  monocytogenes host resistance model by 
exposure to TCDD comes from the results of House, et al. ( 1 990) [House, et aI., 1990] . 
However, this study did demonstrate one of the most sensitive effects of exposure to 
TCDD on a host resistance model. Exposure to as little as a single injection of 0. 1 �g/k:g 
caused a significant increase in the mortality associated with challenge to a mouse-adapted 
influenza Arraiwan/1/64 (H2N2) virus. Following viral infection, a cascade of immune 
responses occurs, including interferon production, enhanced macrophage and NK-cell 
activity, induction of cytotoxic T lymphocyte (crL) activity and antibody production. As 
described above, in this same study, House, et al. ( 1 990) showed that exposure to TCDD 
had no effect on interferon, NK cell activity or macrophage function. While they did not 
measure the effects of TCDD on CTL activity, they did show an effect on the antibody 
responses to both T-dependent and T-independent antigens, although the effects of the low 
dose (0. 1 �g/k:g) of TCDD were modest. Moreover, a dose of 1 0 �g/k:g was required to 
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cause suppression of the specific antibody titers to inhibit viral hemagglutination. Further 
work is necessary to understand the basis for the sensitivity of this influenza model to 
TCDD. 
In contrast to some of the earlier observations, Hinsdill, et ai. ( 1980) [Hinsdill, et 
al., 1 980] reported increased susceptibility to both S. typhimurium var. copenhagan and L. 
monocytogenes in outbred female Swiss Webster mice fed chow containing up to 50 ppb 
TCDD for 8 weeks prior to infection; although the data was quite variable. In addition to 
an increased mortality and shortened time to death, TCDD exposure was associated with an 
increase in the number of viable bacteria recovered from the blood. This effect was 
interpreted by the authors to suggest that TCDD compromises the ability of Kupffer cells to 
clear bacteria from the blood. As discussed above, a recent report by Rosenthal, et ai. 
( 1 989) [Rosenthal, et al . ,  1989] conflrms that the ability of these cells to clear endotoxin is 
reduced. Changes seen with L. monocytogenes were less pronounced than those 
observed following S. typhimurium infection. An increased susceptibility to L .  
monocytogenes i n  B6C3F1  progeny of C57Bl/6N mice administered TCDD by gavage on 
Day 14 of gestation and Days 1 ,  7, and 14 post-partum has also been reported by Luster, 
et al. ( 1980) [Luster, et al., 1 980]. A dose-related increase in mortality was observed with 
statistically significant differences from control mice reported in mice from darns receiving 
5 Ilg!kg TCDD. In this study, however, time to death was not affected by TCDD 
treatment. A modest increase in susceptibility to PYB6 tumor cells was also reported. The 
latter observation was a further indication that TCDD can compromise CM!. 
As previously described in an earlier section, Clark and co-workers have argued 
through a number of research communications that TCDD-induced suppression of cell­
mediated immunity is mediated through the induction of suppressor cells which target 
cytotoxic T cells (CfL). Since it has been proposed that CTL play a role in the resolution 
of certain viral infections, Clark, et ai. ( 1 983)  [Clark, et aI . ,  1 983] evaluated the 
susceptibility of male C57Bl/6 mice to Herpes simplex type II strain 333 infection to test 
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for an in vivo effect on immunosuppression by low doses of TCDD. Treatment via gavage 
once per week for 4 weeks with 0.04, 0.4, or 4 Ilg/kg TCDD significantly increased 
mortality among infected mice. The increased mortality was greatest at the lowest dose 
tested, with the effect less pronounced and similar at both 0.4 and 4 Ilg/kg TCDD. Despite 
this lack of a clear dose-response relationship, the data suggest that susceptibility to certain 
viral infections can be increased by exposure to TCDD. 
In contrast to the suppression of CMI most often associated with perinatal exposure 
to TCDD, exposure in adult rodents is characterized by the suppression of humoral 
immunity. Tucker, et aI. (986) [Tucker, et aI., 1986] have reported that parasitemia 
following infection with Plasmodium yoelii, a non-lethal murine malarial parasite believed 
to be defended against by humoral immune responses, was greater and of longer duration 
in female BCF mice administered a single dose of 10 Ilg/kg TCDD by gavage as compared 
to vehicle-treated controls. 
As discussed in the previous section, White, et al. ( 1986) [White, et aI., 1986] have 
reported a suppression of serum complement and C3 levels in B6C3F l mice following 
exposure to PCDD. Exposure to both TCDO O llg/kg by i.Il.. injection for 14 days) and 
1 ,2,3 ,6,7,8-HCDD 00 Ilg/kg) were shown to significantly increase mortality following 
infection with Streptococcus pneumoniae. Host defense against this bacterium is believed 
to be mediated by complement activation, and thus requires functional C3. 
Susceptibility to infectious agents, including bacteria, viruses, parasites and 
transplantable tumors, has been used as an integrative measure of the effect of TCOD 
exposure on the immunocompetence of laboratory animals in vivo. Collectively, these 
studies demonstrate that at least in mice: ( 1 )  exposure to TCDO can suppress host defense 
mechanisms leading to a greater susceptibility to mortality and morbidity following 
infection; (2) both innate and acquired (and both cell-mediated and humoral) immune 
functions can be compromised; and (3) there is a good correlation between alteration of 
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functional assays of individual components of the immune system and suppression of host 
resistance mediated by these components. 
III. MATERIALS AND METHODS 
A .  A n i mals:  
(C57BL/6 X C3H)F1  (B6C3F1 )  female mice were purchased through the National 
Cancer Institute (Frederick, MD). DBA!2 female mice were purchased from Charles River 
Laboratories (Raleigh, NC). Mice arrived at between 5 and 7 weeks of age and were 
housed 4/cage in a humidity and temperature regulated atmosphere with alternating 12  hour 
light/dark cycles. Food and water were available ad libitum. Particular care was exerted to 
guarantee that both strains of animal were age and weight matched at between 1 9-22 grams 
at the time of experimentation. 
B .  C hemicals:  
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) that was used in in vivo experiments 
was obtained through the National Toxicology Program and Bio-Rad Laboratories 
(Rockville Centre, NY) and kept as a 100 J.lg/rnl solution in com oil (vehicle; Sigma). 
TCDD that was used in in vitro experiments was obtained from Chemsyn Science 
Laboratories (Lenexa, Kansas) and kept at 250C as a 600 J.lM stock solution in 100% 
DMSO. The purity of the latter was assessed by Chemsyn laboratories using gas 
chromatography/mass spectrophotometry and was found to be �98%. No contamination 
by dibenzofurans was detected. Dimethylsulfoxide (DMSO), glucose-6-phosphate, 
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NADPH, NADH, glucose-6-phosphate dehydrogenase, dicumorol, bovine serum albumin 
(BSA), collagenase type I and trypsin inhibitor were purchased from Sigma Chemical Co. 
(St. Louis, MO). 7-Ethoxyresorufin and resorufin were obtained from Pierce Chemical 
Co. (Rockville, IL). 
C .  Culture Media and Reagents: 
Media, media supplements, and balanced salt solutions were obtained from the 
following sources: RPMI 1 640 medium without NaHC03 , Waymouth's MB75 1/1  
medium, EBSS without NaHC03, HBSS without NaHC03, CaCI2, MgCI2.6H20, and 
M g S 02 . 7 H20, and L-Glutamine (Gibco, Grand Island, N.Y.);  KC 2000 Serum­
independent medium (Dulbecco's Modified Iscove's MEM), Penicillin-Streptomycin­
Fungizone solution, and MEM Spinners without L-Gln (Hazelton Research Products, 
Inc.,  Denver, PA); 2-Mercaptoethanol (Bio-Rad Laboratories, Richmond, CA); Nutrient 
Mixture F- 1 2  (HAM) with HEPES, without L-Gln, without NaHC03 (Sigma Chemical 
Co., St. Louis, MO); Fetal Bovine Serum (FBS;  Hyclone Laboratories, Inc. ,  Logan, 
Utah); New Born Calf Serum (NBCS) and Fetal Equine Serum (FES; Flow Laboratories, 
McLean, V A). Complete RPM! media was prepared as a 1 X solution by the addition of 2 
mM L-Gln, 1 % (v/v) Penicillin-Streptomycin-Fungizone solution, 5 X 1 0-5  M 2-
Mercaptoethanol, and the appropriate concentration of serum (5 or 10%; see results) to the 
RPMI stock solution. KC 2000 serum-independent media was prepared as directed, 
except for the addition of Nutrient Mixture F- 12  (HAM) (Sigma) to a final concentration of 
0.5% (w/v). Vitrogen 100 was purchase from Collagen Corporation (Palo Alto, CA). 
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D .  Anti bodies and Immunoreagents: 
FITC-conjugated rat anti-mouse Thy 1 .2 and goat anti-mouse Ig, L3T4 and Lyt-2 
were purchased from Becton-Dickinson (San Jose, CA). FITC-conjugated hamster anti­
mouse CD3-epsilon was purchased from Boehringer-Mannheim Biochemicals. HO- 1 3-4 
mouse anti-mouse Thy 1 .2 culture supernatant was produced in our own laboratory. The 
HO- 1 3-4 hybridoma was obtained through the American Tissue Culture Bank. Goat anti­
mouse IgM F(ab'h, mouse IgM, and peroxidase-conjugated goat anti-mouse IgA, G, and 
M were purchased from Pel-Freez (Rogers, AR), Sigma (St. Louis, MO), and Organon 
Teknika/Cappel Laboratories (Malvern, PA), respectively. Recombinant mouse 
interleukin-2, interleukin-4 and gamma-interferon were purchased from Genzyme 
Corporation (Boston, MA). Staphylococcus aureus Cowan strain I (SAC; Boehringer­
Mannheim Biochemicals, Indianapolis, IN) was obtained and frozen as a 10% solution. 
E .  C hemical Treatments: 
For in vivo dosing the following regimens were used: In acute single exposure 
studies, animals were administered either com oil or 4.2, 14, or 42 �g/kg TCDD via oral 
gavage on day 0 of the study and were sacrificed either on day 2 or day 1 5  of the study. In 
acute 5-day regimens, com oil (vehicle) and TCDD ( 1 ,  10  or 30 �g/kg) were administered 
daily for 5 consecutive days to give cumulative doses of 5, 50 and 1 50 �g/kg. Two days 
rest were allowed prior to experimentation or sensitization during the acute 5 day regimens. 
For subchronic ( 1 4  day) exposures, animals were administered either com oil or 0.3, 1 .0, 
or 3 .0 �g/kg TCDD/day via oral gavage for 14 consecutive days (cumulative doses of 4.2, 
14 ,  and 42 �g/kg). In subchronic studies, organ necropsies and antibody responses were 
perfonned 24 hours after the last chemical treatment. Figure 3 illustrates the scheduling for 
5 7  
the dosing regimens used in these experiments, including the various times at which the 
animals were dosed, sensitized and sacrificed. 
D=Dose 
SN=Sensitize 
SC=Sacrifice 
Day 0 1 2 3 4 5 6 7 8 9 10 1 1  12  13  14  1 5  I I I I I I I I I I I I I I I I 
t t t 
Acute (2 day) D S N  S C  
I I I 
t t t 
Acute ( 14  day) D S N  SC 
I I I 
t t t t t t t 
Acute (5 day) D D D D D S N  S C  
I I I I I I I I I I I I I I I I 
t t t t t t t t t t t t t t t t 
Subchronic ( 1 4  day) D D D D D D D D D D D D D D D SC 
SN 
Figure 3. Dosing Regimens for In Vivo TCDD Administration. 
F .  Splenocyte Preparation:  
Animals were sacrificed by cervical dislocation. Spleens were aseptically removed, 
placed in a 3X volume of sterile EBSS or RPMI media, mashed into single cell 
suspensions, and washed once to remove residual cell debris. For all in vitro T-dependent 
assays, cells were resuspended in RPMI complete media before addition to cultures. For 
B cell and T cell isolations, cells were resuspended in 1 ml of HESS (5% FB S)/spleen. 
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Red blood cells were removed by hypertonic lysis using 3 mls of Gey's working 
solution/spleen and incubating on ice for 5 minutes with occasional mixing. Gey's 
working solution was prepared as previously described [Mishell, et aI . ,  1 980] . 
Splenocytes (minus red blood cells) were then adjusted to 1 X 1 07 cells/rnl in HESS (5% 
FBS) before removal of T cells (B cell isolation procedure) or separated on percoll density 
step gradients (T cell isolation procedure) as described below. 
G .  Necropsies and Antibody Forming Cell Responses: 
Animals were sensitized to the T-dependent antigen, sheep red blood cell (SRBC), 
by administration of 5 X 108 SRBC, via i.p. injection in 1 rnl of saline, on either day 8 for 
acute (5-day) or on day 1 1  for both acute ( 1 4-day) and subchronic ( 14-day) exposed 
animals. On days 2 (acute 2 day), 1 2  (acute 5-day) or 1 5  (acute 14-day and subchronic 
1 4-day), animals were sacrificed, body and organ weights were recorded, and anti-SRBC 
antibody forming cell (AFC) responses were determined as previously described 
[Holsapple, et aI., 1 986b] . We have historically observed that this antibody response 
peaks 4 days after sensitization. In studies comparing the effects of TCDD on the antibody 
response following acute ( 1 4  days rest) and subchronic ( 1 4  day repetitive dosing) 
exposures, background IgM AFC from exposed, but unsensitized, spleens were also 
determined. Refer to Figure 3 which illustrates the scheduling for the dosing regimens 
used in these experiments, including the various times at which the animals were dosed, 
sensitized and sacrificed. Background IgM AFC were enumerated by the reverse plaque 
assay as described by Wood, et al. ( 199 1 )  [Wood, et al., 1 99 1 ]  using a modified version 
of a previously described method [VanOudenaren, et aI., 1 98 1 ]  and were done in direct 
collaboration with Dr. Steve Wood. Briefly, cells were resuspended in HESS and added 
to 96 microtiter plates. Rabbit anti-mouse IgM (Accurate Chemicals, Westbury, NY) and 
detoxified (i.e., removal of immunoglobulin) guinea pig complement were then added and 
5 9  
the mixture pipetted into Cunningham chambers. The chambers were then incubated for 2 
hours at 370C (5% CCh) and the plaques enumerated 
H .  In vitro Assay of the T-Dependent Antibody Response: 
Assays using either bovine serum supplemented RPMI media or KC2000 serum­
independent media were carried out as previously described [Dooley and Holsapple, 1988] 
except for minor modifications. SRBCs (Colorado Serum Co., Denver, CO) were added 
directly to splenocyte suspensions, at a final concentration of 1 .3 X 107 cells/mI, prior to 
addition of cells to 48 well flat bottom culture plates (Costar, Cambridge, MA). Vehicles, 
TCDD (in 0.5% DMSO) and/or SAC (diluted in RPMI medium) were added to each well 
( 1 0  f..ll/well) to attain the appropriate final concentrations. Cultures were incubated for 5 
days under the same conditions as previously described. When serum supplemented 
media was used, cultures were fed on day 1 with 30 f..ll of a feed mixture prepared as 
follows: 0.64% dextrose (w/v), 6.4 1 % essential amino acids (v/v; Gibco), 3.2 1 % non­
essential amino acids (v/v; Gibco), 3 .21  % L-Gln (v/v) , 44.9% MEM Spinners (v/v; 
Hazelton), 9.62% NaHC03 (v/v) , 0.64% Penicillin-Streptomycin-fungizone solution 
(v/v), and 32.05% PBS or NBCS (prepared individually for each lot of serum used). For 
serum-independent media and mouse serum supplements, cultures were fed as above 
except that a 1 % BSA solution in KC 2000 was used in place of the designated serum 
supplement. For assays comparing bovine and normal mouse serum supplemented RPMI 
media, the following modifications were made. Cells were adjusted to 1 . 1  X 107 /ml in 
RPMI complete media (including L-Gln, Penicillin-Streptomycin-Fungizone solution and 
2-mercaptoethanol) without serum. SRBC were added to the splenocyte suspension and 
then added to appropriate wells in 48 well culture plates. Bovine sera and/or normal 
mouse serum were then added directly to the wells to achieve the appropriate 
concentrations (i.e., 5% normal mouse serum was used in these studies unless otherwise 
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noted). Al l  other culture conditions were the same as described above. Cells were 
removed from culture on day 5 and plaqued against SRBCs to detect the number of 
antibody forming cells (AFC)/l06 recovered cells by a modified version of the Ierne 
hemolytic plaque assay [Dooley and Holsapple, 1988]. 
I .  Blood Collection and Serum Preparation : 
Blood was collected from anesthetized mice via cardiac puncture, immediately placed 
into 1 2  X 75 mm glass tubes and allowed to clot at room temperature. Tubes were 
centrifuged at 1000 X g for 30 minutes and serum was collected. Pooled sera were then 
centrifuged again at 1 000 X g for 10 minutes to ensure that all red cells were removed. 
Serum was then sterilized by centrifugation through 0.2 11m microfuge filters (Costar) and 
stored at -70°C. Prior to use in in vitro cultures, sera were heated at 56°C for 30 minutes 
to deactivate endogenous complement. Protein determinations were carried out by the Bio­
Rad protein assay method (Bio-Rad Laboratories, Rockville Centre, NY) using BSA as the 
protein control. 
J .  B Cell and T Cell Isolations: 
In the present studies, two different methods of isolation were employed to isolate 
highly purified B and T cells of different stages of in vivo activation. In both methods, 
three major subpopulations of cells  (resting Go, cycling G 1 and differentiated B and T 
cells) were isolated on percoll density step gradients using a modification of previously 
established methods [DeFranco, et al., 1982; Layton, et aI., 1 985; Monroe, 1 988]. To 
obtain purified B cell subpopulations, as opposed to T cells, methods used to isolate 
resting and cycling B cells depended on whether adherence to plastic was used to remove 
residual macrophages/monocytes from the splenocyte preparation prior to the isolation 
6 1  
procedure. For the isolation of both T cell subpopulations, adherence to plastic was used 
in all experiments. For the purification of cycling B cells, freshly prepared splenocytes 
were resuspended in RPMI complete media containing 5% NBCS at 1 X 107 cells/ml and 
plated on plastic petri dishes ( 10  ml/plate) for 10 hours prior to T cell removal and percoll 
separation. Isolation of resting B cells did not require adherence since no 
macrophages/monocytes were detected at this density; although a small percentage of 
contaminating PMNs were detected at this density on occasion (refer to results and Table 5 
for details). In addition, adherence resulted in significant losses in this population of cells 
and was therefore counterproductive in the isolation procedure to purify this population of 
cells. For the isolation of both populations (resting and cycling), splenocytes were 
collected, treated to remove autologous red blood cells (i.e., hypertonic lysis with Gey's 
solution; see above) and incubated (37°C for 1 hour) with a 1 : 50 dilution of HO- 1 3-4 
mouse anti-mouse Thy- 1 . 2  supernatant plus a 1 : 100 dilution of DNase I (Sigma) and a 
1 : 10 dilution of Low-Tox rabbit complement (Accurate Chemical Co. , Westbury, NY) to 
remove viable T cells. Various densities of percol l  ( 1 . 1 0, 1 .092, 1 .079, and 1 .070 g/ml; 
Pharmacia, Piscataway, NJ) were isoosmotically prepared and adjusted to pH 7 .2. Two 
mls of each of the first 3 densities of percoll were then gently layered into pre-chilled 
Falcon 1 6  ml round bottom tubes on ice (Thomas Scientific, Swedesboro, NJ). Cells 
were washed once in HBSS without FBS and reconstituted in 2 mls of the 1 .070 density 
percoll (2 mls/2 spleens) and layered on top of the 1 .079 density percoll. Gradients were 
capped with 2 mls of HBSS (d= 1 .058 g/ml) and centrifuged at 500 X g for 30 minutes 
(40C) without braking. Cells layering at the interface of the 1 . 092/1 .079 densities have 
been characterized as resting (Go) B cells (as indicated by both previously established 
methods and by FACScan, Wright-Giemsa stained cytospin preparations and Cell Cycle 
analysis in this laboratory). Those cells layering at the interface of the 1 .079/1 .070 
densities contain B cells in various stages of activation and differentiation (cycling; 
predominantly G 1 cells but containing a majority of the total S and G2/M cells). Cells at 
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the interface of 1 .070/ 1 .058 (HBSS)  contain residual macrophages/monocytes, 
differentiated B cells, and dead cell debris (refer to results and Figures 4 and 5 and Tables 
6 and 7 for details). A reference gradient, using density marker beads (pharmacia) in place 
of cells, was prepared and centrifuged under identical conditions to estimate the densities 
of recovered cell populations. Immunofluorescence FACScan analysis for the presence of 
B cells and T cells in the various cell populations revealed resting and cycling B cell 
purities of 95-98% and 97-99%, respectively, as determined by specific staining with goat­
anti-mouse Ig (refer to results and Tables 4 and 5 for details). To obtain the two major 
subpopulations of T cells  (resting and cycling cells) a modified version of the B cell 
isolation procedure (described above) was employed using percoll density centrifugation 
combined with an immunomagnetic negative selection procedure as described by Ladics, et 
ai. ( 1 99 1 )  [Ladics, et aI., 1 99 1 a] . It should be noted that the method for isolation of 
purified T cells  in various states of in vivo activation were worked out in direct 
collaboration with Dr. Greg Ladics. Briefly, splenocytes were prepared and plated for 10 
hours as  described above and treated to remove red blood cells. Cells were then washed 
and immediately separated by centrifugation on percoll density step gradients at the same 
densities used in the B cell isolation procedure (i.e., 1 . 1 0, l .092, 1 .079 and 1 .07 glml). 
Cells banding at the interfaces of 1 .092/1 .079 (resting Go lymphocytes) and 1 .079/1 .07 
(cycling G 1 lymphocytes) were collected (see results and Figure 5), washed and adjusted 
to 2 X 1 07 cells/rnl in RPMI media containing 5% FBS and 5 mM EDT A. FITC­
conjugated goat-anti-mouse Ig, B220 (CD45), and granulocyte antibodies were added to 
the cell suspensions (6 Ilg antibody/rnl of cells) and incubated at 4°C for 1 hour. Cells 
were then washed to remove excess antibody and incubated with the magnetic beads (with 
anti-FITC antibodies bound to the surface; Advanced Magnetics, Cambridge, MA) at a 
bead:cell ratio of 100: 1 for 45 minutes at 4°C in round bottom tubes. Tubes were then 
placed in a magnetic particle concentrator (Dynal) to remove B cells from the splenocyte 
suspensions. Resulting T cells were analyzed by flow cytometry and Wright-Giemsa 
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stained cytospin preparations (as described for isolated B cells above) with routine purities 
of �95% (refer to results and Tables 4 and 5 for details). Cell populations were removed 
from the gradients by aspiration (B cells) or from tubes following removal of magnetic 
beads (T cells), washed in RPMI stock media (without FBS), and analyzed (cell number, 
viabilities, etc.) or used for further experimentation. B and T cell yields were determined 
as the percentage of total lymphocytes recovered from the gradients for each B cell 
subpopulation. Recoveries were determined as the number of B and T cells recovered 
from each band as a percentage of the total B cells at the beginning of the isolation as 
determined by fluorescence FACScan analysis (see results and Figures 2.2 and Table 3 for 
details). 
K .  Immunofluorescence Staining and Flow Cytometry: 
Whole splenocytes and purified lymphocyte populations (recovered from Percoll 
density gradients) were washed 4 times in HBSS and 2 times in phosphate azide buffer 
and added to 96-well U bottom microtiter plates (Costar); 1 X 106 cells/well. Phosphate 
azide buffer was prepared by adding 1 % BSA and 0. 1 % sodium azide to a 1 X PBS stock 
solution. Cells were incubated for 20 min. with FITC-conjugated monoclonal antibodies 
(5 Ilg/I06 cells) to either T cell or B cell markers and analyzed by flow cytometry to 
determine the percentage of T cells or B cells present in each cell preparation. Viable cells 
were detected by prior incubation of all preparations with propidium iodide (5 Ilg/ml; 
Sigma). All flow cytometric analyses of splenocytes and enriched lymphocyte populations 
were carried out with the help of Dr. Malvin L. Stern (Department of Pharmacology and 
Toxicology, MCVNCU, Richmond, VA) using a Becton-Dickinson FACScan™ Flow 
Cytometer; equipped with a Hewlett Packard HP 9000 series computer with applications 
software allowing for single and multiparameter analysis of the data. 
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L .  Cell Cycle Analysis:  
Cell cycle analyses of unseparated splenocytes and purified lymphocytes were carried 
out by the method of Nusse, et al. ( 1 990) [Nusse, et al. ,  1 990]. Briefly, cell nuclei were 
prepared and stained by incubating 2 X 106 cells for 30 minutes in a 0.0584% (w/v) Na­
citrate/0. 1 % (w/v) NaCl solution containing 0.03% Nonidet P40, 10 Ilg/ml RNase and 25 
Ilg/rnl ethidium bromide. After 30 minutes, a second solution was added containing 1 .5% 
citric acid, 0.25 M sucrose and 40 Ilg/rnl ethidium bromide. Cells were then refrigerated at 
40C until analyzed. Isolated nuclei were washed and analyzed by flow cytometry as 
described by Nusse, et al. (1 990). Where indicated, the cell cycle distribution of some cell 
populations were further analyzed using fixed whole cell preparations combined with the 
use of CellFit Cell Cycle analysis software (Becton-Dickinson) and flow cytometry. For 
fixed whole cell analyses, 5 X 1 06 cells were washed and fixed on ice in 95% ethanol. 
Fixed cells were then washed in PBS containing 38 mM sodium citrate and 1 .25 mg/rnl 
RNase and stained with 10 Ilg/rnl propidium iodide. In both procedures, cells in the 3 
major stages of cell cycle (i .e., Go/G 1 ,  S and G2/M) were determined by DNA content 
and expressed as a percentage of the total fluorescing cells. 
M .  Lymphocyte Proliferation Assays: 
For direct addition studies in the absence of mitogens (i.e., LPS or Con A), splenic­
derived dense resting (Go) and cycling (G 1 )  B cells and T cells from naive B6C3Fl mice 
were isolated as described above and adjusted to the proper cell density in RPM! complete 
media containing either FBS 7 1 7  or NBCS at various concentrations as described in the 
results. These serum lots were shown to either not support or support, respectively, a 
suppression of the T-dependent antibody response by TCDD (see results). Cells were 
added to 96 well flat bottom plates (Costar) ( 1  X 105 cells in 1 50 J.Ll) and incubated in the 
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presence of vehicle (0.01 % DMSO) or increasing concentrations of TCDD (0.3 ,  3, 10, 30 
and 60 nM depending on the study) under the same atmospheric conditions as previously 
described for in vitro antibody responses to SRBC. For experiments involving in vivo 
treatment and in vitro proliferation, female B6C3F1 mice were treated with either corn oil 
(vehicle) or TCDD ( l llg/kg/day) for 5 days and their splenic-derived dense B cells isolated 
and adjusted and incubated as described above for in vitro exposures. Proliferation was 
assessed at various time points after treatment (i.e. ,  24, 48, 72, and 96 hours depending 
on the study - see results) as 3H-TdR incorporation (addition of 1 IlCi/well) following a 16 
hour pulse, except for B cell proliferations that were measured following in vivo exposures 
or LPS stimulation, in which only a single measurement was taken at 48 or 72 hours, 
respectively. For direct addition studies involving mitogens, lipopolysaccharide (LPS; S. 
Typhosa) and Concanavalin A (Con A) were added at the beginning of the culture period 
(i.e., simultaneous with vehicle or TCDD treatments) at final concentrations of 10 and 5 
Ilg/ml, respectively. Cells were harvested and the amount of 3H-TdR incorporation was 
determined using liquid scintillation counting as previously described [Dooley and 
Holsapple, 1988] .  
N .  IgM and IgG ELISAs: 
96 well flat bottom microtiter plates (Dynatech, Chantily, V A) were coated overnight 
with goat anti-mouse IgM F(ab'h or goat anti-mouse IgG (Fc specific) primary antibodies 
(Pel-Freez and Jackson Laboratories) at 1 Ilg/ml and 0.5 Ilg/ml, respectively, and 
incubated overnight at 40C in PBS. Plates were washed once with PBS containing 0.05% 
Tween-20 (v/v; Sigma) and coated with blocking buffer (PBS+ Tween-20+5% powdered 
milk) for 2 hours at room temperature to reduce nonspecific Ig binding. Mouse IgM or 
IgG standards were prepared in blocking buffer and standards or 7 day culture 
supernatants ( 1 0-75 Ill) were added to the appropriate wells. Following a 2 hour 
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incubation, plates were washed and incubated in the presence of peroxidase-conjugated 
goat anti-mouse IgM, G, and A (Cappel) for 1 hour at room temperature. Plates were 
washed and the amount of IgM or IgG present in the standards and culture supernatants 
was determined by the addition of peroxidase substrate (Bio-Rad) and spectrophotometric 
detection of absorbance changes at 4 1 4  nm using a Bio-Rad model 2550 EIA plate reader. 
Data was calculated using linear regression analysis of the samples as based on the semi­
log plot of log Ilg standard/well versus absorbance. 
O .  Preparation of Liver and Splenic Microsomes: 
The studies to assess enzyme induction were done in direct collaboration with Mr. 
Hye Gwang Jeong, a visiting student scientist from the Korea Advanced Institute of 
Science and Technology (KAIST), Seoul, Korea. Livers and spleens were removed from 
both B6C3Fl and DBA/2 mice following either acute or subchronic exposures to TCDD, 
and placed in ice cold 0. 1 5  M KCl. Livers were rinsed to remove excess blood and 
homogenized in 3 ml of KCI using a teflon glass homogenizer. Spleens were smashed 
into single cell suspensions, washed, and then homogenized, with the splenic capsule 
intact, in 1 ml KCI by sonication using a Vibra Cell sonic cell disrupter (Sonics and 
Materials Inc., Danbury, CT). S-9 homogenates were prepared as previously described 
[Johnson, et al . ,  1 987] by centrifugation of an aliquot of each liver supernatant and spleen 
cell supernatants at 9000 X g for 1 0  minutes. Microsomes were then prepared from both 
liver and spleen S-9 fractions by differential centrifugation as previously described [Yang, 
et al., 1 977] .  S-9 fractions were centrifuged at 1 05,000 X g for 60 minutes under vacuum 
in an ultracentrifuge. Pellets were rinsed once with 0. 1 5  M KCI and 10 mM EDTA (pH 
7 .4), resuspended in 0.25 M sucrose and stored at -700C until assayed (see below). 
P .  Isolation and Culture of Primary Hepatocytes: 
6 7  
Primary hepatocytes were were isolated using the collagenase perfusion technique of 
Klaunig, et al. ( 1 98 1 )  [Klaunig, et al . ,  198 1 ]  with minor modifications as previously 
described [Yang, et al. ,  1 986; Johnson, et al. ,  1987; Kim, et al. ,  1 987] . Briefly, the liver 
was perfused with 1 00 ml of Ca++- and Mg++-free HBSS containing 1 00 V/ml 
collagenase and 1 00 Ulml trypsin inhibitor. Cells were centrifuged at 50 X g for 5 
minutes, resuspended in Waymouth's AB stock media (without hormone supplements), 
and checked for viabilities using trypan blue exclusion. Viabilities were routinely �80%. 
Cells  were adjusted to 0.5 X 1 05 cells/ml and added (3 mls/well ;  1 .5 X 1 05 cells) to 
Vitrogen 1 00 pre-coated 6 well culture plates (Costar, Cambridge, MA). Plates were 
incubated at 37°C (humidified atmosphere with 5% C02) for 3 hours to allow for 
adherence of viable cells to the plates. Cells were then washed twice in warm stock AB 
media before adding 2 mls of AB media (without hormones and supplemented with L-Gln 
and penicillin-streptomycin) to each well. BSA or serum was added directly to appropriate 
wells at a final protein concentration of 5 mg/ml, and swirled to mix. Vehicle (0.01 % 
DMSO) or TCDD were then added ( 10 IlVwell) and the plates were incubated for 48 hours 
at 37°C in a humidified atmosphere with 5% C02. At 24 hours, media containing 
unattached cells was removed and fresh AB media (with antibiotics), serum and TCDD (or 
vehicle) were added. At the end of the 48 hour culture period, cell monolayers were 
collected by first rinsing each well twice with ice cold PBS (PH 7.2). Two mls of PBS 
were then added and the cells collected by scraping the cultures with a rubber policeman. 
Cell suspensions were centrifuged at 50 X g for 5 minutes, resuspended in 1 ml 0. 1 M 
KP04- buffer (pH 7.4), and stored at -70oC until assayed for enzyme activity. On the day 
of the enzyme assay, cells were thawed and homogenates prepared by sonication using a 
Vibra Cell sonic cell disrupter (Sonics and Materials Inc. ,  Danbury, CT). 
Q .  Measurement of Ethoxyresorufin-O-deethylase (EROD) Activity in 
Microsomes and Cell Homogenates : 
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Total 7-Ethoxyresorufin-O-deethylase (EROD) activity in microsome aliquots and 
cell homogenates was measured by the method of Blank, et al. ( 1987) [Blank, et al. ,  1987] 
with minor modifications. The buffer used in the assay consisted of 0 . 1  M KP04- (pH 
7.4) containing 2 mg/ml BSA, 10 11M dicumorol, 5 mM glucose-6-phosphate, 20 Vlml of 
glucose-6-phosphate dehydrogenase and 0.5 11M NADPH. 2.5 11M ethoxy resorufin was 
added and the formation of resorufin was measured spectrofluorometrically (perkin and 
Elmer LS 50) with excitation and emission wavelengths of 550 and 585 nm, respectively. 
Protein determinations were carried out by the Bio-Rad protein assay method using BSA 
as the protein control (Bio-Rad Laboratories, Rockville Centre, NY). 
R .  Statistical A nalysis: 
All results were evaluated using a one-way analysis of variance for vehicle and 
TCDD-treated responses. When significant treatment effects were observed, a Dunnett's 
T-test was used to determine which groups were significantly different from the controls. 
IV. RESULTS 
A .  Isolation and Characterization of Dense Resting (Go/G l )  and Cycl ing 
(G l ,  S,  and G 2/M) B and T Cells for In vitro I m m u n ot o x i ci t y  
Test ing:  
1 .  Isolation and Analysis of Purities. 
As opposed to the isolation of T cells, B cells can be efficiently isolated by a method 
involving antibody-mediated complement lysis of T cells, coupled with the separation of 
the remaining cells over percoll density step gradients [DeFranco, et aI., 1982; Layton, et 
aI . ,  1 985;  Monroe, 1988] .  Conversely, a method to isolate highly enriched T cells was 
developed which involves the separation of whole splenocytes (minus autologous red 
blood cells) by percoll density gradient centrifugation coupled to immunomagnetic negative 
selection using FITC-conjugated antibodies, directed against cell surface antigens specific 
for either B or T cells, and anti-FITC antibodies, bound to magnetic beads, and subsequent 
removal of the unwanted cell population; as described by Ladics, et al . ( 1 99 1 )  [Ladics, et 
aI., 1 99 1 a] .  These two different, but related, procedures yield two populations of B and 
T cells that have been characterized as dense resting (Go/G 1 )  and cycling cells (as 
described by Layton, et al. for the isolation of B cells [Layton, et aI . ,  1 985]), based 
primarily on their size and DNA:cytoplasmic ratios (i.e., cell density). In addition, to 
obtain highly enriched populations of the two B cell subtypes for the use in functional 
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testing, it was found that slightly different methods of splenocyte preparation had to be 
used. For the isolation of dense resting B cells, lysis of T cells from freshly prepared 
splenocytes and separation on percoll density step gradients (see Figures 4 and 5), yielded 
a population of cells which separated at the interface of 1 .079/1 .092 percoll (band 3) and 
consisted of approximately �95% Ig+ cells  (Table 3). These cells were also found to 
contain only 2% T cells, < 1  % macrophages/monocytes, and approximately 3-5% 
neutrophils as assessed by both flow cytometry and cytospin analyses (Tables 3 and 4). 
Cell yields ranged from 2-5% of the total number of original splenocytes whereas % 
recoveries, as a percentage of the total number of B cells at the start of the isolation, 
averaged 6- 10% (Table 5). Conversely, cycling B cells and T cells isolated from freshly 
prepared splenocytes, at the interface of 1 .07/1 .079 percoll (band 2), were invariably 
contaminated with an excess number of residual macrophages. This point is demonstrated 
in Figure 4 and Tables 1 ,  2, 3 and 4, in which isolation of either whole splenocytes before 
the isolation of T cells, by imrnunomagnetic negative selection (Figure 4 and Tables I and 
2),  or B cells, after complement mediated lysis (Tables 3 and 4),  resulted in 
macrophage/monocyte contaminated (and occasionally PMN contaminated) cycling B and 
T cell preparations (see materials and methods). Therefore, to obtain highly enriched 
cycling cells, a 10 hour adherence step to plastic petri dishes was employed in order to 
remove a significant proportion of macrophages and to induce the spreading and 
enlargement of the remaining monocytes for subsequent removal during percoll 
centrifugation. As shown in Figure 5 and Tables 1 ,  2, 3 and 4, adherence of whole 
splenocytes to plastic resulted in substantial increases in the purities of cell s  isolated in 
band 2 of either percoll separated splenocytes (for T cell isolation) or B cells (following T 
cell lysis). No improvements in purities were seen in band 3 of either cell preparation 
except for the removal of residual PMNs (which occurred only on occasion) which 
resulted in only slight increases in Ig+ B cells in this band (i.e., 95 to 98%; data not 
shown) ; no macrophages/monocytes were found to separate at this density in either 
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Figure 4. Percent Distributions and Yields of Splenocyte Subpopulations Isolated on 
Percoll Density Gradients Without Adherence to Plastic. Whole splenocytes were 
separated into 3 distinct subpopulations of cells based on bouyant cell density by 
centrifugation over percoll density step gradients. Red blood cells were removed by 
hypertonic lysis with Gey's solution prior to isolation (see materials and methods). Data 
represents the mean ± SE (n=4) percent distributions (i.e., number of cells collected in 
each band as a percentage of the total cells recovered from the gradients) and percent yields 
(i.e., the number of cells collected in each band as a percentage of the total number of 
splenocytes before isolation) of the 3 major subpopulations of splenocytes as based on cell 
density. The representative cell types collected in bands 1 , 2 and 3 are fully differentiated 
lymphocytes and macrophages/monocytes, cycling (G 1 )  lymphocytes and resting 
lymphocytes, respectively. d = Cell yields in band 1 do not represent actual yields due to 
variable amounts of monocytic clumping during collection of these cells. 
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Figure 5 .  Percent Distributions and Yields of Splenocyte Subpopulations Isolated on 
Percoll Density Gradients Following a 10 Hour Adherence to Plastic. Whole splenocytes 
were cultured in plastic petri dishes for 10 hours in RPMI complete media containing 5% 
serum and separated into 3 distinct subpopulations of cells based on bouyant cell density 
by centrifugation over percoll density step gradients. Red blood cells were removed by 
hypertonic lysis with Gey's solution prior to isolation (see materials and methods). Data 
represents the mean ± SE (n=4) percent distributions (i.e., number of cells collected in 
each band as a percentage of the total cells recovered from the gradients) and percent yields 
(i .e., the number of cells collected in each band as a percentage of the total number of 
splenocytes before isolation) of the 3 major subpopulations of splenocytes as based on cell 
density. The representative cell types collected in bands 1 , 2 and 3 are fully differentiated 
lymphocytes and macrophages/monocytes, cycling (G 1 )  lymphocytes and resting 
lymphocytes, respectively. d = Cell yields in band 1 do not represent actual yields due to 
variable amounts of monocytic clumping during collection of these cells. 
Table 1 
Flow Cytometric Analysis of Lymphocyte Subpopulations in Spleen Cells Isolated 
Qn P!,<rl.;Qll D!,<nsit;i S t�ll Gradi!,<nts 
Separation Without Adherence 
R!'<I.;Qv!,<r!'<d Band c IIi+ Th;i 1.2+ 
U nfractionated 
Splenocytes 49±2 d 35± 1 
Band 1 
Splenocytes 63±2 15±1  
Band 2 
Splenocytes 5 1 ±2 44±2 
Band 3 
Splenocytes 22±6 65±5 
L3T4+ 
1 8±1  
14±1 
19±1 
28±1 
Separation Mter 10 Hour Adherence to Plastic 
R�Qy!,<red Band 
Unfractionated 
Splenocytes 
Band 1 
Splenocytes 
Band 2 
Splenocytes 
Band 3 
Splenocytes 
IIi+ 
53±2 
73±4 
43±1 
29±6 
Th;i 1.2+ L3T4+ 
43±2 23±3 
1 3±3 1 1±2 
58±3 32±1 
65±4 25±1 
L;it-2+ 
1 1±1  
5±1 
1 3±2 
21±1  
L;it-2+ 
1 3±1 
3±1 
2 1±1  
3 1±1  
c = Refer to Figures 4 and 5 for population designations according to cell density. d = Data 
represents the mean ± SE (n=3) specific fluorescent antibody labelling from three separate 
experiments. 
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Table 2 
Identification of Leukocyte Distributions Within Splenocyte Subpopulations Isolated 
on Percoll Density Step Gradients Usin� Giemsa Stained Cytospin Preparations 
R\<!;,;Qv\<red Band c 
U nfractionated 
Splenocytes 
Band 1 
Splenocytes 
Band 2 
Splenocytes 
Band 3 
Splenocytes 
R\<wv\<red Band 
U nfractionated 
Splenocytes 
Band 1 
Splenocytes 
Band 2 
Splenocytes 
Band 3 
Splenocytes 
Separation Without Adherence 
Lymphocyt\<s PMNs Ma!;,;siMQnQs EQsinQphils 
91±2 d 4±1 4.5± 1 O.5±O. 1 
76±2 2±1 22±1 O.2±O. 1 
93±2 2±O.5 5±1 O . 8±O.4 
8 8±4 1 1±5 O.3±O. 1 O .5±O.2  
Separation Mter 10 Hour Adherence to Plastic 
Lymphocyt\<s PMNs Ma!;';siMQnQs EQsinQphils 
95±3 3±1 2±O.5 O .5±O. 2  
78±4 2±1 20±1 O.5±O.5 
98±1 1±O.5 l±O.4 O .3±O. 3 
97± 1 3±1 O±O O .4±O.3 
c = Refer to Figures 4 and 5 for population designations according to cell density. d = Data 
represents the mean ± SE (n=3) of slides read from three separate experiments. 
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Table 3 
Flow Cytometric Analysis of Purified Splenic Lymphocyte Subpopulations Isolated 
on Percoll Density Step Gradients 
Recovered Band c 
Band 2 B Cells 
Band 3 B Cells 
R�QQv�red Band 
Band 2 B Cells 
Band 2 T Cells 
Band 3 T Cells 
Separation Without Adherence 
1[:+ 
93±1 d 
96±2 
Thy 1.2+ 
0.4±0. 1 
L3T4+ Lyt-2+ 
0 .5±0. 1 0.4±0. 1 
(CD3+ = 2.0 ± 0. 1 %) e 
Separation After 1 0  Hour Adherence to Plastic 
1[:+ Thy 1.2+ L3T4+ Lyt-2+ 
97±1 0 .3±0. 2  0 .5±0. 1 0 . 1 ±0. 1 
3±1 96±1 58±2 36±2 
2±1 96±1 53±3 43±4 
c = Refer to Figures 4 and 5 for population designations according to cell density. d = Data represents 
the mean ± SE (n=3) specific fluorescent antibody labelling from three separate experiments. e = 
Specific staining with anti-CD3-epsilon was used as the selective T cell marker in these 
experiments. 
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Table 4 
Identification of Leukocyte Distributions Within Purified Lymphocyte Subpopulations 
Isolated on Percoll Density Step Gradients Usin� Giemsa Stained Cytospin Preparations 
Recovered Band c 
Band 2 B Cells 
Band 3 B Cells 
Recovered Band 
Band 2 B Cells 
Band 3 B Cells 
Band 2 T Cells 
Band 3 T Cells 
Separation Without Adherence 
Lymphocytes PMNs MacslMonos 
94±1 d 2±0. 1 4±2 
93±1 5±1 0.5±0 .5  
Separation After 10 Hour Adherence to Plastic 
Lymphocytes PMNs MacslMonos 
98±1 0.2±0.2 1±0.5 
98±1 1±0. 1 0 .6±0.6 
97±1  0.5±0.4 1 . 5±0.4 
94±3 5±2 0.6±0.6 
Eosinophils 
0.5±0.5 
2±0.5  
Eosinophils 
0. 3±0. 1 
O.4±O. 1 
0.7±0.6 
0.4±0.4 
c = Refer to Figures 4 and 5 for population designations according to cell density. d = Data represents the 
mean ± SE (n=3) of slides read from three separate experiments. 
Table 5 
Percent Yields and Recoveries of Purified Lymphocyte 
Subpopulations Isolated on Percoll Density St«p Gradients 
Separation Without Adherence 
Recovered Band c 
Band 2 B Cells 
B and 3 B Cells 
Percent Yields Percent Recoveries 
27±2 d 
4±1 
54±3 
8±3 
Separation After 10 Hour Adherence to Plastic 
Recovered Band 
Band 2 B Cells 
Band 3 B Cells 
Band 2 T Cells 
Band 3 T Cells 
Percent Yields Percent Recoveries 
3 1±2 
< 1  
1 4± 1  
3±1 
64±4 
<1  
30±3 
7±1 
c = Refer to Figures 4 and 5 for population designations according to cell 
density. d = Data represents the mean ± SE (n=3) of three separate 
experiments. 
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procedure. It should also be noted that plating was found to greatly interfere with the 
recoveries of the dense resting B cells (band 3) and resulted in significant losses in cell 
yields (Table 5) .  In fact, this effect was found to complicate the use of plating for the 
isolation of the resting B cell population and made analysis of these cells impossible, given 
the small number of cells that were recovered (Table 5). Figure 5 and Table 5 show the 
percentage of cycling splenocytes and B and T cells (band 2) recovered after a 1 0  hour 
adherence to plastic, which resulted in an increase in purity as compared to no adherence 
(Figure 4 and Tables 1 , 2, 3  and 4). More specifically, cytospin analyses of these cell 
preparations demonstrated that the number of contaminating macrophages/monocytes had 
been greatly reduced (i.e., 5% to 1 % in the splenocyte band 2 and 4% to 1 % in B cell band 
2), as were the numbers of contaminating neutrophils (Tables 2 and 5). % yields and % 
recoveries were also found to be increased for isolated cycling B cells (i.e., 3 1  % and 64% 
versus 27% and 54% , respectively) following the adherence step. This effect was 
reflective of a loss in adherent cells during the plating procedure and not to a change in the 
separation of these cells during isolation. 
2 .  Cell  Cycle Analysis and Mitogen Responses. 
Table 6 illustrates the cell cycle distribution of unfractionated and cycling (band 2) 
whole splenocytes, resting (band 3) and cycling (band 2) B cells, and cycling (band 2) T 
cells isolated on percoll density step gradients. Cycling cells of all 3 cell populations 
isolated with or without adherence showed a similar pattern of cell cycle distribution 
regardless of which approach was used. In addition, the pattern of cell cycle distribution 
closely paralleled the cycle distribution of whole splenocytes and demonstrates that neither 
adherence nor the isolation procedure alters the overall distribution of the cycling cells. 
Moreover, cycling lymphocytes make up the majority of cells within the spleen, as 
demonstrated by the percent distributions as shown in Figures 4 (without adherence) 
Table 6 
Cell Cycle Distribution of Splenocyte and Purified Lymphocyte 
SUbpopulations Isolated on Percoll Density Step Gradients 
Separation Without Adherence 
R�QQv�r�Q BilllQ c QQ/Gl S Q21M 
U nfractionated 
Splenocytes 76 1 8  6 
Band 2 
Splenocytes 72 2 1  7 
Band 2 B Cells 67 23 10  
B and 2 B Cells 79 d 1 3  7 
Band 3 B Cells 85 d 2 14  
Separation After 10  Hour Adherence to Plastic 
R�!;;Qv�r�Q Band GQ!Ql S Q21M 
U nfractionated 
Splenocytes 73 19 8 
Band 2 
Splenocytes 68 22 10  
Band 2 B Cells 67 22 1 1  
Band 2 T Cells 7 1  20 9 
c = Refer to Figures 4 and 5 for population designations according to cell 
density. d = Cell cycle analyses of these cell populations were determined 
using fixed intact cells as opposed to isolated nuclei (see methods). 
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and 5 (with adherence); further supporting the primary use of this population of cells in in 
Y.it.m functional assays as a reflection of lymphocyte populations in whole splenocyte 
responses. In comparison to un separated splenocytes, some decrease in Go/G 1 cells were 
seen, whereas S and G2/M cells were slightly increased. This latter effect was also seen 
following adherence alone (Table 6; unseparated splenocytes and splenocyte cell band 2), 
and is speculatively caused by the removal of interfering macrophages/monocytes and/or 
neutrophils. 
Resting B cells (band 3), from no adherence only, were analyzed for cell cycle 
distribution by two methods, one using isolated nuclei and the other using fixed whole cell 
preparations (see materials and methods). It was found that analysis of the dense resting 
cells (both T and B cells) by the method of Nusse, et ai. [Nusse, et aI., 1 990] , yielded 
distorted values for cycle distribution which were unlike either freshly prepared 
splenocytes or isolated cycling cells (i.e., cycling B cells were also analyzed using both 
methods; Table 6). Analysis of this B cell population using fixed cells showed an increase 
in Go/G 1 cells and a decrease in S phase cells as opposed to either splenocyte cell band 2 
or band 2 B cells (isolated by either method described above). Some differences were also 
detected between the two methods of analysis for band 2 B cells but were not as dramatic 
as for the resting B cell population. However, cytospin analyses of these two populations 
of cells visually confmned the larger nuclear:cytoplasrnic ratios of the resting cells in band 
3 as compared to the smaller ratio that was seen in cytospins of the cycling cells in band 2. 
An increase in G2/M cells were also found in band 3 B cells. Interestingly, this 
observation was consistent with the findings of Layton, et al. ( 1 985) [Layton, et aI., 1 985] 
who concluded that a small number of G2/M cells have a density that would make them 
indistinguishable from the Go/G 1 cells. Alternatively, this finding may also indicate an 
interference by contaminating neutrophils which make up the majority of non-B cells in 
this band (i.e., up to 5%; Table 4). The multi-lobed nature of the neutrophil nucleus may 
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by sufficient to increase their fluorescence during DNA analysis. This effect however, has 
not been determined. 
To further demonstrate the enrichment and functional nature of the B and T cells 
purified using the isolation procedures described above, mitogen responses for both 
unseparated and separated splenocytes and isolated cycling (band 2) and resting (band 3) B 
and T cells were performed. Table 7 illustrates the degree of cellular transformation in the 
presence of lipopolysaccharide (LPS; B cell selective mitogen) and Concanavalin A (Con 
A; T cell selective mitogen) as measured by 3 H-thymidine deoxyribose (3H-TdR) 
incorporation over 96 hours in culture. The proliferative responses of cells obtained with 
and without adherence are provided. As compared with either unseparated or separated 
band 2 splenocytes, band 2 B cells were found to be fully functional following the 
isolation procedure, with little difference between cells obtained with or without adherence. 
This is an important observation in that the 10 hour plating step did not appear to alter the 
functional capacity of these cells for mitogen transformation and supports the usefulness of 
adherence to remove residual macrophages/monocytes to obtain highly enriched cycling B 
cells at no expense to B cell function. Moreover, these cells were found to have no 
capacity to proliferate above background levels in the presence of Con A, further indicating 
the relative purities of B cells obtained by the method described. Likewise, resting and 
cycling T cells were found to selectively respond to Con A versus LPS in the mitogen 
responses, with differences also noted between T cells isolated from bands 3 (resting) and 
2 (cycling) in response to Con A as were seen in the same populations of B cells (Table 7). 
Cycling T cells responded to a much greater degree than resting T cells but neither 
population attained the degree of proliferation that was seen in unfractionated or separated 
splenocytes. Moreover, the background proliferation of cycling T cells was much greater 
than resting T cells, further distinguishing this population as at least partially consisting of 
more mature or pre-activated cells than are found in the cells of band 3 .  
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Table 7 
Mitogen Responses of Splenocyte and Purified Lymphocyte Subpopulations Isolated on 
Percoll Density StkP Gradients 
1 U Mit0i!en Response W'tho t Adh erence 
LPS (CPM±SE) Con A (CPM±SE) 
R�yered Band c 48 72 96 48 72 96 
U nfractionated 88389 d 54458 32563 5 1 993 55 1 1 3 1 7382 
Splenocytes ±3055 ±966 ±2360 ±5638 ±4435 ± 127 1  
Band 2 1 19878 49 100 34944 539 1 3  44944 17607 
Splenocytes ±1723 ±2005 ±899 ±3090 ± 1 0 1 7  ±454 
Band 3 198 14  50598 53542 3223 2485 3477 
Splenocytes ±53 1  ±1968 ±778 ±930 ±222 ±1555 
Band 2 1 3 1 090 50973 39 1 7 1  4 1 3  497 1019 
B Cells ±4085 ±3883 ±2367 ± 1 39 ±36 ±280 
Band 3 141 16  4201 1 88328 -- e -- --
B Cells ±656 ±1906 ± 1734 
Mitoi!en Response After 10 Hour Adherence to Plastic 
LPS (CPM±SE) Con A (CPM±SE) 
Recovered Band 48 72 96 48 72 96 
U nfractionated 849 17  487 17  40383 16744 46092 39027 
Splenocytes ±55 16  ±2345 ± 1 376 ±824 ±2926 ±943 
Band 2 1 12299 49523 45982 6062 1 2449 1 0843 
Splenocytes ±5 1 28 ±1079 ± 1 5 3 1  ±497 ± 1 1 56 ± 1 176 
Band 3 45770 57 1 84 25044 1 373 593 447 
S plenocytes ±5 1 37 ±2 1 27 ±835 1 ±585 ±288 ± 176 
Band 2 1 52977 46979 39898 849 1 1 56 3 1 8  
B Cells ±6075 ±3896 ±2307 ±165 ±41 3  ±33 
Band 3 -- e -- -- - - - - --
B Cells 
Band 2 1499 1947 3066 3590 5256 1 64 
T Cells ± 1 33 ±239 ±794 ±75 1 ± 1032 ±32 1 0  
Band 3 523 499 45 1 1227 1 542 636 
T Cells ± 1 56 ±46 ±93 ±288 ±459 ±2 1 8  
c = Refer to Figures 4 and 5 for population deslgnauons according to cell denSity. d = Cell proliferation 
was determined by 3 H-TdR incorporation. Values represent the mean ± SE of absolute CPM of 
quadruplicate cultures harvested at 48, 72 and 96 hours (See materials and methods for details). e = Not 
determined 
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Because of the limitation in the number of cells obtained for band 3 (dense resting) B 
cells, mitogen responses were only assessed in the presence of LPS (as opposed to LPS 
and Con A). However, as consistent with our other observations (i .e., cell cycle analysis) 
and with other reports [Layton, et aI., 1 985], these cells responded differently than the 
cycling B cells to this mitogen. Both the peak day and magnitude of proliferation was 
found to be slightly different than in the cycling B cells. Differences were also found in 
the degree of background proliferation, in which the band 3 B cells had a much lower 
average proliferation than was found for either unseparated splenocytes or enriched cycling 
B cells (data not shown). Band 3 B cells isolated following adherence were not assessed 
for their response to either mitogen because of the lower yields that were obtained. 
B .  Effects of TCDD on the In vitro T -Dependent Antibody Response: 
1 . Serum Dependency for Suppression . 
One of the first observations made concerning the effects of TCDD on the in vitro T­
dependent antibody response, was the dependency not only on the lot, but on the 
concentration of serum present in the culture media. To verify and further characterize this 
effect, we obtained 23 lots of serum (2 1 lots of fetal bovine serum, 1 lot of newborn calf 
serum, and 1 lot of fetal equine serum; FBS, NBCS, and FES respectively), all of which 
could support a good in vitro antibody response to SRBC, and determined their ability to 
support the suppressive effects of 30 nM TCDD (0.0 1 % DMSO) on this response at serum 
concentrations of both 5 and 10%. Of these 23 lots, only 5 lots of serum (3 lots of FBS, 
the one lot of NBCS, and the one lot of FES) could support the suppression by TCDD on 
the peak day of the response (day 5). The remaining lots (all FBS) seemed to demonstrate 
a "protective-like" effect against TCDD exposure (i.e., did not support the suppression by 
TCDD), and in several cases showed enhancements in the AFC response following TCDO 
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addition; as compared to vehicle-treated controls. The latter effect is depicted most notably 
in Figure 6, in which TCDD addition to cultures containing 5% FBS of lot 890 caused a 
>2-fold enhancement in the AFC response on day 5 of culture (at 30 nM TCDD). At 1 0% 
FBS lot 890, no enhancements were seen (but rather suppression at 3 nM) and further 
demonstrated the complex interaction between TCDD and growth factors present in FBS. 
We further examined the serum-dependency of the suppression produced by TCDD by 
looking  at the dose responsiveness of TCDD in each of the 5 remaining lots at 
concentrations of both 5 and 1 0%.  Shown in Figure 7 (Figures A and B) is a comparison 
of the effects of TCDD in each of 5 representative lots of serum at both 5 and 1 0%, 
respectively. As noted above, these lots were selected based upon their ability to support a 
suppression at a concentration of 5% in the presence of 30 nM TCDD. As seen in Figure 7 
(A), when log dose response curves were established using 0.3, 3.0, and 30 nM TCDD 
(0.0 1 % DMSO) in a 5% concentration of each serum, we found that only 1 lot of FBS (lot 
847), the single lot of NBCS (lot 453), and the single lot of FES could support a full dose 
response suppression. In the remaining two lots (FBS 7 17 and 856) TCDD did not 
produce a dose-related suppression. In comparing this profile of effects with what is seen 
at 1 0% serum (Figure A versus B), only the NBCS (lot 453) continued to support a full 
dose response suppression by TCDD. The remaining 4 lots demonstrated either a loss in 
dose responsiveness or an enhancement (FBS 7 17 ,  at 0.3 and 3 nM) in the presence of 
TCDD. With exception of lot 856 ( 1  trial only), all sera were tested at least 2 times for 
dose related effects by TCDD. Collectively, it can be seen that, whereas the FBS (lot 847) 
and FES support a suppression of the T-dependent antibody response only at a 
concentration of 5% serum, the NBCS could support a suppression at either 5 or 1 0%.  
Subsequent to these experiments, two additional lots of NBCS (lots 512 and 3 1 3; Armour 
Pharmaceuticals) were analyzed for support of the suppressive effects of TCDD on the in 
Yi.tru antibody response. As seen in Figure 8, NBCS lot 5 1 2  was found to also support an 
equivalent suppression of the antibody response at both concentrations. The same effect 
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Figure 6. Enhancement of the In Vitro T-Dependent Antibody Response by TCDD in the 
Presence of Fetal Bovine Sera is Dependent on the Lot and Concentration of Serum. Data 
represents the effect of TCDD on the day 5 anti-SRBC antibody forming cell (AFC) 
response/1 06 recovered B6C3Fl splenocytes in cultures containing media supplemented 
with either 5% or 10% fetal bovine serum lot 890. Abbreviations are defined as follows: 
NA=naive (media only); VH=vehicle control (0.01 % DMSO); FBS=fetal bovine serum. 
Data is presented as the mean ± SE of 6 replicate cultures/treatment group and is 
representative of at least 2 separate experiments. Letter codes for significance as compared 
to the vehicle control are defmed as follows: a=p:::;O.O I .  
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A 
-0- FBS 7 1 7  5% 
------ FBS 856 5% 
--{j- FES 5% 
--- FBS 847 5% 
--/r- NBCS 5% 
B 
30.0 nM TCDD 
-0- FBS 7 1 7 1 0% 
____ FBS 856 1 0% 
--{j- FES 1 0% 
____ FBS 847 1 0% 
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Figure 7. Serum Dependency for Suppression of the In Vitro T-Dependent Antibody 
Response by TCDD. Data represents the day 5 anti-SRBC antibody forming cell (AFC) 
response/106 recovered B6C3Fl splenocytes in culture and is presented as a percentage of 
the control AFC response in the presence of increasing concentrations of TCDD. Figures 
A (top) and B (bottom) are the results of cultures containing media supplemented with 
either 5% or 1 0%, respectively, of the different lots serum tested. Abbreviations are 
defined as follows: FBS=fetal bovine serum; FES=fetal equine serum; NBCS=newborn 
calf serum. Data presented is representative of at least 2 separate experiments. 
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Figure 8. Suppression of the In Vitro T-Dependent Antibody Response by TCDD in the 
Presence of Newborn Calf Serum Is Not Dependent Upon the Lot or Concentration Used 
in Culture. Data represents the effect of TCDD on the day 5 anti-SRBC antibody forming 
cell (AFC) response/l 06 recovered B6C3F l splenocytes in cultures containing media 
supplemented with either (figure A) 5% or (figure B) 10% newborn calf serum 5 1 2. 
Abbreviations are defined as follows: NA=naive (media only); VH=vehicle (0.0 1 % 
DMSO); NBCS=newborn calf serum. Data is presented as the mean ± SE of 6 replicate 
cultures/treatment group and is representative of at least 2 separate experiments. Letter 
codes for significance as compared to the vehicle control are defined as follows: 
a=p50.0 1 .  
8 8  
was seen in NBCS lot 3 1 3  and supports the conclusion that the synergistic serum mediator 
of the TCDD-induced suppression is a generalized component of all newborn calf sera; as 
opposed to FBS which demonstrated an enormous degree of lot to lot variation in this 
response. It should also be noted that these effects did not correlate with the level of 
endotoxins found in the five representative lots of serum presented in Figure 7. Endotoxin 
levels were determined by the serum suppliers (see materials and methods) using the LAL 
Gel-Clot method with endotoxin levels for each of the 5 representative lots being described 
as follows: lot 7 17 - 0.2 ng/mI, lot 847 - 0.05 ng/ml and lot 856 - 0.025 ng/ml; NBCS (lot 
453) - 1 1 . 1  ng/mI; FES (lot 1 63) - 0.3 ng/mI. 
2 .  En hancements Fol lowing In Vivo Exposu re. 
The enhancements in the in vitro T-dependent antibody response to SRBC that were 
seen following direct addition of TCDD to cultures containing FBS were not found to be a 
unique characteristic of in vitro exposures. Figure 9 illustrates the effect of in vivo 
exposure on the in vitro antibody response. Following a 5 day repetitive exposure of 
B6C3 F l  female mice to 1 ,  1 0  and 30 �g/kg TCDD, splenocytes were removed and 
stimulated with SRBC in cultures supplemented with either 5% (Figure 9 A) or 10% 
(Figure 9 B) of the various lots of FBS and NBCS as indicated (see materials and 
methods). As can be seen in Figure 9, enhancements were found in the AFC responses of 
cultures containing cells exposed in vivo at levels of either 10  or 30 �g/kg TCDD. Some 
suppression was seen at the 1 �g/kg exposure level but was not a consistent effect. 
Interestingly, a slight difference was seen in the enhancements following in vivo exposures 
as opposed to in vitro, in which the enhancements seen following in...YiYQ exposure were 
not dependent on the serum lot. This difference is demonstrated in Figure 9, where 
exposure of mice to the 50 �g/kg cumulative dose of TCDD produced enhancements in the 
antibody responses of the exposed splenocytes when cultured in the presence of 5% 
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Figure 9. Enhancement of the In Vitro T-Dependent Antibody Response Following In 
Vivo Exposure of Splenocytes to TCDD. Data represents the day 5 anti-SRBC antibody 
forming cell (AFC) response/ 1 06 recovered B6C3Fl splenocytes in cultures containing 
media supplemented with either (figure A) 5% or (figure B) 10% of various lots of serum 
following i n  vivo exposure of mice to TCDD for 5 consecutive days (see methods). 
Abbreviations are defined as follows: FBS=fetal bovine seI1l.l1l; NBCS=newborn calf 
serum. Data is presented as the mean ± SE of 6 replicate cultures/treatment group and is 
representative of at least 2 separate experiments. Letter codes for significance as compared 
to the corn oil (vehicle)-treated control cell response are defined as follows: a=p:S;O. O l ;  
b=p:S;O.05.  
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serum, even in the presence of NBCS. However, this effect was not seen at 10% serum, 
where enhancements were seen in all 3 lots of FBS , but not in the NBCS . More consistent 
with the effects during in vitro exposures, there was a concentration dependency for these 
effects, in which differences were seen in the magnitude of the enhancements when 
comparing the responses obtained using 5 versus 1 0% serum (Figures 9 A and B). 
3 .  Comparison of the Effects of TCDD and SAC Under Serum­
Supplemented Culture Conditions. 
When compiling the previous findings indicating that TCDD appears to act primarily 
on the B lymphocyte [Dooley and Holsapple, 1988] with the current observation that the 
effects of TCDD on the antibody response to SRBC is dependent on serum-derived growth 
factors to produce either enhancements or suppression of the in vitro antibody response, 
we were struck by the unique profile of activity. It was through the use of these key 
observations that we began to look at the effects of the polyclonal B cell activator, 
Staphylococcus aureus Cowan strain I (SAC), on the .in..Yin:Q antibody response. Because 
the literature (i .e., as described above in the literature review) suggests that there might be 
similarities between TCDD and SAC, a comparison was made between the actions of SAC 
and TCDD on the in vitro T-dependent antibody response in 2 separate lots of serum (one 
which supported the suppression by TCDD - 5% NBCS lot 453, and one which did not -
1 0% FBS lot 7 1 7). It should also be noted that protein determinations were conducted 
(Bio-Rad protein assay) on serum lots NBCS 453 and FBS 7 17 and revealed that media 
supplemented with 5% NBCS (5 mg/ml protein) was approximately equivalent to the 
protein content of the media supplemented with 10% FBS (5.5 mg/ml). Therefore, 
differences in total protein cannot explain the immunomodulatory effects of the serum and 
support the role by a specific serum-derived growth factor. As can be seen in Figure 1 0  (A 
and B), TCDD, at concentrations of 0.3 ,  3.0, and 30 nM, caused a dose dependent 
91 
Figure 10. Effect of TCDD on the In Vitro T-Dependent Antibody Response in 
the Presence of Fetal Bovine and Newborn Calf Serum . Data represents the day 5 
anti-SRBC antibody forming cell (AFC) response/106 recovered B6C3F1 
splenocytes in cultures containing media supplemented with either (figure A) 5% 
NBCS or (figure B) 10% FBS (lot 717) in the presence of increasing 
concentrations of TCDD. Abbreviations are defined as follows: NA=naive (media 
only); VH=vehicle control (0.01 % DMSO); FBS=fetal bovine serum; 
NBCS=newborn calf serum. Data is presented as the mean ± SE of 6 replicate 
cultures/treatment group and is representative of at least 2 separate experiments. 
Letter codes for significance as compared to the vehicle-treated control are defined 
according to the parameter measured as indicated: AFC response/106 recovered 
cells - a=p�O.Ol; Recovered cell number - c=p�O.Ol; Viable cell number -
f=p�0.05 . 
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suppression of the iILYin:Q T-dependent response in media containing 5% NBCS (lot 453; 
Figure 10 A) whereas the same concentrations of TCDD in media containing 10% FBS (lot 
7 1 7 ;  Figure 10  B) showed no suppression, but instead produced a small enhancement at 
concentrations of 0.3 and 3 .0 nM. Vehicle-treated controls (0.01 % DMSO) demonstrated 
no effect. Likewise, when SAC was added to identically prepared cultures, at final 
concentrations ranging from 0.00025 to 0.004%, it showed the same profile of effects 
(Figure 1 1 ) .  In media containing 5% NBCS (lot 453), a dose dependent suppression of 
the T -dependent response was observed, whereas in media containing 10% FBS (lot 7 1 7), 
there was a loss of suppressive effects by SAC on this response; with the 3 lowest 
concentrations (0.00025, 0.0005, and 0.00 1 %) producing a slight enhancement. Both 
TCDD and SAC suppressed this response to a near equivalent degree in the presence of 
10% NBCS (30 nM TCDD and 0.00 1 % SAC) as demonstrated in Figure 1 2; which 
further demonstrates that neither TCDD nor SAC produce a serum-concentration­
dependent suppression of the antibody response in NBCS. Because of the labor intensity 
of these studies, and the non-dose-dependent effects by TCDD, comparisons were not 
carried out at 5% FBS 7 17 (see Figure 7).  Although these data appear to show identical 
profiles between the effects of TCDD and SAC on the T-dependent response, there were 
also some differences. In the case of SAC's effects on the T-dependent response in the 
presence of 5% NBCS, there was a dose dependent increase in recovered cell numbers 
which were significant at all concentrations of SAC (p�O.O I ;  consistent throughout 3 
separate experiments; Figure 1 1 ) .  Concomitantly, this increase in cell number was 
accompanied by a dose dependent decrease in cellular viability, again significant at all 
concentrations (p�O.O I ). However, no significant change in viable cell numbers occurred 
even though the total numbers of plaques were reduced by the treatment. In the presence 
of 1 0% FBS, as was the case with 5% NBCS, there was a dose dependent increase in cell 
number which plateaued at a concentration of 0.00 1 % SAC, but the effects on cell 
viabilities were not as prominent. Only 1 out of 3 separate experiments, each showing 
94 
Figure 11. Effect of SAC on the In Vitro T-Dependent Antibody Response in 
the Presence of Fetal Bovine and Newborn Calf Serum. Data represents the day 5 
anti-SRBC antibody forming cell (AFC) response/l06 recovered B6C3F1 
splenocytes in cultures containing media supplemented with either (figure A) 5% 
NBCS or (figure B) 10% FBS (lot 717) in the presence of increasing 
concentrations of Staphylococcus aureus Cowan strain I (SAC). Abbreviations are 
defined as follows: NA=naive (media only); FBS=fetal bovine serum; 
NBCS=newborn calf serum. Data is presented as the mean ± SE of 6 replicate 
cultures/treatment group and is representative of at least 2 separate experiments. 
Letter codes for significance as compared to the vehicle-treated control are defined 
according to the parameter measured as indicated: AFC response/l()6 recovered 
cells - a=p�O.O 1, b=p�0.05; Recovered cell number - c=p�O.O 1; Viable cell 
number - no significant differences were detected. 
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Figure 12. Suppression of the In Vitro T-Dependent Antibody Response by SAC in the 
Presence of Newborn Calf Serum Is Not Dependent Upon the Concentration Used in 
Culture. Data represents the effect of either TCDD or SAC on the day 5 anti-SRBC 
antibody forming cell (AFC) response/l 06 recovered B6C3 F l  splenocytes in cultures 
containing media supplemented with 10% newborn calf serum. Abbreviations are defined 
as follows: NA=naive (media only); VH=vehicle (0.01  % DMSO); SAC=Staphylococcus 
aureus Cowan strain 1. Data is presented as the mean ± SE of 6 replicate cultures/treatment 
group and is representative of at least 2 separate experiments. Letter codes for significance 
as compared to the media or vehicle controls are dermed as follows: a=p�O.0 1 .  
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almost identical effects on the T-dependent response, showed any effect on cell viability in 
the presence of 1 0% FBS (lot 7 17),  and only at concentrations � 0.005% SAC. In 
comparison, TCDD, in the presence of 5% NBCS, caused significant increases in cell 
number (p:S;O.O I )  only at a concentration of 30 nM (consistent throughout 3 separate 
experiments) which was accompanied by only a slight decrease in cellular viability (unlike 
what was seen with SAC; Figures 1 0  and 1 1 ).  Again in contrast to SAC, TCDD, in the 
presence of 1 0% FBS (lot 7 17) ,  showed no significant effects on cell number or cell 
viability. 
Because of the similarities between the actions of TCDD and SAC on the in vitro 
antibody response, experiments were also conducted to determine the potential interaction 
between these two agents when administered in combination to in vitro cultures stimulated 
with S RBC. As shown in Figure 1 3, the combination of TCDD + SAC caused a greater 
degree of suppression of the antibody response than either of the two agents administered 
alone at suboptimal concentrations (TCDD=0.3 nM; SAC=O.OO I %). This effect was 
produced in two separate experiments (Figures 1 3  A and B) and demonstrates the 
interactive potential of TCDD and SAC in suppression of the in vitro T-dependent antibody 
response. 
4 . Comparison of the Effects of TCDD and SAC Under Serum­
Free Culture Conditions. 
Having demonstrated that TCDD and SAC can suppress the primary T-dependent 
antibody response in a manner which is dependent on the lot and concentration of serum 
present in the culture media, it was of interest to develop a serum-free culture system to 
investigate the effects of TCDD on this response in the absence of serum growth factors 
(sensitization with SRBC; day 5 response). In preliminary studies, it was determined that 
serum-free conditions did not support a very pronounced T-dependent response (:S;1 0  
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Figure 13. Potentiation of Effects Between TCDD and SAC in Suppression of the In 
.Yi.tm T-Dependent Antibody Response. Data represents the effects of a combination of 
suboptimal concentrations of TCDD and SAC on the day 5 anti-SRBC antibody forming 
cell (AFC) response/1 06 viable B6C3F l splenocytes in cultures containing media 
supplemented with 5% newborn calf serum. Abbreviations are defined as fol lows: 
DMSO=dimethylsulfoxide (vehicle); SAC=Staphylococcus aureus Cowan strain 1 .  
Figures A (top) and B (bottom) represent two separate experiments as indicated. Data is  
presented as the mean ± SE of 6 replicate cultures/treatment group. Letter codes for 
significance as compared to the vehicle control are defined as follows: a=p:S;O.Ol .  
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AFC/Culture). Although this finding may seem to hinder its usefulness in the study of 
many agents which can interfere (i.e., suppress) with humoral immune responses, it can 
be very useful in the study of agents which can cause the activation of lymphocytes. In 
this type of antigen driven (T-dependent) system, however, T cell-derived growth and 
differentiation factors would be available so that the effect elicited by agents that potentiate 
the activation of lymphocytes would be manifested as an enhancement in the AFC 
response; as compared to either media or vehicle-treated controls. As depicted in Figure 14 
(Figure A), 30 nM TCDD, added to cultured splenocytes stimulated with SRBCs in a 
serum-independent environment, increased the T-dependent AFC response/culture I S-fold 
over the vehicle-treated controls. These results were obtained in the absence of any 
significant effects on either cell number or viabilities and were consistent throughout 5 
separate experiments. Following identical methods as those used for TCDD, we 
administered a dose responsive range of SAC concentrations to whole splenocytes which 
were cultured under the same serum-independent conditions. As demonstrated (Figure 14  
B) ,  SAC, at concentrations ranging from 0.0005 to 0.002%, caused a dose related increase 
in the AFC response which culminated in as high as an 1 8-fold increase. However, as 
was the case under serum supplemented conditions,  SAC differed from TCDD in that 
significant increases in recovered cell numbers were indicated. Likewise, there was a 
slight decrease in the number of viable cells recovered, indicating again that TCDD and 
SAC have similar but slightly different modes of action on the in vitro T-dependent 
response. Additional studies have shown that the increases in the AFC response by TCDD 
and SAC under serum-free culture conditions only occurs in the presence of antigen 
stimulation (i.e. , SRBC), suggesting a possible requirement for antigen stimulated soluble 
mediators in the enhanced response by TCDD and SAC, and 
that the AFC responses measured in earlier studies were specific anti-SRBC AFCs and not 
non-specific plaques formed as an artifact of the serum-free culture system (Figure 1 5). 
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Figure 14. Effect of TCDD and SAC on the In Vitro T-Dependent Antibody Response 
Under Serum-Free Culture Conditions. Data represents the effect of either (figure A) 
TCDD or (figure B) SAC on the day 5 anti-SRBC antibody forming cell CAFC) response/ 
B6C3F l splenocyte in cultures containing KC2000 serum-independent media (see 
materials and methods). Abbreviations are defined as follows: NA=naive (media only); 
VH=vehicle (0.01  % DMSO); SAC=Staphy!ococcus aureus Cowan strain 1. Data is 
presented as the mean ± SE of 6 replicate cultures/treatment group and is representative of 
at least 2 separate experiments. Letter codes for significance as compared to the media or 
vehicle controls are defined as follows: a=pg).O I ,  b=p�0.05. 
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Figure 15. Antigen Dependency for Enhancement of the In Vitro T-Dependent Antibody 
Response by TCDD and SAC Under Serum-Free Culture Conditions. Data represents the 
effect of either TCDD or SAC on the day 5 antibody forming cell (AFC) response/ 
B6C3F l  splenocyte in  cultures containing KC2000 serum-independent media in the 
presence or absence of the sheep red blood cell (SRBC) antigen. Abbreviations are 
defined as follows:  NA=naive (media only); VH=vehicle (0.01  % DMSO); SAC= 
Staphylococcus aureus Cowan strain I. Data is presented as the mean ± SE of 6 replicate 
cultures/treatment group and is representative of at least 2 separate experiments. Letter 
codes for significance as compared to the media or vehicle controls are defined as follows: 
a=p�O.O l ,  b=p�0.05 . 
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C .  Effects of TCDD on Splenic-Derived Dense Resting (Go) B Cells: 
1 . Serum Dependency for Proliferation and Differentiation Into IgM 
Secreting Cells Following Di rect Addition of TCDD. 
Given the apparent enhancements in the in...YiJN AFC response and the similarities in 
effects between TCDD and SAC, studies were performed to determine if TCDD could 
cause the activation and differentiation of dense resting B lymphocytes upon direct addition 
to culture. Splenic-derived dense B cells were isolated from naive B6C3F l mice (see 
material and methods) and placed into cultures containing media supplemented with sera 
that were shown to either support the suppression of the T-dependent antibody response 
by TCDD (5% NBCS lot 453) or show a "protective-like" action to the effects of TCDD 
( 1 0% FBS lot 7 17).  As demonstrated in Figure 1 6  A, 30 and 60 nM TCDD added to 
cultures of dense resting B cells in the presence of 10% FBS caused a significant increase 
in the proliferation of these cells, as compared to the vehicle-treated cultures. This effect 
was most apparent at 72 hours after treatment and continued to be significantly increased 
up to 96 hours. No effect was seen at 48 hours. In contrast, cultures prepared in 5% 
NBCS demonstrated no proliferative effects by TCDD even up to 96 hours of culture. The 
vehicle used in these experiments (0.01 % DMSO) demonstrated no effect on the naive 
response of these cells regardless of the serum used (data not shown) . In subsequent 
experiments, it was further determined that 30 nM was the lowest concentration of TCDD 
that was found to enhance the proliferative capacity of isolated resting B cells in culture 
(Figure 1 7). No effects were seen at concentrations up to 1 0  nM within a 96 hour culture 
period. 
Additionally, as shown in Figure 18,  TCDD (30 nM; a concentration giving maximal 
proliferation in serum lot 7 17) caused an increase in the level of IgM secretion in isolated 
dense resting B lymphocytes on day 7 of culture as compared to either media or vehicle-
103 
Figure 16. Serum Dependency for Proliferation of Splenic-Derived Dense 
Resting B Cells Following Direct Addition of TCDD. Highly purified dense 
resting B cells were isolated as described (see materials and methods) and cultured 
(1 X lOS/well) with media supplemented with either (figure A) 10% fetal bovine 
serum lot 717 or (figure B) 5% newborn calf serum in the presence of increasing 
concentrations of TCDD (i.e., 10, 30 and 60 nM). Cellular proliferation was 
measured at 48,72 and 96 hours after culture initiation as determined by 3H-TdR 
incorporation following a 16 hour pulse time. Abbreviations are defined as 
follows: FBS=fetal bovine serum; NBCS=newborn calf serum; VH=vehicle 
(0.01 % DMSO). Data is presented as the mean ± SE of absolute CPM of 
quadruplicate cultures. Letter codes for significance as compared to the vehicle­
treated control are defined as follows: a=p�.01. 
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Figure 17. Activation of Dense Resting B Cells Requires the Maximal Suppressive 
Concentration of TCDD. Highly purified dense resting B cells were isolated as described 
(see materials and methods) and cultured ( 1  X 105/well) with media supplemented with 
either 1 0% fetal bovine serum lot 7 17 or 5% newborn calf serum in the presence of 
increasing concentrations of TCDD (i.e., 3 ,  10  and 30 nM). Cellular proliferation was 
measured at 72 hours after culture initiation as determined by 3H-TdR incorporation 
following a 1 6  hour pulse time. Abbreviations are defmed as follows: FBS=fetal bovine 
serum; NBCS=newborn calf serum; NA=naive (media only); VH=vehicle (0.01  % 
DMSO). Data is presented as the mean ± SE of absolute CPM of quadruplicate cultures. 
Letter codes for significance as compared to the vehicle-treated control are defined as 
follows: a=p:$;O.O 1 .  
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Figure 18. Serum Dependency for Stimulation of IgM Secretion From Splenic-Derived 
Dense Resting B Cells Following Direct Addition of TCDD. Highly purified dense resting 
B cells were isolated as described (see materials and methods) and cultured (5 X lOS/well) 
with media supplemented with either 10% fetal bovine serum lot 7 1 7 or 5% newborn calf 
serum in the presence of 30 nM TCDD. Supernatants were collected on day 7 of culture 
and assayed for total murine IgM (see materials and methods). Data is presented as the 
mean ± S E  ng IgM/culture of 6 replicate cultures. Letter codes for significance as 
compared to the vehicle-treated control are defmed as follows: a=p�O.O l .  
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treated controls. Like the effects seen on proliferation, this increase in immunoglobulin 
production did not occur in the presence of 5% NBCS; further supporting the serum 
dependency for the enhancements of the antibody response by TCDD. 
2 . Depletion of Dense Resting B Cells Following In Viyo 
Sensitization of TCDD Exposed Mice. 
B cells in different stages of the cell cycle (particularly resting Go and cycling G I 
cells) have distinct buoyant densities. This characteristic therefore allows for the isolation 
of B cell subpopulations using the well established method of density centrifugation on 
percoll density step gradients (see materials and methods). To determine if TCDD has the 
capacity to alter these populations in vivo (in the absence or presence of antigen challenge) 
an experiment was designed to monitor any changes in these B cell subpopulations. The 
rationale follows that if TCDD caused an arrest in the differentiation of nonnally activated 
B cells (the presumed consequence of TCDD's actions on the B lymphocyte; [Holsapple, 
et al. ,  1 986a; Dooley and Holsapple, 1988;  Luster, et al. ,  1988b]), then it seemed possible 
that this type of effect would be manifested on the density gradients by new band 
fonnations at densities near to, or less than, that of the cycling B cell (an undifferentiated 
phenotype). Accordingly, an experiment was devised in which four groups of 8- 1 2  week 
old mice (3/group) were treated with either 1 Ilg/kg TCDD (groups 2 and 4) or corn oil 
(vehicle; groups 1 and 3) for 5 days and rested for 2 days. Animals in groups 1 and 2 
(unsensitized) were sacrificed on day 7, their spleens removed and pooled, and the various 
B cell populations separated on percoll density gradients. As shown in Figure 1 9  (groups 
1 and 2), changes occurred in both the resting (band 3) and cycling (band 2) cell 
populations isolated from the TCDD-treated mouse spleens as compared to the corn oil­
treated controls. These changes were manifested as the fonnation of a less distinct resting 
cell band, and the fonnation of a population of cells which produced a very non-compact 
108 
Figure 19. Effect of TCDD Exposure on Splenic B Cell Subpopulations Isolated 
From Female B6C3Fl Mice. Eight to twelve week old B6C3F l mice were 
separated into 4 treatment groups (3 mice/group). Mice were administered either 
vehicle (corn oil; groups 1 and 3) or 1 Ilg/kg TCDD (groups 2 and 4) for 5 days, 
rested for 2 days, and either sacrificed (day 7 after initial dosing; groups 1 and 2) 
or sensitized by i.p. injection with sheep red blood cells (SRBCs; see materials and 
methods) and then sacrificed on the peak of an in vivo T-dependent antibody 
response (day 4). B cell subpopulations were isolated as described in materials 
and methods. Data are presented as observed on either day 7 after TCDD treatment 
(groups 1 and 2) or on day 4 following sensitization of TCDD-treated animals with 
SRBCs (groups 3 and 4). A table is provided to include recovered cell numbers 
and yields of each respective subpopulation. The data presented are representative 
of two separate experiments giving almost identical results. 
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band at a density that was slightly less than that of the matched corn oil-treated resting 
cells. In addition, there was a second band of cells fonned, which was also less compact 
and appeared at a density j ust higher than the density of the matched corn oil-treated 
blasting cells. When the various populations were collected and analyzed for cell number 
and % yields (based on cells recovered as a percentage of the total lymphocytes present in 
the original splenocyte preparation) some additional fmdings were observed (Table/Figure 
1 9). As compared to the corn oil-treated B cell populations, the overall B cell yield had 
increased in the spleens of the TCDD-treated animals ( 17% vs 24.5%); indicating the 
possibility that these cells had been activated in the absence of antigen challenge. This 
effect was characterized by increases in the number and % yield of cells banding at or near 
the densities which are recognized as the resting and the blasting cell populations. No 
change in  cell number or yield was evident in the population of cells characterized as 
containing fully differentiated plasma cells (although other cell types are present; i .e. ,  
macrophages). These effects were observed in the absence of any apparent alteration in 
either spleen weight or total number of lymphocytes recovered from the spleen. The 
second phase of this study was initiated by sensitizing groups 3 and 4 (day 7 after initial 
dosing) i .p. with 5 X 108 SRBCs (in 0.2 ml saline) and allowing these mice to respond to 
this antigen for 4 days prior to isolating the various B cell populations as described above. 
Interestingly, whereas the three B cell subpopulations from the corn oil-treated animals 
again appeared normal on the percoll gradients, the isolated B cell populations from the 
TCDD-treated splenocytes were marked by several distinct changes, the most obvious 
being a complete loss of the resting B cell pool. This was further characterized by the lack 
of detection of any cells banding at a buoyant density 2! 1 .082 g/ml on the percoll step 
gradient. An additional finding was the fonnation of an even more distinct and denser 
band, at a density just slightly higher than that of the cycling B cells, which was similar to 
that seen in the cells isolated from the unsensitized TCDD-treated animals (Figure 1 9; 
groups 3 and 4). When the cell number and % yields of each population were analyzed, 
1 1  1 
we observed a decrease in the % yield of total B cells recovered (Table; Figure 19).  
Although we have not investigated this effect fully, we feel that because these yields are 
assessed according to the total number of lymphocytes recovered from the spleen, T cell 
proliferation following antigen stimulation (in the absence of appreciable B cell 
proliferation) has skewed the yields accordingly. Thus, the data would appear to be more 
a function of altered B cell responses in these animals than a loss in total B cells recovered 
(i.e. , this i s  in  comparison to a normal T-dependent antigen driven response where 
increases in the B cell yields are expected to occur). However, some B cell loss is 
evidenced by the fact that the number of recovered cells for both the cycling (band 2) and 
differentiated (band 1 )  cells are only slightly decreased below controls while the resting B 
cells have been completely depleted. 
3 . Serum Dependency for Proliferation Following In vivo 
Exposure to TCDD. 
To correlate the effects of direct exposure of TCDD on splenic-derived dense B 
lymphocytes (i.e., activation; as evidenced by an increase in proliferation and production 
of IgM) with the alterations found in the splenic B cell subpopulations isolated from 
TCDD-treated mice (as described above), further experiments were conducted to determine 
whether dense B lymphocytes isolated from TCDD exposed animals, like those exposed 
directly in culture, would show: 1 )  a capacity to spontaneously proliferate in culture; and 2) 
a serum dependency for this effect. As shown in Figure 20, splenic-derived dense B 
lymphocytes isolated from female B6C3Fl  mice exposed to 1 I-J.glkglday of TCDD for 5 
days (with 2 days rest), showed a l O-fold increase in proliferative capacity as compared to 
the matched com oil-treated control cells. This effect was observed when cells were 
cultured in media containing 10% FBS but not 5% NBCS, and further demonstrates the 
importance of serum-derived growth factors in the modulation of splenic-derived dense B 
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Figure 20. Serum Dependency for Proliferation of Splenic-Derived Dense B Cells 
Following In Vivo exposure of Female B6C3Fl  Mice. Mice were administered either 
corn oil (vehicle) or 1 �g/kg TCDD for 5 consecutive days before isolation of splenic 
dense resting B cells. Cells were cultured ( 1  X l OS/well) with media supplemented with 
either 10% fetal bovine serum or 5% newborn calf serum under conditions as described in 
materials and methods. Cellular proliferation was measured at 48 hours after culture 
initiation as determined by 3H-TdR incorporation following a 1 6  hour pulse time. Data is 
presented as the mean ± SE of absolute CPM of quadruplicate cultures. Letter codes for 
significance as compared to the vehicle-treated control are defined as follows: a=p�O.0 1 .  
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lymphocyte responses to the effects of dioxin. Cycling B cells, when assayed under 
comparable conditions, were not found to spontaneously proliferate in culture, but rather 
showed no effect fol lowing the in vivo exposure regimen described above (data not 
shown). 
4 . Gamma-Interferon Potentiates the Proliferation Induced by 
T C D D .  
Previous studies i n  this laboratory have shown that the pleiotropic cytokine, garnma­
interferon (G-IFN), can block the immunosuppressive effects of TCDD on the in vitro T­
dependent antibody response (Dooley, Holsapple, Snyder and Yang, unpublished 
observations). Therefore, experiments were conducted to determine the potential 
interactive effect of G-IFN on the TCDD-induced increase in proliferation of dense resting 
B cells when administered simultaneously to cultured cells. In addition, the effects of 
interleukin-2 (lL-2) on both SAC and TCDD-exposed cells were also investigated because 
of the potentiating effects of this cytokine on the proliferation of SAC activated resting B 
cells and to determine if the "activation-like" effect of TCDD on dense resting B cells was 
related to the activation induced by SAC. Moreover, potential cytokine interactions were 
also determined by adding both IL-2 and G-IFN in combinations to TCDD-treated 
cultures, in which the time of IL-2 and G-IFN additions were switched between 0 and 24 
hours of culture as indicated (Figure 2 1 ;  t=O and t=24). A 48 hour time point was chosen 
to assess the effects of both agents since preliminary studies had determined that only low 
amounts of proliferation occurred within this time period when cells were exposed to either 
agent alone (see Figure 1 6). As demonstrated in Figure 2 1 ,  neither TCDD (30 nM) and 
SAC (0.001 %) nor IL-2 and G-IFN (or the combination; data not shown) caused any 
appreciable proliferation of the dense resting B cells above naive or vehicle-treated controls 
when administered alone within the 48 hour culture period. IL-2 was also shown to have 
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Figure 21 .  Gamma-Interferon Potentiates the Activation of Dense Resting B Cells by 
TCDD. Highly purified dense resting B cells were isolated as described (see materials and 
methods) and cultured ( 1  X 1OS/well) with media supplemented with 1 0% fetal bovine 
serum (lot 7 17). SAC and TCDD were added at the start of culture (t=O) whereas IL-2 (25 
U/ml) and G-IFN (50 U/ml) were added at either the start of (t=O) or at 24 hours after 
(t=24) culture initiation as indicated in the legend. Cellular proliferation was measured at 
48 hours after culture initiation (24 hours after last cytokine addition) as determined by 3H­
TdR incorporation following a 1 6  hour pulse time. Controls for the combinations of IL-2 
and G-IFN at t=O and t=24 are not shown in the figure but gave the same response as the 
media control. Data is presented as the mean ± SE of absolute CPM of quadruplicate 
cultures. Abbreviations are defined as follows: DMSO=dimethylsulfoxide; SAC= 
Staphylococcus aureus Cowan strain I; IL-2=interleukin 2; G-IFN=gamma-interferon . 
Letter codes for significance as compared to the vehicle-treated control are defined as 
follows: a=p�O.O 1 .  
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no effect on potentiating the TCDD-induced effects on proliferation. Interestingly 
however, G-IFN (50 V/ml) added in combination with TCDD, potentiated the activation of 
the dense resting B cells, demonstrating further that TCDD and G-IFN have an interaction 
at the level of the B lymphocyte. For SAC-induced effects on the proliferation of resting B 
cells, the opposite effect from TCDD was seen. SAC in combination with IL-2 caused a 
proliferation of the B cells to a level comparable with that of the TCDD + G-IFN 
combination. However, SAC + G-IFN did not produce proliferation of these cells. These 
findings further suggest that the actions of TCDD and SAC on the B lymphocyte are 
similar but distinct. Other interesting observations were determined when the 
combinations of IL-2 and G-IFN were added to TCDD and SAC treated cells. In 
particular, IL-2 given in combination with G-IFN at t=O blocked the increased proliferation 
induced by G-IFN + TCDD alone. However, if cells were exposed to the combination of 
TCDD + IL-2 for 24 hours and then exposed to G-IFN the proliferative response was 
reestablished. Conversely,  the same combination that suppressed TCDD induced 
proliferation (i.e., TCDD + IL-2 + G-IFN at t=O) enhanced the proliferation of SAC 
stimulated B cells above the response by SAC + IL-2 alone; this effect however, was only 
seen when these cytokines were added simultaneously to culture and not when added at 
different times (see Figure 2 1 ). This study further demonstrates the capacity of TCDD to 
induce an "activation-like" signal in the resting B lymphocyte and that complex cytokine 
interactions are important in modulating this effect (particularly IL-2 and G-IFN; products 
of the Th 1 subtype of helper T cells). 
5 . Effects on LPS-StimuJated Prol iferation and Differentiation. 
To determine whether the TCDD-induced immunoenhancing (or stimulatory) effects 
in resting B cells (both in vivQ and in vitro) and the immunosuppressive effects in whole 
lymphocyte responses are causally related, studies were conducted to characterize the 
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effects of TCDD on resting B cells following stimulation with Lipopolysaccharide (LPS). 
LPS-induced B cell proliferation and differentiation was chosen as the in vitro model 
system for a number of reasons: 1 )  LPS is a selective B cell mitogen and can stimulate B 
cells to proliferate and differentiate in the absence of macrophages and/or T cells; 2) 
differentiation of B cells in response to LPS does not require the addition of soluble T cell 
factors and insures that responses mediated by TCDD are due to direct effects on the B cell 
and not to interactions with soluble mediators that are secreted by the macrophage or T cell; 
3) the whole lymphocyte response to LPS has been previously shown to be a sensitive in 
yin:Q system for the suppressive effects of TCDD and demonstrates a parallel relationship 
with the effects of TCDD on the T-dependent antibody response to SRBC [Holsapple, et 
aI., 1 986a] . Table 8 shows the effects of increasing concentrations of TCDD (0.3 ,  3 and 
30 nM) on both proliferation (3H-TdR incorporation) and differentiation (IgM and IgG 
secretion; day 7) of LPS-stimulated dense resting B cells. As demonstrated, TCDD did not 
have any significant effect on either response in the presence of either 1 0% FBS (lot 7 1 7) 
or 5% NBCS (lot 453) to either enhance or suppress the function of resting B cells. 
Vehicle exposure had no effect on either response as compared to the naive control (data 
not shown). In fact, NBCS alone was found to be suppressive on LPS-induced 
proliferation and immunoglobulin secretion as compared to FBS, thus suggesting that 
resting B cells play little role in whole lymphocyte responses to antigen in the presence of 
suppressive serum conditions. The importance of this study was to demonstrate that, 
although TCDD appears to enhance resting B cell responses (under specified culture 
conditions), resting B cells are insensitive to the suppressive effects of TCDD in a model 
system that has been previously shown to be sensitive to this effect. Therefore, it is 
concluded from this finding that the immunoenhancing (in either resting B cells or whole 
lymphocytes in the presence of appropriate FBS) and immunosuppressive effects of TCDD 
(as seen in the T-dependent antibody response to SRBC) are not causally related. 
Table 8 
E�ect of :rc;DI� on LPS-Stimulated Resting B Cell Proliferation and 
DIfferentiation m Fetal Bovine versus Newborn Calf Serum 
3H-TdR Incorporation (mean cpm ± SE) 
Treatment FBS NBCS 
0.0 1 %  DMSO 53905 ± 2568 c 336 ± 25 
0.3 nM TCDD 57327 ± 3558 435 ± 54 
3.0 nM TCDD 5227 1 ± 120 1  399 ± 60 
30 nM TCDD 50836 ± 1799 473 ± 61  
Ilg IgM/Cuiture (mean ± SE) 
Treatment FB S NBCS 
0.0 1 %  DMSO 1 .35 ± 0 . 14  d 0.0 1 ± 0.00 1 
0.3 nM TCDD 1 .48 ± 0. 17  0.01 ± 0.00 1 
3.0 nM TCDD 1 . 3 1  ± 0.22 0.01 ± 0.00 1  
30 nM TCDD 1 .37 ± 0. 1 6  0.01 ± 0.00 1 
ng IgG/Culture (mean ± SE) 
Treatment FBS NBCS 
0.0 1 %  DMSO 1 . 04 ± 0.09 ___ e 
0.3 nM TCDD 1 .03 ± 0.08 
3.0 nM TCDD 0.85 ± 0. 1 2  
30 nM TCDD 0.76 ± 0.05 
c = Values represent the mean ± SE of absolute CPM of quadruplicate cultures 
harvested at 72 hours in the presence of increasing concentrations of TCDD and 
10  Jlg/ml LPS (See materials and methods for details). d = Supernatants from 6 
cultures/treatment group were collected on day 7 and measured for total murine 
IgM and IgG. e = No IgG was detected. 
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D .  Effects of TCDD on Cycling (G 1 )  B Cells: 
1 . Serum-Dependent Effects on Background and LPS-Stimulated 
Proliferation and Differentiation. 
1 1 8  
Since TCDD was shown to cause enhancements in resting B cell background 
responses but to have no effect on LPS-stimulated proliferation or differentiation, further 
studies were conducted using cycling B cells  to determine if this population of cells 
(primarily G 1 cells) are the sensitive cells for the immunosuppressive effects of TCDD. In 
line with studies conducted in resting B cells (as above), studies were conducted to look at 
the direct effects of TCDD on both background and LPS-stimulated proliferation and 
differentiation in cycling B cells. Table 9 shows the effects of increasing concentrations of 
TCDD (0.3 ,  3 and 30 nM) on the background proliferation of cycling B cells cultured in 
the presence of either 1 0% FBS (lot 7 1 7;  conditions which did not support suppression of 
the T-dependent antibody response) or 5% NBCS (lot 453; conditions shown to support 
suppression of the T-dependent antibody response). As demonstrated, TCDD had a 
consistent suppressive effect on background proliferation at all concentrations, and in the 
presence of both serum environments, that was most noted at 72 and 96 hours of culture. 
However, there was a serum dependency for the degree of suppression produced in the 
two serums in which the suppression of proliferation was more severe in the presence of 
NBCS than was seen in the presence of the FBS ;  the same pattern that was seen in the 
whole lymphocyte responses to SRBC. It is also noteworthy to point out that NBCS was 
again shown to support a lower proliferation of these cells than FBS and was similar to 
what was seen in  the resting B cell responses to LPS. IgM secretion was also decreased 
on day 7 of culture in the presence of the FBS but not NBCS (Table 1 0). No IgG was 
detected in either culture supernatant (data not shown). This selective effect on IgM 
secretion is probably due to the low amounts of background proliferation, and thus 
Table 9 
Effect of TCDD on Background Proliferation of Cycling (G 1 )  B Cells in the 
Presence of Fetal Bovine versus Newborn Calf Serum 
FB S 3H-TdR Incorporation (mean cpm ± SE) 
Treatment 48 HR 72 HR 96 HR 
0.0 1 %  DMSO 6898 ± 435 c 14475 ± 395 27266 ± 1 3 1 3  
0.3 nM TCDD 7 1 49 ± 3 1 8  1 2 1 44 ± 237 a 22595 ± 22 1 a 
3 .0 nM TCDD 4568 ± 1 09 a 1 1 280 ± 242 a 19242 ± 824 a 
30 nM TCDD 4540 ± 1 82 a 10615  ± 478 a 1 9993 ± 1 1 92 a 
NBCS 3H-TdR Incorporation (mean cpm ± SE) 
Treatment 48 HR 72 HR 96 HR 
0.0 1 %  DMSO 990 ± 484 35 1 3 ± 7 1 1  2998 ± 4 1 8  
0.3 nM TCDD 1460 ± 478 2546 ± 1 14 2 1 56 ± 1 22 a 
3.0 nM TCDD 764 ± 136  657 ± 31  a 896 ± 1 92 a 
30 nM TCDD 601 ± 65 596 ± 43 a 689 ± 52 a 
c = 1 X l oS B cells/well were cultured in the presence of increasing concentrations of TCDD (see 
materials and methods) and measured for proliferation at 48, 72 and 96 hours of culture as 
determined by 3H-TdR incorporation. Values represent the mean ± SE of absolute CPM of 
quadruplicate cultures. Data represents at least 3 separate experiments giving almost identical 
results. Letter codes for significance as compared to the vehicle control (0.01 % DMSO) are defmed 
as follows: a = p�O.O l .  
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Table 10 
Effect o� TCDD on Background IgM Secretion From Cycling (G 1 )  
B Cells In the Presence of Fetal Bovine versus Newborn Calf Serum 
Experiment 1 Ilg IgM/Culture (mean ± SE) 
Treatment FBS NBCS 
0.0 1 %  DMSO 1 .35 ± 0. 1 8  c 0.08 ± 0.01 
O.3 nM TCDD 1 . 27 ± 0. 1 3  0.08 ± 0.01 
3.0 nM TCDD 1 .09 ± 0.0 1 0.08 ± 0.01 
30 nM TCDD 0.93 ± 0.05 0.06 ± 0.0 1 
Experiment 2 Ilg IgM/Culture (mean ± SE) 
Treatment FBS NBCS 
0.0 1 %  DMSO 0.84 ± 0.06 0.05 ± 0.003 
0.3 nM TCDD 0.76 ± 0.06 0.05 ± 0.002 
3.0 nM TCDD 0.63 ± 0.03 b 0.04 ± 0.00 1 
30 nM TCDD 0.52 ± 0.03 a 0.04 ± 0.00 1 
c = 5 X 1 05 B cells/well were cultured in the presence of increasing concentrations 
of TCDD for 7 days. Supernatants were collected and assayed for total murine IgM 
(see materials and methods). Data is presented as the mean ± SE ).Lg IgM/culture of 
6 replicate cultures. Two representative experiments are shown. Letter codes for 
significance as compared to the vehicle control (0.01 % DMSO) are defined as 
follows: a = p�O.Ol ;  b = p�0.05. 
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secreted antibody, that is  achieved in the presence of the NBCS as compared to FBS ,  
where the difference between the responses in  the two sera is  reflective of  higher levels of 
new antibody secreted in the presence of FBS during the culture period. In either case, the 
findings of this study are similar to those of Sharma and Gehring ( 1 979) [Sharma and 
Gehring, 1 979] , where effects on background proliferation were seen following direct 
addition of TCDD to whole splenocyte cultures in the presence of FBS, and further 
supporting the notion that the primary effects of TCDD on lymphocyte function are effects 
on their ability to obtain optimal proliferation following antigen stimulation. 
Table 1 1  shows the effect of TCDD on LPS-stimulated proliferation of cycling B 
cells (at 72 hours of culture) in the presence of the two opposing serum environments. As 
demonstrated, TCDD had a significant effect on LPS-stimulated proliferation at 
concentrations as low as 0.3 nM (NBCS).  Most notable of these effects was again the 
serum dependency for the suppression of proliferation which was similar to the effects 
seen on background proliferation. Specifically, NBCS was shown to support a more 
dramatic and more consistent effect on LPS-stimulated proliferation than did the FBS,  
further supporting the effects of  TCDD on B cell proliferation and the correlation between 
the suppression of cycling B cell responses and the effects of TCDD on the in vitro whole 
lymphocyte responses to S RBC. It is again noteworthy to point out that NBCS was 
shown to suppress the proliferation of these cells by LPS as compared to responses in the 
presence of FBS,  similar to what was seen in the resting B cell responses to LPS and 
background responses of the cycling B cells, and further suggests that some interactive 
effect of serum components within the NBCS are important for suppression of these 
responses by TCDD. In close parallel to the effects of TCDD on proliferation of the 
cycling B cells, total IgM secretion following LPS-stimulation (day 7) was suppressed in a 
dose-related fashion (Figure 22). IgG secretion was also measured in these responses, but 
showed some variability in the effects by TCDD. As shown in Table 1 2, two experiments 
showed a slight but significant suppression of IgG secretion (two of four separate 
Table 1 1  
Effect
. 
of TCDD on LPS-Stimulated Proliferation of Cycling (G 1 )  B 
Cells In the Presence of Fetal Bovine versus Newborn Calf Serum 
Experiment 1 3H-TdR Incorporation (mean cpm ± SE) 
Treatment FB S NBCS 
0.01 %  DMSO 49257 ± 37 17  c 6873 ± 199 
0.3 nM TCDD 40978 ± 2538 5524 ± 1 44 b 
3.0 nM TCDD 36356 ± 2368 b 5 108 ± 3 1 8  a 
30 nM TCDD 40099 ± 1720 5394 ± 257 b 
Experiment 2 3H-TdR Incorporation (mean cpm ± SE) 
Treatment FB S NBCS 
0.0 1 %  DMSO 1 62939 ± 4 1 62 1 2400 ± 578 
0.3 nM TCDD 1 5 1945 ± 3 1 44 9852 ± 629 b 
3.0 nM TCDD 1 36257 ± 2847 a 9070 ± 265 a 
30 nM TCDD 1 39056 ± 3293 a 8749 ± 250 a 
c = 1 X 1 05 B cells/well were cultured in the presence of increasing 
concentrations of TCDD and 10 Ilg/ml LPS (see materials and methods). Cell 
proliferation was measured at 72 hours as determined by 3H-TdR incorporation. 
Values represent the mean ± SE of absolute CPM of quadruplicate cultures. Two 
representative experiments are shown. Letter codes for significance as compared 
to the vehicle control (0.01 % DMSO) are defined as follows: a = p�O.Ol ;  b = 
p�0.05. 
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Figure 22. Serum Dependency for Suppression of LPS-Stimulated IgM 
Secretion From Splenic-Derived Cycling (G 1) B Cells Following Direct Addition 
of TCDD. Highly purified cycling B cells were isolated as described (see 
materials and methods) and cultured (5 X lOS/well) with media supplemented with 
either (figure A) 10% fetal bovine serum (lot 717) or (figure B) 5% newborn calf 
serum in the presence lipopolysaccharide (LPS; 10 �g/m1) and increasing 
concentrations TCDD. Supernatants were collected on day 7 of culture and 
assayed for total murine IgM (see materials and methods). Data is presented as the 
mean ± SE �g IgM/culture of 6 replicate cultures. Two representative experiments 
are shown for each culture condition. Letter codes for significance as compared to 
the vehicle-treated control are defined as follows: a=p:5;O.Ol; b=p$;O.05. 
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Table 1 2  
Effect o� TCDD on LPS-Stimulated IgG Secretion From Cycling (G 1 )  
B Cells in the Presence of Fetal Bovine versus Newborn Calf Serum 
Experiment 1 ng IgG/Culture (mean ± SE) 
Treatment FB S NBCS 
O.O l % DMSO 6.52 ± 0.23 c 1 .0 1  ± 0. 1 0  
0.3 nM TCDD 6.39 ± 0.20 1 .20 ± 0.23 
3.0 nM TCDD 7 . 1 1  ± 0.43 0.87 ± 0.03 
30 nM TCDD 6.45 ± 0. 1 8  0.90 ± 0.04 
Experiment 2 ng IgG/Culture (mean ± SE) 
Treatment FBS NBCS 
0.0 1 %  DMSO 22.04 ± 1 .65 8 .07 ± 0.25 
0.3 nM TCDD 20. 19  ± 0.50 6.33 ± 0.59 
3 .0 nM TCDD 20.54 ± 0.79 5.92 ± 0.49 b 
30 nM TCDD 1 5 . 1 2  ± 0.74 a 5 .42 ± 0.26 a 
c = 5 X 1 05 B cells/well were cultured for 7 days in the presence of increasing 
concentrations of TCDD and 10 Ilg/ml LPS. Supernatants were collected and 
assayed for total murine IgG (see materials and methods). Data is presented as 
the mean ± SE ng IgG/culture of 6 replicate cultures. Two representative 
experiments are shown. Letter codes for significance as compared to the vehicle 
control (0.01 % DMSO) are defmed as follows: a = p�O.OI ;  b = p�0.05. 
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experiments) following LPS-stimulation in the presence of TCDD, but was not a consistent 
effect. However, enhancements in either IgM or IgO were never seen in these studies. 
From these latter studies several interesting observations were made concerning the effects 
of TCDD on the B lymphocyte, however the most important was the establishment of a 
direct correlation between the serum dependency for suppression of IgM antibody 
secretion following LPS-stimulation of cycling B cells and the serum dependency for 
suppression of the in vitro T-dependent antibody response to SRBC. This finding is 
important by conclusively identifying the cycling (0 1 )  B cell as the sensitive target cell in 
suppression of antibody responses by TCDD. 
2 . Effect of Pre-exposure on IL-2- and IL-4-Mediated Proliferation. 
Because of the similarities to SAC, and because of the stimulatory effect on resting B 
cells, additional studies were carried out to determine if either recombinant IL-2 or IL-4 
(both being B cell activation factors) could synergistically act along with the TCDD 
treatment to activate cycling B cells as TCDD treatment alone activated resting B cells. In 
preliminary experiments cycling B cells were exposed to either TCDD or the combination 
of TCDD and recombinant cytokines and was found not to cause proliferation of the 
cycling B cells within a 72 hour time period. However, this did not rule out the possibility 
that pre-treatment of the cells with TCDD was required in order to have the proper 
sequence of stimuli that would normally take place in a whole splenocyte response. 
Therefore, experiments were carried out in which purified cycling B cells were cultured for 
24 hours in the presence of TCDD (30 nM) and 10% FBS, washed and then reincubated 
for an additional 48 hours in the presence of increasing concentrations of either IL-2 or IL-
4. Proliferation of the cells was measured at 72 hours following a 1 6  hour pulse with 3H­
TdR. As shown in Figure 23, IL-2 seemed to potentiate the effects of the TCDD and 
resulted in significant increases in proliferation of the cycling B cells at the 50 Dlml 
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Figure 23. Effect of TCDD Pre-Exposure on Cycling (G 1 )  B Cell Proliferation in the 
Presence of ll.-2 and ll.-4. Highly purified cycling B cells were isolated as described (see 
materials and methods) and cultured (5 X 1 06/well) with media containing 10% fetal 
bovine serum and either vehicle (0.01  % DMSO) or TCDD (30 nM) for 24 hours. Cells 
were washed and replated in microtiter wells (1 X l OS/well) in the presence of increasing 
concentrations of IL-2 and IL-4. Cellular proliferation was measured 24 hours after 
cytokine additions as determined by 3H-TdR incorporation following a 16  hour pulse time. 
Data is presented as the mean ± SE of absolute CPM of quadruplicate cultures. Letter 
codes for significance as compared to the vehicle-treated control are defined as follows: 
a=p:S:O.O l .  
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concentration as compared to the vehicle-treated control. However, the effects of IL-2 on 
the proliferative response was demonstrated to be biphasic, in which higher concentrations 
of IL-2 suppressed proliferation as compared to the vehicle control. Recombinant IL-4 did 
not alter the background proliferation of these cells at any concentration, and had a nonnal 
proliferative pattern as compared to control. These results demonstrate that the stimulatory 
actions of TCDD on cycling B cells can be manifested if the proper cytokines are available 
following initial exposure. In addition, the selectivity for the potentiation of the actions by 
IL-2 (as opposed to IL-4) again finds similarity to the actions of SAC on the B cell, in 
which IL-2 is the primary growth factor during SAC activation, and further suggests the 
interactive role of IL-2 in the modulation of TCDD's effects on the B lymphocyte. 
E .  Effects of TCDD on Background and Con A-Stimulated T Cell 
Prol iferation : 
As determined from previous studies looking at suppression of the T-dependent 
antibody response to SRBC, and from previous and the present studies characterizing the 
effects on the LPS response, the B lymphocyte appears to be the primary target for 
suppression of antibody responses whereas the T cell appears to express a relative 
refractoriness [Holsapple, et al . ,  1985; Tucker, et al., 1986; Holsapple, et al . ,  1986a; 
Dooley and Holsapple, 1988;  Luster, et aI., 1988b; Dooley, et aI., 1990] . Studies were 
therefore conducted in isolated T cells to determine if effects on either background or Con 
A-stimulated proliferation of these cells would indicate a similar pattern of effects as the 
whole cell responses (described above) when compared to the effects of TCDD on the 
LPS-stimulated response in cycling B cells. Con A-stimulated proliferation has been 
shown to be a selective model for T cell activation and is a selective stimulus for the T cell, 
as LPS is for the B cell. It should be noted that the cycling B and T cells as isolated in 
these studies showed equivalency at all levels of their morphological and functional 
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characteristics (see materials and methods and results above). Resting T cells were first 
probed for effects by TCDD on either background or Con A-stimulated proliferation. In 
these studies, no effect was seen by TCDD to either enhance or suppress proliferation in 
either system (data not shown). It should be noted however, that background and Con A­
stimulated proliferation in these cells was very low and made it difficult to make any 
conclusive arguments based on the results. Figure 24 shows the effects of TCDD on 
background (Figure A) and Con A-stimulated (Figure B) proliferation that were seen in the 
presence of 10% FBS (lot 7 17). As is demonstrated in this figure, TCDD (3 and 30 nM) 
caused little effect on background proliferation of these cells whereas Con A-stimulated 
proliferation was significantly enhanced by the TCDD (3 and 30 nM) treatment in a dose­
related manner. The effect was most evident at the 72 hour time point and showed little to 
no effect at either 24 or 48 hours. A second experiment did show a decrease in 
background proliferation that was significant at all time points and enhancements in Con A­
stimulated proliferation were again observed (data not shown). Lastly, and most important 
in  these studies, was to determine the effects of TCDD on background and Con A­
stimulated proliferation of cycling T cells in the presence of 5% NBCS; serum conditions 
that are selective in supporting suppression of the whole lymphocyte T-dependent and 
LPS-stimulated cycling B cell antibody responses. As shown in Figure 25 A, TCDD 
showed a slight suppression of background proliferation at the 72 hour time period. 
Conversely, cultures stimulated with Con A showed no effect by the TCDD treatment to 
either enhance or suppress the proliferation of these cells (Figure 25 B). Collectively, the 
results of these studies using T cells, in comparison to cycling B cells, demonstrate that the 
T cell is less sensitive to the effects of TCDD when mitogen-stimulated proliferation is 
used as an endpoint. Not only was there an absence of suppression, even in the presence 
of the suppressive serum environment (i.e. , 5% NBCS), but significant enhancements 
were seen. This latter effect is interesting from the standpoint that the stimulation of 
enhancements in the T-dependent antibody response by TCDD is probably due not only to 
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Figure 24. Effect of TCDD on Background and Con A-Stimulated Proliferation of 
Cycling (G 1 )  T Cells in the Presence of Fetal Bovine Serum. Highly purified cycling T 
cells were isolated as described (see materials and methods) and cultured (1 X l OS/well) 
with media supplemented with 10% fetal bovine serum (lot 7 1 7) +/- Con A (5 Ilg/ml) in 
the presence of either vehicle or 30 nM TCDD. Background (figure A) and Con A­
stimulated (figure B) proliferation were measured at 24, 48, 72 and 96 hours after culture 
initiation as determined by 3 H -TdR incorporation following a 1 6  hour pulse time. 
Abbreviations are defined as follows: NA=naive (media only); VH=vehicle (0.01 % 
DMSO). Data is presented as the mean ± SE of absolute CPM of quadruplicate cultures. 
Letter codes for significance as compared to the vehicle-treated control are defined as 
follows: a=p�O.O 1 .  
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Figure 25. Effect of TCDD on Background and Con A-Stimulated Proliferation of 
Cycling (G 1) T Cells in the Presence of Newborn Calf Serum. Highly purified cycling T 
cells were isolated as described (see materials and methods) and cultured (1 X l OS/well) 
with media supplemented with 10% fetal bovine serum (lot 7 1 7) +/- Con A (5 J..Lg/ml) in 
the presence of either vehicle or 30 nM TCDD. Background (figure A) and Con A­
stimulated (figure B) proliferation were measured at 48, 72 and 96 hours after culture 
initiation as determined by 3H-TdR incorporation following a 1 6  hour pulse time. 
Abbreviations are defined as follows: VH=vehicle (0.01 % DMSO). Data is presented as 
the mean ± SE of absolute CPM of quadruplicate cultures. Letter codes for significance as 
compared to the vehicle-treated control are defmed as follows: a=p$;O.O l ;  b=p$;Q.05. 
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the stimulatory effects on the resting B cell, but to enhancements of stimulation in the T cell 
as well. In terms of suppression, although proliferation was unaffected by TCDD direct 
exposure, there is still the possibility that cytokine production by these cells is altered in a 
manner which would not provide the necessary help to antigen stimulated B cells. 
However, in light of the dramatic effects on the cycling B cell (or B cells in general) ,  and 
previous reports that have found the T cell to be a less sensitive target in this response 
[Dooley and Holsapple, 1988; Dooley, et aI., 1990] , it is unlikely that this effect would be 
of any consequence on the suppression of the antibody response. 
F .  Role of the Ah-Gene Locus in Suppression of the In vitro Antibody 
Response and the Modulation of B Cell Function by TeDD: 
As reported by Holsapple, et al .  ( 1986) [Holsapple, et al. ,  1986a] and by Davis and 
Safe ( 199 1 )  [Davis and S afe, 1990] , suppression of in....Yi.tru antibody responses by TCDD, 
as opposed to in vivo, does not appear to correlate with a role by the Ah-receptor gene 
locus. However, in light of the apparent modulatory role of calf sera on both the TCDD­
induced effects on in vitro antibody responses and B cell responses in general (i.e., direct 
modulation of proliferation and differentiation), it was of interest to determine the effects of 
TCDD on the in vitro antibody response in the presence of normal mouse serum; the 
natural serum environment in which mouse spleen cells are exposed in vivo. In addition, 
splenocytes from both Ah-high responder (B6C3Fl )  and Ah-Iow responder (DBA/2) mice 
were compared. Specifically, these studies were three tiered in composition. In the first 
set of studies, the effects of increasing concentrations of TCDD (0.3 ,  3 and 30 nM) on the 
in vitro antibody responses to SRBC of splenocytes derived from both B6C3Fl and 
DBA/2 mice were compared in the presence of increasing concentrations of NBCS (3, 4 
and 5%). In the second set of studies, the effects of increasing concentrations of TCDD 
(0.3, 3 and 30 nM) on the in vitro antibody responses to SRBC in splenocytes derived 
1 3 3  
from both B6C3F1  and DBA/2 mice were compared in the presence of increasing 
concentrations of normal mouse sera (3, 4 and 5%). The latter were also compared in 
cross-over experiments in which the effects of TCDD on splenocyte responses from each 
strain were tested in cultures containing mouse serum from each of the two strains. These 
studies were to specifically determine if the A h-phenotype of the two strains could 
influence the composition of the sera to enhance or block the direct actions of TCDD on 
this response. Lastly, studies were conducted to determine the modulatory role of serum 
(i.e. ,  FBS,  NBCS, B6C3F1  and DBA/2) on the TCDD-induced ethoxyresorufin-O­
deethylase (EROD; P4501 A l )  activity in primary hepatocytes cultured under comparable in 
YiJrQ conditions as splenocytes in the AFC responses. Collectively, the objective of these 
studies was to determine if the role of the Ah-gene locus in the modulation of in vitro 
antibody responses by TCDD was dependent upon the presence of an appropriate serum 
environment. 
Figure 26 shows the effects of increasing concentrations of TCDD (0.3 ,  3 and 30 
nM) on the in vitro T-dependent antibody response to SRBC of B6C3F1 (Figure A) and 
DBA/2 (Figure B )  splenocytes in the presence of increasing concentrations of NBCS (3, 4 
and 5%). As can be seen under these culture conditions, TCDD causes a comparable 
suppression of the antibody response in both B6C3F1 and DBA/2 splenocytes. This 
finding is consistent with previous reports [Holsapple, et aI. ,  1986a] and would suggest 
that the direct effects of TCDD on this response is mediated through an Ah-independent 
mechanism. 
In the second series of experiments, a model of the in vitro T -dependent antibody 
response in the presence of normal mouse sera was developed. Two interesting findings 
however, should be noted: 1 )  suppressive macrophages (as evidenced by the cytolytic 
morphology of the cells in culture) complicated the use of freshly isolated splenocytes in 
the studies where NMS was used and may account for the historical perception that NMS 
is immunosuppressive. Therefore, a 3 hour adherence to plastic was used to reduce the 
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Figure 26.  Effect of TCDD on the In Vitro T-Dependent Antibody Response of B6C3Fl 
and DBN2 Splenocytes in the Presence of Newborn Calf Serum. Data represents the day 
5 anti-SRBC antibody forming cell (AFC) response/106 recovered B6C3Fl (figure A) or 
DBA/2 (figure B) splenocytes in cultures containing media supplemented with increasing 
concentrations of newborn calf serum (3 to 5%) and TCDD (0.3 to 30 nM). Abbreviations 
are defined as follows: NBCS=newborn calf serum; VH=vehicle (0.01 % DMSO). Data 
is presented as the mean ± SE of 4 replicate cultures/treatment group and is representative 
of at least 2 separate experiments. Letter codes for significance as compared to the vehicle­
treated control cell response are defined as follows: a=p�O.OI ;  b=p�0.05. 
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number of macrophages that were present in the spleens of naive animals, which in turn 
allowed for a strong antibody response to occur in the presence of normal mouse serum 
(see materials and methods for details); 2) the serum titration curve for support of growth 
and antibody responses was much sharper in normal mouse sera than in calf sera with 
concentrations greater than 5% significantly suppressing both growth and antibody 
production. As illustrated in Figure 27, when B6C3Fl splenocytes are adhered and 
cultured in the presence of B6C3Fl normal mouse sera, at concentrations up to 5% of the 
culture media, antibody responses were obtained that were comparable to those obtained in 
either FBS or NBCS . It should also be noted that the experiments conducted as presented 
in Figure 26 (antibody responses in NBCS) were carried out using the adherence 
procedure to ensure that direct comparisons between responses in calf and mouse sera 
could be made. 
Figure 28 shows the effect of increasing concentrations of TCDD (0.3, 3 and 30 nM) 
on the antibody responses of both B6C3F I and DBA/2 splenocytes when cultured in the 
presence of increasing concentrations of B6C3Fl normal mouse serum (3, 4 and 5%). In 
contrast to the effects seen in NBCS, responses of the two splenocyte populations to the 
effects of TCDD addition demonstrated an Ah-dependency which parallels the effects that 
are seen following acute in vivo exposure [Vecchi, et aI., 1980; Vecchi, et aI. , 1 983] .  
Specifically, the responses of B6C3Fl splenocytes were strongly suppressed at all 
concentrations of TCDD whereas the responses of DBA/2 splenocytes were not 
suppressed. In fact, the responses in the DBA/2 splenocytes were significantly enhanced 
(at 0.3 and 3 nM) in a similar manner as was shown to occur in the B6C3Fl splenocytes 
when cultured in the presence of either TCDD or SAC and 1 0% FBS (see Figures 10  and 
1 1 ) .  In subsequent experiments, it was determined that the Ah-dependent phenomena was 
not dependent upon the strain-derived type of sera that was used to supplement the culture 
media. As shown in Figure 29, the responses of both B6C3Fl (Figure A) and DBA/2 
(Figure B) splenocytes to TCDD direct addition were the same regardless of whether 
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Figure 27. In Vitro T-Dependent Antibody Response in the Presence of Increasing 
Concentrations of Normal Mouse Serum. Data represents the concentration-dependent 
support of the day 5 anti-SRBC antibody forming cell (AFC) response/106 recovered 
B6C3Fl splenocytes in cultures containing media supplemented with increasing 
concentrations of B6C3Fl normal mouse serum. Splenocytes were adhered to plastic (see 
materials and methods) for 3 hours in media containing 5% NBCS and then washed prior 
to culture in the presence of normal mouse serum and SRBC antigen. 
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Figure 28. Ah-Dependent Suppression of the In Vitro T-Dependent Antibody Response 
in the Presence of Nomal Mouse Serum. Data represents the day 5 anti-SRBC antibody 
forming cell (AFC) response/l 06 recovered B6C3Fl (figure A) or DBA/2 (figure B) 
splenocytes in cultures containing media supplemented with increasing concentrations of 
B6C3F l normal mouse serum (3 to 5%) and TCDD (0.3  to 30 nM). Abbreviations are 
defined as follows: NMS=normal mouse serum; VH=vehicle (0.01 % DMSO). Data is 
presented as the mean ± SE of 4 replicate cultures/treatment group. Letter codes for 
significance as compared to the vehicle-treated control cell response are defined as follows: 
a=p:5:0.0 1 ;  b=p:5:0.05. 
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Figure 29. Ah-Dependent Suppression of the In Vitro T-Dependent Antibody 
Response is Dependent on the Genotype of the Responding Splenocytes. Data 
represents the day 5 anti-SRBC antibody forming cell (AFC) response/l 06 
recovered B6C3F l (figure A) or DBA/2 (figure B) splenocytes in cultures with 
media supplemented with either 5% B6C3FI or 5% DBA/2 normal mouse serum 
(as indicated) in the presence of increasing concentrations of TCDD (0.3 to 30 
nM). Abbreviations are defined as follows: NMS=normal mouse serum; 
VH=vehicle (0.01 % DMSO). Data is presented as the mean ± SE of 4 replicate 
cultures/treatment group and is representative of 2 separate experiments. Letter 
codes for significance as compared to the vehicle-treated control cell response are 
defined as follows: a=p�O.01. 
1 3 9 
IS1 NBCS 
A 1 2000 
8000 
4000 
3000 mil 0 B6C3F1 NMS VH 3 nM 
C/) • DBN2 NMS TCDD ...J ...J 
W () 
c 2000 w a: w > 
0 () w a: 
CD 1 000 
0 
?"" 
U U. < 
0 
VH 0.3 nM TCDD 3.0 nM TCDD 30 nM TCDD 
� NBCS 
B 8000 
6000 
4000 
2000 
5000 fD B6C3F 1 NMS 0 VH 3 nM 
m DBN2 NMS TCOO C/) ...J 
...J 4000 w () 
C w a: w 3000 > 
0 () w 2000 a: 
CD 
0 ?"" 
U 1 000 u. < 
0 
VH 0.3 nM TCDD 3.0 nM TCDD 30 nM TCDD 
TREATMENT 
1 4 0 
B6C3Fl or DBN2 serum was used. It should also be pointed out that responses of the 
two splenocyte populations in the presence of 3 nM TCDD and 5% NBCS (Figure 29; 
inserts), as a comparison control, were suppressed equivalently between the two strains as 
previously shown (see Figure 26). 
Lastly, experiments were designed to determine if the modulatory effects of the 
serum on the in vitro responses of splenocytes to the effects of TCDD were the result of 
the modulation of responses mediated through the Ah-receptor; as has been previously 
shown in reports where Ah-responsiveness was measured in human leukocytes [Kouri, et 
ai., 1 979] . Specifically, these studies were to determine if the serum environment could 
influence the induction of ethoxyresorufin-O-deethylase (EROD; P450 1 A l )  activity in 
cultured primary hepatocytes. Induction of this enzyme system has been shown to be 
mediated by the Ah-receptor and correlates with the Ah-receptor genotype following in 
vivo exposure of mice [Vecchi, et ai., 1 983] . Figure 30 demonstrates the effects of either 
1 0% FBS (lot 7 1 7)  or 5% NBCS (lot 453) on the TCDD-induced (0.3 and 3 nM) 
induction of EROD activity in primary hepatocytes over a 48 hour culture preiod. Bovine 
serum albumin (BSA at 5 mglml) was included in these experiments as a protein control, 
where NBCS and FBS,  at their respective concentrations, were of approximately equal 
protein contents (i.e. , 5 mglml). As is shown, NBCS was found to enhance the EROD 
activity above the BSA control in a dose related manner, whereas the FBS was the same as 
the BSA protein control and neither enhanced nor supported a dose-related response of the 
effects of TCDD. Additionally, Figure 3 1  demonstrates that NBCS enhances the induction 
of EROD activity ( 1  nM TCDD) regardless of concentration (3 and 5%) whereas the FBS 
shows some alteration in the responses depending on the concentration used in the culture 
media. Only 5 mglml BSA was used as a control in these experiments and it should be 
pointed out that the alteration in protein content was found to alter the EROD inductive 
response of hepatocytes in culture in a similar manner and could account for the difference 
that is seen between 5 and 1 0% FBS in this experiment (data not shown). Interestingly 
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Figure 30. Serum Dependency for TCDD-Induced Ethoxyresorufin-O-deethylase 
(EROD) Activity in Primary Hepatocytes From B6C3F1 Mice. Data represents the total 
TCDD-induced EROD specific activity in B6C3F1 primary hepatocytes cultured in AB 
media for 48 hours in the presence of media supplemented with 5 mg/ml protein of either 
bovine serum albumin (protein control), newborn calf serum (lot 453) or fetal bovine 
serum (lot 7 17 ;  see materials and methods). Basal EROD activity in the presence of the 
vehicle is indicated in the inserted figure. Data is presented as the mean ± SE of 3 replicate 
cultures/treatment group and is representative of 2 separate experiments. Abbreviations are 
defined as follows: BSA=bovine serum albumin; NBCS=newborn calf serum; FBS=fetai 
bovine serum. Letter codes for significance as compared to the BSA basal or TCDD­
treated control response are defined as follows: a=p�O.0 1 .  d = BSA + 3 nM TCDD was 
used as a maximal induction control at 5 mg/ml protein for both NBCS and FBS.  
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Figure 31. Effect of Serum Concentration on TCDD-Induced Ethoxyresorufin-O­
deethylase (EROD) Activity in Primary Hepatocytes From B6C3Fl Mice. Data represents 
the basal (figure A) and total TCDD-induced (figure B) EROD specific activity in B6C3Fl 
primary hepatocytes cultured in AB media supplemented with increasing concentrations of 
newborn calf and fetal bovine serum (see materials and methods). 5% newborn calf serum 
and 10% fetal bovine serum represent approximately 5 mg/ml protein contents of these 
respective sera. The BSA control was represents 5 mglml protein. Data is presented as the 
mean ± SE of 3 replicate cultures/treatment group and is representative of 2 separate 
experiments. Abbreviations are defined as follows: BSA=bovine serum albumin; 
NBCS=newborn calf serum; FBS=fetal bovine serum. Letter codes for significance as 
compared to the BSA basal or TCDD-treated control response are defmed as follows: 
a=pS;O.O I ;  b=pS;0.05. 
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however, the in vitro T-dependent antibody responses of splenocytes cultured in media 
containing 5% FBS (lot 7 1 7) were found to support suppression of the antibody response 
by TCOO (although it did not demonstrate a dose-related effect) and suggests that it is not 
just the response that is mediated by the Ah-receptor, but the level which is important (i.e., 
different  thresholds for enhancements and suppression of the antibody response). 
Subsequently, experiments were carried out to determine the relative influences of calf and 
mouse sera on the EROO inductive response of primary hepatocytes. Figure 32 shows the 
EROO activity generated in B6C3Fl primary hepatocyte cultures containing either FBS, 
NBCS or normal mouse sera (from B6C3Fl or OBA/2 mice), at equal protein contents, 
and in the presence of increasing concentrations of TCOO (0. 1  and 1 nM). As 
demonstrated, both NBCS and normal mouse sera from both strains enhanced the EROO 
activity generated in B6C3Fl hepatocytes above FBS (as the control in this experiment) . 
This finding is consistent with the antibody responses in B6C3Fl splenocytes, in which 
normal mouse sera from either strain supported a similar suppression of the response as 
was demonstrated in NBCS (see Figures 26 and 29). This experiment was important from 
the standpoint that the profile of activity at 0. 1 and 1 nM TCOO were the same, where 
additional experiments comparing the effects of calf and mouse sera on hepatocyte EROO 
activity were carried out at the single TCOO concentration of 1 nM. In a second 
experiment, the effects of calf and normal mouse sera on TCOO-induced ( 1  nM) EROO 
activity in B6C3Fl primary hepatocyte cultures were compared to the BSA protein control. 
Figure 33 demonstrates that the same pattern of effects were obtained as compared to the 
BSA control and further correlates the effects of TCOO on hepatocyte EROO activity with 
effects on splenocyte antibody responses. Additionally, experiments were carried out to 
determine the modulatory role of both calf and normal mouse sera on the TCOO-induced ( 1  
nM) EROO activity in hepatocytes from the OBN2 Ah-Iow responder mouse strain. As 
previously noted, normal mouse sera was not found to support suppression of the in vitro 
antibody response by TCOO in OBN2 splenocytes when directly compared to effects in 
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Figure 32. Comparative Effects of FBS ,  NBCS and NMS on Ethoxyresorufin-O­
deethylase (EROD) Activity in Primary Hepatocytes From B6C3F1 Mice Cultured in the 
Presence of Increasing Concentrations of TCDD. Data represents the absolute TCDD­
induced EROD specific activity (i.e., TCDD-induced minus basal activity) in B6C3F1 
primary hepatocytes cultured in AB media supplemented with 5 mg/ml protein of either 
fetal bovine serum (lot 7 17) ,  newborn calf serum, B6C3F1 normal mouse serum or 
DBA/2 normal mouse serum in the presence of increasing concentrations of TCDD (0. 1 
and 1 nM). Data is presented as the mean ± SE of 3 replicate cultures/treatment group and 
is representative of 2 separate experiments. Abbreviations are defined as follows: 
FBS=fetal bovine serum; NBCS=newborn calf serum; NMS=normal mouse serum. 
Letter codes for significance as compared to the FBS control response at each 
concentration of TCDD are defined as follows: a=p�O.O l ;  b=�.05. 
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Figure 33. Comparative Effects of BSA, FBS ,  NBCS and NMS on the TCDD-Induced 
Ethoxyresorufin-O-deethylase (EROD) Activity in Primary Hepatocytes From B6C3Fl 
Mice. Data represents the basal (figure A) and total TCDD-induced (figure B) EROD 
specific activity in B6C3F1 primary hepatocytes cultured in AB media supplemented with 
5 mg/rnl protein of either bovine serum albumin, fetal bovine serum (lot 7 17) ,  newborn 
calf serum, B6C3Fl normal mouse serum or DBN2 normal mouse serum in the presence 
of 1 nM TCDD. Abbreviations are defined as follows: BSA=bovine serum albumin; 
FBS=fetal bovine serum; NBCS=newborn calf serum; NMS=normal mouse serum. Data 
is presented as the mean ± SE of 3 replicate cultures/treatment group and is representative 
of 2 separate experiments. Letter codes for significance as compared to the vehicle or 
TCDD-treated BSA control response are defmed as follows: a=pg).O l .  
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Figure 34. Comparative Effects of BSA, FBS, NBCS and NMS on the TCDD-Induced 
Ethoxyresorufin-O-deethylase (EROD) Activity in Primary Hepatocytes From DBA/2 
Mice. Data represents the basal (Figure A) and total TCDD-induced (Figure B) EROD 
specific activity in DBA/2 primary hepatocytes cultured in AB media supplemented with 5 
mg/ml protein of either bovine serum albumin, fetal bovine serum (lot 7 1 7), newborn calf 
serum, B6C3Fl normal mouse serum or DBN2 normal mouse serum in the presence of 1 
nM TCDD. Abbreviations are defined as follows: BSA=bovine serum albumin; FBS=fetal 
bovine serum; NBCS=newborn calf serum; NMS=normal mouse serum. Data is 
presented as the mean ± SE of 3 replicate cultures/treatment group and is representative of 
2 separate experiments. Letter codes for significance as compared to the vehicle or TCDD­
treated BSA control response are defined as follows: a=p$().Ol .  
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the presence of NBCS . As demonstrated in Figure 34, when the sera were again 
compared, on an equal protein bases, in the OBA/2 (as opposed to the B6C3F l )  
hepatocytes, only the NBCS continued to support an enhanced induction of EROO 
activity. The FBS and the normal mouse sera from both strains did not support induction 
of EROO activity by TCOO (1 nM) above the BSA protein control. 
Collectively, these studies establish a direct correlation between the suppression of 
both whole splenocyte T-dependent and LPS-stimulated cycling B cell antibody responses 
and responses mediated by the Ah-gene locus. Both the lymphocyte antibody responses 
and EROO activity in primary hepatocytes are influenced by TCOO in a similar manner. 
Moreover, to reiterate a point that was mentioned above, it appears that it is not simply 
whether or not an Ah-receptor mediated response is elicited by TCOO, but whether or not 
the level of responsiveness reaches an appropriate threshold to produce either the 
enhancements or suppression of antibody responses when exposed to TCOO. For 
example, both 10% FBS and BSA (the protein constituent contained in the serum-free 
media) support a lower induction of EROO activity in primary hepatocytes and 
enhancements in the T-dependent antibody response. Conversely, NBCS enhances the 
EROO activity, above either FBS or BSA, and supports suppression of the antibody 
response. Mouse sera, on the other hand, either supports a lower or enhanced EROO 
activity and suppression of the T-dependent antibody response, relative to either BSA and 
FBS or NBCS, depending upon the Ah-genotype of the hepatocytes or splenocytes used 
for in vitro experimentation. 
G .  Effects of TCDD on the In Viyo T-Dependent Antibody R esponse 
Following Acute and Subchronic E xposures of B6C3Fl (A h - h i gh 
responder) and DBAi2 (A h-Iow responder) Mice :  
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As indicated above, acute exposure of mice to TCDD leads to changes in organ 
weights (i.e . ,  specifically liver and thymus, reflecting hepatomegaly and involution, 
respectively) and a suppression of humoral and cell-mediated immunity that is consistent 
with a role by the Ah-gene locus [Sharma and Gehring, 1979; Vecchi, et ai., 1983] . 
However, while these findings are fairly descriptive of acute dosing regimens, one report 
has indicated that differences may exist in the toxicities produced by TCDD, and closely 
related congeners, depending on the length of exposure. Specifically, Holsapple, et al. 
( 1986) [Holsapple, et al., 1 986b] have reported that subchronic exposure of B6C3F1 mice 
to the low affinity A h-receptor ligand, 2,7-dichlorodibenzo-p-dioxin (2,7-DCDD), caused 
a comparable suppression of the in vivo antibody forming cell (AFC) response to SRBC to 
that seen with TCDD; even in the absence of significant induction of liver P450 activity 
(i.e., aryl hydrocarbon hydroxylase activity; AHH) [Holsapple, et aI . ,  1986b] . This 
finding was one of the first to demonstrate that low affinity agonists for the Ah-receptor, 
while having little or no effect on immunity when given acutely, could have dramatic 
effects on these immune parameters when administered sequentially over a longer period of 
time. 
Studies were therefore conducted to determine if a similar pattern of effects could be 
induced following subchronic administration of TCDD to DBA/2 (Ah-low responder) 
mice. These mice are less responsive to liver P450 enzyme induction and toxicity induced 
by TCDD following acute exposures, than are B6C3F1 mice. The reasoning follows the 
premise that if sequential dosing can enhance the suppression of humoral immunity in 
B6C3F1 mice by what appears to be non-Ah-receptor mediated mechanisms, as previously 
observed during the subchronic exposure to 2,7-DCDD, then subchronic exposures of 
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DBA/2 mice to TCDD may likewise be able to increase suppression of the antibody 
response without significant increases in liver weight or liver ethoxyresorufin-O-deethylase 
(EROD; P450 1AI )  activity. Experiments were therefore conducted to compare the TCDD­
induced effects on organ weights, both background and T-dependent antigen (SRBC)­
stimulated antibody responses, and the microsomal P450 activities generated in both the 
liver and spleen of B6C3Fl and DBN2 female mice following acute (single dose; 14 days 
rest) and subchronic (repetitive daily exposure for 14 days) exposures to the same 
cumulative doses of TCDD. In addition, flow cytometric analyses were performed to 
determine if the effects of subchronic TCDD exposure on splenic lymphocyte 
subpopulations, relative to either acute (2 days rest) or acute ( 14  days rest), correlate with 
the effects on splenic microsomal EROD induction or antibody responses. 
1 .  E ffects Following Acute (Single  Dose; 14 Days Rest) Exposures: 
Table 13 illustrates the changes that occurred in body and organ weight parameters 
following acute (single dose; 1 4  days rest) exposure of B6C3Fl (Ah-high responder) and 
DBA/2 (Ah-Iow responder) mice to TCDD. Of particular importance are the abrupt 
changes in liver (hepatomegaly), thymus (involution), and spleen (involution) weights in 
the B6C3Fl strain which occurred in a dose-related manner (i.e., when normalized to % of 
body weight). In contrast, DBA/2 mice demonstrated little change in liver, thymus or 
spleen weights except at the highest dose tested (42 Ilg/kg). Table 14 shows the acute (14 
days rest) effects of TCDD on both the background (IgM AFC) and T-dependent antigen 
(SRBC)-stimulated antibody responses (presented as AFC/106 recovered cells) in B6C3FI 
and DBN2 mice. In the B6C3FI strain, highly significant reductions in both background 
and antigen-stimulated antibody responses, as well as spleen cell numbers, were obtained 
which dose-dependently followed the changes in both liver and thymus weights. 
Moreover, microsomal EROD activity in the liver was also greatly enhanced in a dose-
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Table 1 3  
Body and Organ Weights of S RBC-Sensitized B6C3Fl and DBA/2 Mice Following 
Acute 04 day) Exposure to 2.3,7,8-Tetrachlorodibenzo-p-dioxin C2.3,7,8-TCDD) 
Parameter 
Body Weight (g) 
Liver Weight (g) 
% Body Weight 
Thymus Weight (mg) 
% Body Weight 
Spleen Weight (mg) 
% Body Weight 
Parameter 
Body Weight (g) 
Liver Weight (g) 
% Body Weight 
Thymus Weight (mg) 
% Body Weight 
Spleen Weight (mg) 
% Body Weight 
Vehicle 
(corn oil) 
2 1 .08 ± 0.67 c 
1 . 1 5  ± 0.06 
5 .46 ± 0 . 18  
82.50 ± 3.93 
0.40 ± 0.03 
105.75 ± 5 .76 
0 .51  ± 0.02 
Vehicle 
(corn oil) 
20.56 ± 0.46 
0.96 ± 0.03 
4.68 ± 0 . 16 
56.60 ± 4. 1 3  
0.27 ± 0.02 
1 1 3.00 ± 3.44 
0.55 ± 0.03 
B6C3F1 Mice 
2.3.7.8-TCDD (u.gLlsg) 
4.2 1 4  42 
2 1 .3 1  ± 0.7l 22.06 ± 0.68 2 1 .70 ± 0.47 
1 .25 ± 0.07 1 .37 ± 0.04 1 .47 ± 0.09 b 
5.85 ± 0. 1 3  6.21 ± 0 . 12 b 6.75 ± 0.25 a 
73.75 ± 2.66 66.50 ± 3.52 b 53.25 ± 2.36 a 
0.35 ± 0.02 0.30 ± 0.02 b 0.24 ± 0.01 a 
79.25 ± 5.59 86.25 ± 4.77 b 73.75 ± 7.97 a 
0.37 ± 0.02 a 0.39 ± 0.03 b 0.34 ± 0.03 a 
DBA12 Mice 
2.3.7.8-TCDD (u.gLlsg) 
4.2 1 4  42 
22.36 ± 0.65 22.0 1 ± 0.57 20.35 ± 0.73 
1 .00 ± 0.04 1 .06 ± 0.07 0.99 ± 0.03 
4.47 ± 0.09 4.80 ± 0.28 4.89 ± 0. 1 8  
56.80 ± 8 . 19  52.80 ± 6.93 6 1 .40 ± 8.25 
0.26 ± 0.04 0.24 ± 0.03 0.30 ± 0.04 
126.20 ± 16.90 105.00 ± 5. 1 1  80.60 ± 1 .03 
0.56 ± 0.07 0.48 ± 0.02 0.40 ± 0.02 b 
c = Values represent the mean ± SE of organ weights derived from 4-5 animals/treatment group. 
S ignificance, as determined by Ihe Dunnett's T test, is indicated by asterisks: b = 160.05; a = 160.01 .  
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Table 14 
Day 4 IgM Antibody Forming Cell Response in  B6C3Fl and DBA/2 Mice Following 
AI<l.H� (14 Qi!�) EXI2osyr� tQ 2.3.1.8-T�tri!l<hIQrodibenzQ-12-QiQlS;in (2.3.1.8-TCDD) 
�6C3El Mi� 
2 3 1.8-TCDD (lJ,g[kg) 
Param�t�r CQ[n Qil 4,2 14 42 
Cells/SRBC-
Sensitized Spleen 12.33 ± 0.69 c 8.09 ± 0.50 a 6.80 ± 0.58 a 8.08 ± 0.69 a 
Anti-SRBC APC/ 
Spleen (X 1()3) 1 5 1  ± 22 25 ± 6 a 23 ± 6 a 19 ± 8 a 
Anti-SRBC APC/1 06 
Recovered Cells 1209 ± 122 322 ± 9 1  a 344 ± 109 a 2 19  ± 88 a 
Cells/Unsensitized 
Spleen 9.50 ± 0.60 6.80 ± 0.20 b 8.20 ± 0.26 8.30 ± 0. 1 9  
IgM APC/ 
Spleen (X 103) 120 ± 10  75 ± 7 a 50 ± 10 a 29 ± 9 a 
IgM APC/106 
Recovered Cells 1299 ± 1 84 1 101 ± 22 a 7 14  ± 147 a 355 ± 94 a 
DBAaMi�� 
2.3.1.8-ICDD (lJ,g[kg) 
Earam�t�r CQrn Qil 4,2 1 4  42 
Cells/SRBC-
Sensitized Spleen 1 1 .37 ± 0.80 10.98 ± 0.58 10.00 ± 0.95 8.75 ± 1 .42 
Anti-SRBC APC/ 
Spleen (X 1()3) 86 ± 1 1  80 ± 6 34 ± 6 a 32 ± 7 a 
Anti-SRBC APC/106 
Recovered Cells 781  ± 129 729 ± 52 363 ± 82 b 370 ± 73 b 
Cells/Unsensitized 
Spleen 1 2.40 ± 0.84 12.50 ± 0.78 1 1 .00 ± 0.26 1 1 .20 ± 0.34 
IgM APC/ 
Spleen (X 1 ()3) 4 1  ± 3 36 ± 1 34 ± 2 23 ± 2 a 
IgM APC/I06 
Recovered Cells 339 ± 50 327 ± 19 287 ± 1 5  200 ± 22 a 
c = Values represent the mean ± SE of the day 4 IgM APC response derived from 4-5 animals/treatment 
group. Significance, as determined by the Dunnett's T test, is indicated by asterisks: b = p$O.05; a = 
p�O.0 1 .  
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dependent manner, and further correlated with the changes in both organ weights and 
antibody responses (Table 1 5) .  Conversely, splenic microsomal EROD activity was not 
induced, but rather reduced, following TCDD exposure (Table 15) .  Flow cytometric 
analyses of the splenocytes, derived from treated but unsensitized B6C3 F l  mice, revealed 
slight increases in the percentage and slight decreases in the absolute numbers of both Ig+ 
B cells and Lyt-2+ and L3T4+ T cells (Table 1 6). However, the effects on the lymphocyte 
populations were not found to differ from the effects seen following an acute exposure 
with only 2 days rest (Table 17); which was used as a length of exposure control in these 
experiments. In contrast to the B6C3Fl strain, antibody responses (AFC/106 recovered 
cells) in the DBA/2 strain were less affected by acute exposure. Likewise, liver 
microsomal EROD activity was lower in the DBA/2 mice and showed significant levels of 
activity only at the two highest doses of TCDD ( 1 4  and 42 Ilglkg). Microsomal EROD 
activity in the spleen was undetectable. Flow cytometric analyses of splenocytes, derived 
from treated but unsensitized DBA/2 mice, demonstrated slight effects on the absolute 
numbers of both Ig+ B cells and Lyt-2+ and L3T4+ T cells; similar to what was seen in the 
B 6C3 F l  strain (Table 1 6) .  As in the analysis of B6C3Fl splenocytes, the effects on the 
lymphocyte populations were not found to differ from the effects seen following an acute 
exposure followed by only 2 days rest (Table 17);  the length of exposure control in these 
experiments. 
2. E ffects Fol lowing Subchronic (Repetitive 14 Day) Exposures: 
In close parallel to acute exposures, body and organ weights in the B6C3F l strain 
were similarly affected following the subchronic (repetitive 14  day) exposures to TCDD 
(Table 1 8) .  These effects were characterized by significant and dose-related increases in 
liver weight p arameters, and coordinate decreases in both thymus and spleen weights. 
Likewise, both the background and antigen-stimulated antibody responses were 
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Table 1 5  
Hepatic and Splenic Microsomal Parameters i n  B6C3Fl and DBA/2 Mice Following 
Acute (14 day) Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin C2.3,7,8-TCDD) 
Vehicle 
Parameter (com oil) 
Body Weight (g) 21 .90 ± 0.66 c 
Liver Weight (g) 1 . 1 3  ± 0.06 
% Body Weight 5 . 14  ± 0 . 12 
Hepatic Microsomal 
Protein (mg/g liver) 1 1 .68 ± 0.66 
Hepatic EROD Activity 
(pmoVmg protein/min) 15 .21  ± 0.58 
Spleen Weight (mg) 85 .50 ± 6.54 
% Body Weight 0.39 ± 0.02 
Splenic Microsomal 
Protein (jlg/mg spleen) 12 .02 ± 0.09 
Splenic EROD Activity 
(pmoVg protein/min) 160.00 ± 10.00 
Vehicle 
Parameter (com oil) 
Body Weight (g) 20.37 ± 0.60 
Liver Weight (g) 0.86 ± 0.02 
% Body Weight 4.25 ± 0. 1 1  
Hepatic Microsomal 
Protein (mg/g liver) 8.88 ± 0.55 
Hepatic EROD Activity 
(pmoVmg protein/min) 17.36 ± 0.99 
Spleen Weight (mg) 77.80 ± 4.22 
% Body Weight 0.38 ± 0.Q2 
Splenic Microsomal 
Protein (jlg/mg spleen) 2 1 . 1 1 ± 0.09 
Splenic EROD Activity 
(pmol/mg protein/min) ----- d 
B6C3Fl Mice 
2 3,7,8-TCDD (ug/kg) 
4.2 1 4  42 
2 1 .28 ± 0.40 22.29 ± 0.58 22.66 ± 1 .50 
1 .20 ± 0.06 1 .39 ± 0.09 1 .39 ± 0. 1 0  
5.62 ± 0.21 6.24 ± 0.25 a 6. 1 5  ± 0.19 a 
15 .54 ± 0.3 1 a 17.70 ± 0.69 a 19.42 ± 0.61 a 
569.04 ± 33.59 a 763.89 ± 22.77a 1087.93 ± 33.72 a 
7 1 .25 ± 4.50 74.75 ± 4.21 65.00 ± 3 .29 b 
0.33 ± 0.02 0.33 ± om 0.29 ± 0.03 b 
1 8.39 ± 0. 12  a 20.34 ± 0 . 12 a 20.39 ± 0.14 a 
70.00 ± 10.00 a 1 10.00 ± 10.00 a 20.00 ± 10.00 a 
DBA12 Mice 
4.2 
20.59 ± 0.43 
0.92 ± 0.03 
4.57 ± 0. 1 5  
9.40 ± 0.70 
53.66 ± 8.98 
2,3,7,8-TCDD (Llg/kg) 
1 4  4 2  
20. 10  ± 0.3 1 2 1 .49 ± 0.61 
0.90 ± 0.03 1 .05 ± om a 
4.7 1 ± 0.23 4.92 ± 0. 1 3  b 
12.24 ± 0.48 a 13 .93 ± 0.74 a 
243.81 ± 14.07 a 496.72 ± 4 1 .46 a 
74.50 ± 7 .31  82.75 ± 10.52 78.20 ± 2.04 
0.36 ± 0.03 0.4 1 ± 0.06 0.37 ± 0.01 
17 .26 ± 0.12 a 19.79 ± 0. 13  a 24.21 ± 0. 14 a 
c = Values represent the mean ± SE of organ weights derived from 4-5 unsensitized animals/treatment 
group. S ignificance, as determined by the Dunnett's T test, is indicated by asterisks: b = p�0.05; a = 
p�.Ol .  d = No measurable EROD activity was detected. 
TABLE 16 
Row Cytometric Analysis of Splenic Lymphocyte Populations in B6C3F1 and DBA/2 Mice Following Acute (14 day) Exposure to 
2.3,7 ,8-T�trachlorodibenzo-12-dioxin 
% of Total Splenocytes Absolute Number of Cells/Spleen (X 107) 
S train{freatmen t Cells/Spleen (X 107) 19+ Thy- 1 .2+ Lyt-2+ L3T4+ 19+ Thy- 1 .2+ Lyt-2+ L3T4+ 
B6C3F1 
7.23 c 49.70 35.30 9.70 1 8 .50 4.74 3.35 0.92 1 .41  
Corn Oil ± 2. 1 3  ± 1 .60 ± 1 .80 ± 0.50 ± 0.70 ± 0.24 ± 0. 1 3  ± 0.02 ± 0.36 
6.89 56. 10 a 39.80 10.80 20.40 3.86 b 2.73 0.74 1 . 1 3  
4.2 Ilg/kg TCDD ± 0.24 ± 1 .00 ± 1 .30 ± 0.60 ± 1 .20 ± 0.07 ± 0.06 ± 0.05 ± 0.30 
8.2 1 54 . 10  39.30 10.40 2 1 .20 4.45 3 .24 0.79 LOS 
14.0 Ilg/kg TCDD ± 0.37 ± 1 .40 ± 1 .9O ± 0.40 ± 1 .20 ± 0.3 1 ± 0.29 ± 0.09 ± 0.44 
8.3 1 58.20 a 37.90 10.40 2 1 .00 4 .84 3 . 1 5  0.86 1 .75 
42.0 Ilg/kg TCDD ± 0.20 ± 0.80 ± 1 .90 ± 0.50 ± 0.60 ± 0. 14  ± 0. 19  ± 0.04 ± 0.07 
% of Total Splenocytes Absolute Number of Cells/Spleen (X 107) 
Strain/Treatment Cells/Spleen (X 107) 19+ Thy-1 .2+ Lyt-2+ L3T4+ 19+ Thy- 1 .2+ Lyt-2+ L3T4+ 
DBA/2 
12.50 58.80 1 3 .80 3.80 10.60 7.37 1 .73 0.48 1 .32 
Corn Oil ± 0.84 ± 1 .90 ± 0.90 ± 0.30 ± 0.50 ± 0.65 ± 0.2 1 ± 0.05 ± 0. 10  
12.25 65.20 1 5 .00 4.00 1 5 .50 a 8.00 1 .84 0.49 1 .90 a 
4.2 1lg/kg TCDD ± 0.76 ± 0.50 ± 0.60 ± 0.30 ± 1 .00 ± 0.47 ± 0. 14 ± 0.05 ± 0. 16  
1 1 .00 58.00 12 . 10  2.60 b 1 1 .90 6.37 1 .34 0.29 b 1 .30 
14.0 Ilg/kg TCDD ± 0.27 ± 1 .50 ± 2.70 ± 0.30 ± 0.70 ± 0. 1 5  ± 0.3 1 ± 0.03 ± 0.09 
1 1 .30 63.20 1 1 .20 3.00 1 1 .90 7 . 14  1 .27 0.34 1 .34 
42.0 Ilg/kg TCDD ± 0.32 ± 2 . 10  ± 0.70 ± 0.30 ± 0.50 ± 0.40 ± 0.08 ± 0.03 ± 0.06 
c Values represent the mean ± SE specific staining of splenocytes derived from 4-5 animals/treatment group. Significance, as determined by the Dunnett's T 
test, is indicated by asterisks: b = pSO.05; a = pSO.0 1 .  ....... 
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TABLE 17 
Flow Cytometric Analysis of Splenic Lymphocyte Populations in  B6C3F1 and DBA/2 Mice Following Acute (2 day) Exposure to 
2,3,7,8-Tetrachlorodibenzo-12-dioxin 
% of Total Splenocytes Absolute Number of Cells/Spleen ex 107) 
Strain/freaunent Cells/Spleen (X 107) Ig+ Thy-1 .2+ Lyt-2+ L3T4+ Ig+ Thy- l .2+ Lyt-2+ L3T4+ 
B6C3Fl 
9.39 c 55 .20 47.20 10.90 26.40 5 .20 4.41 1 .02 2.47 
Com Oil ± 0.34 ± 1 .40 ± 0.80 ± 0 . 10  ± 0.90 ± 0.30 ± 0. 1 2  ± 0.04 ± 0.09 
8.01 56.30 47.60 1 1 .30 26.00 4 .59 3 .80 0.90 2.08 
4.2 �g/kg TCDD ± 0.36 ± 1 . 10 ± 2.70 ± 0.50 ± 1 .20 ± 0.27 ± 0.22 ± 0.05 ± 0. 1 3  
8.75 57.80 44.50 10.30 26.00 5.05 3.90 0.91 2.27 
14.0 �g/kg TCDD ± 0.57 ± 1 .40 ± 1 .70 ± 0.60 ± 1 . 1 0  ± 0.28 ± 0.32 ± 0. 1 1  ± 0. 19  
8.92 57.70 47.90 10.50 26. 1 0  5 . 1 5  4.27 0.93 2.40 
42.0 �g/kg TCDD ± 0.28 ± 0.60 ± 1 .50 ± 0.30 ± 0.70 ± 0.20 ± 0. 1 8  ± 0.03 ± 0. 10  
% of  Total Splenocytes Absolute Number of Cells/Spleen (X 107) 
Strain/freaunent Cells/Spleen (X 107) Ig+ Thy- l .2+ Lyt-2+ L3T4+ Ig+ Thy- l .2+ Lyt-2+ L3T4+ 
DBA/2 
9.97 68.60 2 1 . 1 0  5 .30 16.40 7 .00 2 . 15  0.53 1 .67 
Com Oil ± 0.83 ± 2.00 ± 1 .20 ± 0.60 ± 0.40 ± 0.30 ± 0.07 ± 0.02 ± 0.07 
8.29 67.50 19 .90 5 . 10  15 .40 5.56 1 .61 b 0.41 1 .26 b 
4.2 �g/kg TCDD ± 0.84 ± 1 .70 ± 2.20 ± 0.60 ± 1 .30 ± 0.47 ± 0. 14  ± 0.04 ± 0. 1 1  
7 . 10  70.50 24.70 5 .80 18.70 5.00 b 1 .76 0.4 1 b 1 .32 
14.0 �g/kg TCDD ± 0.44 ± 1 . 10 ± 0.70 ± 0.30 ± 0.60 ± 0.27 ± 0. 1 2  ± 0.02 ± 0.08 
7.80 69.70 19.80 4.80 1 5.30 5.40 1 .47 a 0.37 b 1 . 1 7  b 
42.0 �g/kg TCDD ± 1 .26 ± 2.30 ± 2.90 ± 0.40 ± 1 .20 ± 0.73 ± 0.05 ± 0.03 ± 0. 1 1  
c Values represent the mean ± SE specific staining of splenocytes derived from 4-5 animals/treaunent group. Significance, as determined by the Dunnett's T 
test, is inclicated by asterisks: b = p$0.05; a = p$O.01 .  ...... V1 
V1 
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Table 1 8  
Body an� Organ Weights of SRBC-Sensitized B6C3Fl and DBN2 Mice Following 
Subchromc 04 day) Exposure to 2,3,7,8-Tetrachlorodibenzo-v-dioxin C2.3,7,8-TCDDl 
B6C3F1 Mice 
Vehicle 2.3.1.8-TCDD (u.g{kg) 
PIlIllm!<l!<I (\:=Qrn Qil) 4 2 1 4  42 
Body Weight (g) 2 l .2 1  ± 0.46 c 2 l .79 ± 0.99 2 l .94 ± 0.72 22.02 ± 0.4 1 
Liver Weight (g) 1 . 1 3  ± 0.04 1 .38 ± 0. 12  b 1 .5 1  ± 0.02 a 1 .53 ± 0.02 a 
% Body Weight 5 .36 ± 0.26 6.32 ± 0.26 b 6.91 ± 0 . 18  a 6.96 ± 0. 18  a 
Thymus Weight (mg) 57.75 ± 2.25 62.50 ± 3.38 49.25 ± 2.66 34.00 ± 2.80 a 
% Body Weight 0.27 ± O.Q] 0.29 ± 0.0 1 0.23 ± 0.02 b 0 . 15  ± O.Q] a 
Spleen Weight (mg) 97.50 ± 4.29 80.00 ± 6.57 8 l .00 ± 4.56 78.75 ± 4 . 13  
% Body Weight 0.46 ± 0.02 0.37 ± 0.02 b 0.37 ± 0.03 b 0.36 ± 0.02 b 
DBAI2Mi\:=!< 
Vehicle 2.3.1.8-ICQD (u.g{kg) 
Pllrllm!<l!<r (\:=Qrn Qil) 4,2 1 4  42 
Body Weight (g) 20.66 ± 0.65 20.60 ± 0.22 20.36 ± 0.62 20.20 ± 0.30 
Liver Weight (g) l .00 ± 0.05 l .0 1  ± O.Q ] 1 .03 ± 0.03 1 . 1 0  ± 0.Q3 
% Body Weight 4.82 ± 0. 1 1  4.90 ± 0.06 5.07 ± 0.2 1 5 .43 ± 0. 1 3  b 
Thymus Weight (mg) 66.00 ± 2.35 52.25 ± 5.20 b 42.80 ± 2.96 a 40.00 ± 2.86 a 
% Body Weight 0.32 ± 0.02 0.25 ± 0.03 0.21 ± 0.02 a 0.20 ± 0.01 a 
Spleen Weight (mg) 89.60 ± 2.62 82.50 ± 1 . 19 77.40 ± 2.62 b 8 1 .75 ± 5.76 
% Body Weight 0.43 ± 0.01 0.40 ± O.Q ] 0.38 ± 0.02 b 0.40 ± 0.02 
c 
= Values represent the mean ± SE of organ weights derived from 4-5 animals/treatment group. 
Significance, as determined by the Dunnett's T test, is indicated by asterisks: b = �.05; a = �O.Q] .  
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Table 19  
Day 4 Ig� Antibody FOrming Cell Response in B6C3Fl and DBN2 Mice Following Subchromc 04 day) Exposure to 2,3.7,8-Tetrachlorodibenzo-v-dioxin (2.3,7,8-TCDm 
Parameter 
Cells/SRBC­
Sensitized Spleen 
Anti-SRBC AFC/ 
Spleen (X 1<P) 
Anti-SRBC AFC/106 
Recovered Cells 
Cells/Unsensitized 
Spleen 
IgM AFC/ 
Spleen (X 1<P) 
IgM AFC/I06 
Recovered Cells 
Parameter 
Cells/SRBC­
Sensitized Spleen 
Anti-SRBC AFC/ 
Spleen (X 1<P) 
Anti-SRBC AFC/106 
Recovered Cells 
Cells/Unsensitized 
Spleen 
IgM AFC/ 
Spleen (X 1<P) 
IgM AFC/I06 
Recovered Cells 
Com Oil 
1 3.77 ± 0.38 c 
298 ± 44 
2468 ± 320 
1 2.30 ± 1 .50 
48 ± 2 
402 ± 56 
Com Oil 
1 5 .62 ± 0 .51  
151  ± 16 
962 ± 72 
12 .40 ± 0.84 
85 ± 8 
670 ± 70 
B6C3Fl Mice 
2,3,7 8-TCDD (ug/kg) 
4.2 1 4  42 
1 1 .76 ± 0.66 b 10.97 ± 0.44 a 10.69 ± 0.38 a 
45 ± 6 a 19 ± 1 a 22 ± 4 a 
387 ± 4 1  a 176 ± 1 3  a 2 12  ± 45 a 
10.20 ± 0.51 9.00 ± 0.27 8.40 ± 0.25 
29 ± 2 a 24 ± 1 a 18 ± 2 a 
283 ± 8 269 ± 8 b  207 ± 1 3  a 
DBA!2 Mice 
4 2  
1 5.00 ± 0.46 
80 ± 7 a 
534 ± 100 a 
1 2.50 ± 0.78 
70 ± 4 
601 ± 39 
2.3,78-TCDD (ug/kg) 
1 4  42 
1 3 .02 ± 0.55 1 5.00 ± 1 .32 
48 ± 13 a 32 ± 8 a 
377 ± 105 a 222 ± 61 a  
1 1 .00 ± 0.26 1 1 .20 ± 0.34 
46 ± 3 a  54 ± 6 a  
4 1 5 ± 28 a  493 ± 56 b  
c = Values represent the mean ± SE of the day 4 IgM AFC response derived from 4-5 animals/treatment 
group. Significance, as determined by the Dunnett's T test, is indicated by asterisks: b = p�.05; a = 
p�O.01 .  
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Table 20 
Hepatic �nd Splenic Microsomal Parameters in B6C3F1 and DBA/2 Mice Following 
Subchromc (1 4  day) Exposure to 2.3.7.8-Tetrachlorodibenzo-p-dioxin (2.3.7.8-TCDD) 
B6C3Fl Mi\;� 
Vehicle 2.3.1.8-lCQD (u,gL!>g} 
Pllrllm�t�r (\;Qrn Qil} 4.2 1 4  42 
Body Weight (g) 21 .74 ± 0.74 c 21 .89 ± 0.93 20.29 ± 0.34 20. 10 ± 0.5 1 
Liver Weight (g) 1 . 1 3  ± 0.07 1 .39 ± 0.06 a 1 .35 ± 0.03 b 1 .36 ± 0.03 a 
% Body Weight 5 . 1 8 ± 0 . 15  6.35 ± 0. 1 1  a 6.65 ± 0.04 a 6.79 ± 0. 1 7  a 
Hepatic Microsomal 
Protein (mg/g liver) 15 .02 ± 0.88 18.52 ± 0 . 18.52 b 21 .55 ± 0.72 b 22.35 ± 0.3 1 a 
Hepatic EROD Activity 
(pmol/mg protein/min) 4.00 ± 2.00 821 .00 ± 18.00 a 961 .00 ± 8 1 .00 a 1029.00 ± 6.00 a 
Spleen Weight (mg) 72.75 ± 7.58 55.75 ± 7.97 50.75 ± 7.09 5 1 .00 ± 5 .73 
% Body Weight 0.33 ± 0.03 0.25 ± 0.03 0.25 ± 0.04 0.25 ± 0.03 
Splenic Microsomal 
Protein (j.J.g/mg spleen) 1 1 .24 ± 0 . 13  24. 1 2  ± 0.58 a 8.21 ± 0. 1 3  a 9 .53 ± 0.07 b 
Splenic EROD Activity 
(pmol/g protein/min) 90.00 ± 10.00 940.00 ± 18.0 a 1 662.00 ± 50.0 a 53 1 .00 ± 18.00a 
DBALZMi\;!< 
Vehicle 2.3.1.8-lCDQ (u,gL!>g} 
PlIrllm�t�r (\;Qrn Qil} 4.2 1 4  42 
Body Weight (g) 19 .47 ± 0.50 19.79 ± 0.61 19 .81  ± 0.91 20.71  ± 1 . 1 3  
Liver Weight (g) 0.82 ± 0.07 0.92 ± 0.06 0.96 ± 0.09 1 .08 ± 0.05 b 
% Body Weight 4 . 1 8  ± 0.26 4.65 ± 0.23 4.87 ± 0.42 5 .24 ± 0. l 6  
Hepatic Microsomal 
Protein (mg/g liver) 12.04 ± 0.69 1 3 .97 ± 0.63 1 5.47 ± 1 .28 b 14.86 ± 0.21 b 
Hepatic EROD Activity 
(pmol/mg protein/min) 10.8 1 ± 0.77 52.4 1 ± 7.90 267 . l 5  ± 39.35 a 326.78 ± 7 1 .37a 
Spleen Weight (mg) 72.00 ± 9.27 70.00 ± 8.50 67.50 ± 6.67 62.25 ± 1 .65 
% Body Weight 0.37 ± 0.04 0.35 ± 0.04 0.34 ± 0.03 0.30 ± 0.02 
Splenic Microsomal 
Protein (j.J.g/mg spleen) 14 . 17  ± 0.07 16.50 ± 0. 13  a 8.35 ± 0.03 a 7 .93 ± 0.09 a 
Splenic EROD Activity 
150.00 ± 10.00 a (pmol/g protein/min) 20.00 ± 10.00 80.00 ± 10.00 a 30.00 ± 10.00 
c = Values represent the mean ± SE of organ weights derived from 4-5 unsensitized animals/treatment 
group. Significance, as determined by the Dunnett's T test, is indicated by asterisks: b = p�0.05; a = 
p�O.Ol .  
TABLE 2 1  
Flow Cytometric Analysis of Splenic Lymphocyte Populations i n  B6C3F 1 and DBA/2 Mice Following Subchronic ( 14  day) Exposure 
to 2,3,7,8-Tetrachlorodibenw-12-dioxin 
% of Total Splenocytes Absolute Number of Cells/Spleen (X 107) 
S train/Treatment Cells/Spleen (X 107) Ig+ Thy- l .2+ Lyt-2+ L3T4+ Ig+ Thy- l .2+ Lyt-2+ L3T4+ 
B6C3Fl 
13 .63 c 55.70 32.70 5.00 16.10 7.49 4 .38 0.68 1 .5 1  
Corn Oil ± 1 .4 1  ± 0.60 ± 2.90 ± 0.30 ± 1 .50 ± 0.68 ± 0. 1 1  ± 0.09 ± 0.65 
10.28 b 61 .30 a 36.00 5.00 20.40 a 6.30 3 .72 0.5 1 2.07 
4.2 Ilg/kg TCDD ± 0.52 ± 0.90 ± 1 .90 ± 0.20 ± 0.50 ± 0.34 ± 0.34 ± 0.03 ± 0. 12  
9 . 10  a 6 1 . 10  a 30.50 6. 10  18 .30 5.55 b 2.77 b 0.55 1 .66 
14.0 Ilg/kg TCDD ± 0.28 ± 1 .00 ± 0.80 ± 0.60 ± 0.50 ± 0. 16  ± 0.03 ± 0.05 ± 0.07 
8.62 a 63.70 a 37.20 6.80 b 19.60 b 5.48 b 3.21 0.59 1 .70 
42.0 Ilg/kg TCDD ± 0.27 ± 0.60 ± 1 . 10 ± 0.20 ± 0.90 ± 0. 1 7  ± 0. 18  ± 0.03 ± 0 . 12  
% of Total Splenocytes Absolute Number of Cells/Spleen (X 107) 
Strain!freatment Cells/Spleen (X 107) Ig+ Thy-1 .2+ Lyt-2+ L3T4+ Ig+ Thy- 1 .2+ Lyt-2+ L3T4+ 
DBA/2 
12.59 60.70 2 1 .70 3.40 15 .00 7 .71  2.76 0.44 1 .9 1  
Corn Oil ± 0.26 ± 1 .30 ± 0.90 ± 0.20 ± 0.70 ± 0.26 ± 0. 16  ± 0.03 ± 0. 1 1  
12. 1 1  65.00 b 25. 10  3 .60 17 .60 a 7.88 3 .01 0.43 2 . 1 2  
4 . 2  Ilg/kg TCDD ± 0.90 ± 0.90 ± 1 .00 ± 0.20 ± 0.50 ± 0.64 ± 0. 1 1  ± om ± 0. 1 1  
1 1 . 1 7  65. 10  a 24.90 4 . 10  17.40 b 7.27 2.78 0.45 1 .95 
14.0 Ilg/kg TCDD ± 0.33 ± 0.90 ± 1 .30 ± 0.40 ± 0.60 ± 0.24 ± 0.21 ± 0.05 ± 0.1 1 
10.93 70.60 a 27.20* 4.00 18.50 a 7 .71  2.98 0.44 2.03 
42.0 Ilg/kg TCDD ± 0. 17  ± 0.50 ± 1 .70 ± 0.20 ± 0.60 ± 0.09 ± 0. 1 8  ± 0.02 ± 0.07 
c Values represent Lhe mean ± SE specific staining of splenocytes derived from 4-5 animals/treatment group. Significance, as determined by Lhe Dunnett's T 
..-test, is indicated by asterisks: b = p�0.05; a = p�O.01 .  U\ 
\0 
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significantly and dose-dependently suppressed and correlated with both the degree of 
hepatomegaly and induction of liver microsomal EROD activity (fables 1 9  and 20). In 
addition, splenic microsomal EROD activity was enhanced at all exposure levels. Flow 
cytometric analyses of these splenocytes, again derived from treated but unsensitized 
B 6C3Fl mice, demonstrated a greater degree of effects on both the percentage and the 
absolute numbers of both Ig+ B cells and Lyt-2+ and L3T4+ T cells (Table 2 1 ). The most 
noted change however was in the Ig+ cells, where the percentage of these cells were dose­
relatedly increased while the absolute numbers were decreased. No significant change in 
the absolute numbers of T cells was determined. The interpretation of this finding would 
be the selective loss of a non-B/non-T cell from the spleens of these animals; most likely of 
the macrophage/monocyte lineage. 
Subchronic exposures in DBN2 mice produced changes in both lymphoid organ 
weight and humoral immune parameters which were inconsistent with either results 
obtained following acute exposures or with changes in the liver weight or liver microsomal 
EROD activity (Table 20). In addition, thymic involution was greatly enhanced in these 
mice. This effect on tllymus weight was consistent throughout several experiments, where 
subchronic exposure in the DBN2 strain usually caused a greater degree of thymic atrophy 
than was seen in the B6C3Fl mice when exposed under the same conditions (data not 
shown). More consistent with effects of TCDD on the thymus, as opposed to those on the 
liver, suppression of both the background and antigen-stimulated antibody responses in the 
DBA/2 mice were significantly enhanced following the repetitive 14 day exposure regimen 
(Table 1 8), and was consistent throughout several experiments. Coordinately, splenic 
microsomal EROD activity was enhanced at the 4.2 and 14 Ilg/kg exposure levels, and 
may be related to the enhanced suppression that is seen following subchronic exposures in 
DBA/2 mice (fable 20). Flow cytometric analyses of these splenocytes, again derived 
from treated but unsensitized DBA/2 mice, demonstrated a greater degree of effects; 
particularly with respect to the loss of a non-B/non-T cell (fable 2 1 ). As in the case of 
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splenocytes derived from the B6C3Fl strain following this treatment regimen, the most 
noted change was an increase in the percentage of Ig+ cells; without a change in the 
absolute numbers of any of the lymphocyte populations. The interpretation is the same, in 
which there appears to be the loss of a non-B/non-T cell from the spleens of these mice; 
most likely of the macrophage/monocyte lineage. Moreover, the loss in splenic EROD 
activity at the 42 Ilg/kg cumulative dose in both strains correlates with the loss of this non­
B/non-T cell population, thus implicating this population of cells as the primary cell type 
involved with the TCDD-induced P450 activity in the spleen. 
v. DISCUSSION 
A s  i ndicated in  the review of the literature, the compound 2,3 ,7 ,8-
tetrachlorodibenzo-p-dioxin (TCDD) represents the most potent congener of a family of 
biologically active halogenated aromatic hydrocarbons [Poland, et aI . ,  1979]. It has 
attracted much interest in recent years for both its frequent association with environmental 
contamination and its broad spectrum of toxic effects in numerous species, including man. 
Exposure in animals is most characterized by thymic atrophy,  functional 
immunosuppression, liver porphyria, and induction of liver P450 enzymes [Poland, et al., 
1979]. In contrast, the most notable effect in man is chloracne, a condition of the skin in 
which exposure to TCDD causes hyperplasia and hyperkeratinization of the epidermis 
[Poland and Kende, 1976] . These earlier studies have led various investigators, including 
this laboratory, to investigate the mechanism by which TCDD can cause such diverse 
effects in a wide variety of tissues and organ systems. Biological models are necessary in 
determining the biochemical and functional mechanism of dioxin's action and various non­
lymphoid tissues and cell lines have been employed to address this i ssue [Poland and 
Knutson, 1 982; Hudson, et aI. ,  1985; Hudson, et aI . ,  1 986] . Additionally, several 
findings have suggested a role by TCDD in the alteration of either activation or 
proliferation of various cell types; including the B lymphocyte. Of these types of studies, 
two such observations deserve special mention. First is the finding by Knutson and 
Poland ( 1980) [Knutson and Poland, 1980] in which exposure of the murine teratoma cell 
line XB to TCDD caused a decrease in their capacity to proliferate. Second, and more 
important, was the observation by Tucker, et aI. [Tucker, et aI., 1 986] in which a 
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significant suppression in DNA synthesis was noted following addition of TCDD to LPS­
stimulated cultures, further suggesting an effect by TCDD on the early stages of B cell 
activation and proliferation. 
In terms of more specific effects on humoral immunity, TCDD's proftle of activity 
has been somewhat unclear and found to be rather unique in nature. This point is  
exemplified in reports from several laboratories which have demonstrated the effects of 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity to be comprised of 
dual components - immune enhancements and immune suppression. The manifestation of 
these effects however, has depended on the level of exposure that is used in rodent model 
systems. For example, Sharma and Gehring ( 1 979) and Clark, et al. ( 1 98 1 )  have 
reported that exposure of naive animals to lower doses of TCDD caused an increase in the 
level of spontaneous lymphocyte transformation (3H-TdR incorporation), serum 
antibodies, and background splenic AFC formation in the absence of antigen stimulation, 
and at a level of dioxin which did not cause detectable induction of metabolic enzymes in 
the liver [Sharma and Gehring, 1979; Clark, et al. ,  198 1 ] .  Interestingly, suppression of 
mitogen responsiveness of whole splenocytes to both phytohemagglutinin (PHA) and 
pokeweed mitogen (PWM) directly correlated with the spontaneous proliferation detected 
in these cells at both 2 and 4 weeks post-exposure. Both had returned to control levels by 
8 weeks. Additionally, Clark and co-workers [Clark, et al., 198 1 ]  further noted that low 
levels of TCDD (0.4 and 4 Ilg/kg), given once a week for four weeks, caused an increase 
in the number of spleen colony-forming cells in bone marrow by 25-39%, suggesting that 
TCDD could be acting at some specific site to initiate an "activation-like" signal within 
hematopoietic cells. These observations are also consistent with a similar proftle of activity 
on lymphocyte function in humans. Lipson ( 1987) has demonstrated that either direct (in 
Yilm) or ill...Y.iY.Q exposures of human peripheral blood lymphocytes (PBL) to the TCDD­
related compounds, polybrominated biphenyls (PBB),  causes an increase in B cell 
activation [Lipson, 1987] .  As reported, concentrations of PBB as low as 0.001 Ilg (3 . 1  X 
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1 0-6 J.lIllol)/ 1 05 PBL decreased lymphocyte responses to pokeweed mitogen (PWM) 
whereas higher concentrations stimulated the in vitro synthesis and release of 
immunoglobulins; most notably IgG. Similarly, PBL obtained from PBB-exposed 
Michigan farmers demonstrated an enhanced release of IgG in culture following PWM 
stimulation. Moreover, as noted in the epidemiological reports of Tognoni and Bonaccorsi 
( 1 982), increases in spontaneous lymphocyte proliferation and mitogen responsiveness 
have also been found in PBL obtained from children exposed to TCDD in Seveso, Italy 
[Tognoni and Bonaccorsi, 1982] . This is also indicated in the present studies in which 
enhancements were detected in in vitro antibody responses following either in vivo or 
direct in vitro exposures under specific exposure and culture conditions. Conversely, 
higher doses of TCDD (i.e., those causing a detectable induction of the liver and producing 
atrophy of the thymus) were found to inhibit both mitogen-stimulated and primary 
antibody responses to SRBC for up to 42 days following exposure [Clark, et aI. ,  198 1 ;  
Vecchi, et al. ,  1983].  Furthermore, the degree of antibody response suppression was 
found to correlate with the ability of TCDD to induce liver P450 enzyme activity, as based 
on both the dose-responsive behavior of TCDD and the sensitivity of various strains of 
mice [Vecchi, et al. ,  1980; Vecchi, et al., 1983].  These studies therefore demonstrate a 
dose-related biphasic response to dioxin in the whole animal which suggests a segregation 
in the effects of exposure on lymphocyte responsiveness. Moreover, it was previously 
determined that the primary cell affected by TCDD in suppression of antibody responses is 
the B lymphocyte and that an alteration in early signalling events during B lymphocyte 
activation leads to improper differentiation of these cells and suppression in their ability to 
secrete antibody [Tucker, et aI., 1986; Holsapple, et aI., 1986a; Dooley and Holsapple, 
1 988;  Luster, et aI. ,  1988b] . Given these findings, it was the overall objective of the 
current investigation to determine the relationship between the immune enhancing and 
immunosuppressive effects of TCDD on humoral immunity as related to it's effects on the 
two main subpopulations of B cells within the spleen. Specific emphasis was placed on 
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determining whether these two phenomena are mechanistically related or mutually 
exclusive components of TCDD's profile of immunomodulatory activity. Additionally, 
studies were conducted to determine whether these two opposing actions of TCDD are 
correlated with responses that are mediated by the Ah-receptor and the Ah-gene locus. 
In the first series of experiments that were carried out in the laboratory, it was 
determined that a similar duality in effects could be induced by TCDD on the in vitro T­
dependent antibody response under selective culturing conditions. Specifically, it was 
determined that the degree of suppression of in vitro antibody responses in Ah-high 
responder B6C3F l female mouse splenocytes i s  dependent on both the lot and 
concentration of supplemental serum that is present during the time of exposure. In the 
presence of fetal bovine sera (FBS),  both enhancements and suppression were seen but 
were dependent upon both the concentration of TCDD administered and the concentration 
of serum which was used in support of the response (i.e., 5% versus 1 0%;  see Figure 7). 
Under totally serum-free conditions (i.e., bovine serum albumin - BSA - as an equivalent 
protein source), only enhancements in the anti-SRBC AFC response could be seen. 
Opposingly, newborn calf sera (all lots tested to date) supported a dose-related suppression 
of the anti-SRBC AFC response regardless of the concentration used (only 5 and 1 0% sera 
were tested in these studies). Therefore, in relation to the dual effects induced by TCDD 
on antibody responses, alteration of the serum environment during in...Yil;rQ culture could be 
used as a tool to explore this phenomena. All subsequent experiments took full advantage 
of this effect by comparing the actions of TCDD on both whole lymphocyte and isolated B 
cell antibody responses in the presence of both a selectively suppressive and selectively 
enhancing serum environment. From these studies it is evident that these two modulatory 
actions of TCOD are separate entities and that the manifestation of these effects i s  
determined by  the lymphocyte cell type, stage of cell cycle and the presence of modulatory 
hormones present in serum. 
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Collectively, the observations above suggested that: 1 )  TCDD acts primarily on the B 
lymphocyte; 2) TCDD has characteristics of a polyclonal B cell activator; and 3) the 
suppression of the T-dependent antibody response is dependent on serum-derived growth 
factors. Therefore, the second series of experiments centered on the similarities between 
TCDD and the polyclonal B cell activator, Staphylococcus aureus Cowan strain I (SAC). 
S AC is described in the literature as a T cell-independent polyclonal B cell activator, in that 
it can bind to (via protein A immunoglobulin binding molecules on the bacterial cell 
surface) and cause the activation of resting B cells in the absence of T cells [Kehrl, et al., 
1984].  However, it is  inefficient at differentiating these cells in the absence of T cell­
derived growth and differentiation factors. It is also interesting that the proliferation of 
resting B cells following S AC activation is modulated by serum-derived growth factors 
which can increase or decrease the ability of these cells to proliferate and/or differentiate 
[Choi and Xia, 1987; Wasik:, et aI., 1987]. Activation by SAC is further unique in that it 
stimulates the expression of the high-affinity IL-2 receptor on the surface of resting B cells 
[Tanaka, et aI., 1988].  In fact, it has been speculated that it is the activation of B cells in 
an IL-2-dependent manner which may render these cells susceptible to modulation by the 
serum-derived growth factors. Moreover, it has recently been described that the early 
acting cytokine, IL-2, can directly modulate B cell activation and differentiation. 
However, this type of activation scheme seems to be dependent on the type of stimulus 
received by the B cell and its role in a "normal" T-dependent antibody response is still 
unclear [Jelinek and Lipsky, 1987; Abbas, 1988] . Since IL-2 would be included as one of 
the first major B cell modulatory cytokines to be released by the T cell during a T­
dependent response (normally functioning as a T cell growth factor), it would seem logical 
to assume that B cells activated in such a way as to express the high-afftnity IL-2 receptor, 
would be rendered susceptible to "apparent" suppression, due to the anti-proliferative 
effect of a non-supportive serum; without significant effects on response kinetics. It 
should also be noted that our laboratory has previously demonstrated that IL-2 secretion by 
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Con A activation of T cells is not affected by TCDD exposure [Dooley, et aI., 1990) . 
Thus, a comparison was made between the actions of SAC and TCDD on the T-dependent 
response in 2 separate lots of serum (one which supported the suppression by TCDD - 5% 
NBCS lot 453, and one which did not - 10% FBS lot 7 17) .  From these studies it was 
determined that the effects of TCDD on the T-dependent antibody response by B6C3Fl 
splenocytes are similar to the effects of SAC. This similarity was based on the observation 
that under the same serum supplemented conditions which were shown to support either 
enhancements (i.e., FBS or BSA) or suppression (i .e., NBCS) of the in vitro anti-SRBC 
antibody response, direct addition of SAC to these cultures caused the same pattern of 
effects. Likewise, under totally serum-free culture conditions, SAC produced dose­
dependent enhancements in the the AFC response of approximately equal magnitude as 
TCDD at equivalent suppressive doses. These studies are important from the standpoint 
that TCDD has actions that are similar to those of an in vitro polyclonal B cell activator and 
that hormonal influences can determine whether enhancements or suppression can be 
manifested by either of these two agents. More importantly, it demonstrates that the 
actions of TCDD on humoral immunity could be mediated outside the Ah-gene locus by 
cellular mechanisms that control lymphocyte activation, and which are hormonally 
regulated by their respective environment. The proposed actions of SAC on the in vitro T­
dependent antibody response to SRBC is illustrated in Figure 35. This model was used as 
a working hypothesis for subsequent experiments to determine the direct actions of TCDD 
on lymphocyte function and the relationship between the actions of TCDD and SAC. 
Given the dual nature of effects elicited by both TCDD and SAC on in...Yi!;rQ antibody 
responses, further investigations were initiated with several additional objectives in mind. 
First, because of the close parallel between the effects of TCDD and SAC, studies were 
preformed to determine the relative sensitivities of the two main populations of B cells 
within the spleen to direct TCDD exposure - i.e., resting (Go) and cycling (primarily G 1 )  
B cells a s  based on separation of these cells on discontinuous percoll density gradients. 
168 
Figure 35. Proposed Actions of Staphylococcus Aureus Cowan Strain I (SAC) 
on B Cell Activation and Differentiation in the In Vitro T-Dependent Antibody 
Response. 
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Specifically, these studies were carried out to determine if enhancements and suppression 
of B cell responses are a function of differential effects on these two populations of cells 
and were based primarily on reports that SAC and anti-immunoglobulin antibodies have 
opposing actions on these two cell types - i.e., activation of resting and a more generalized 
suppressive effect on activated, cycling, B cells [Defranco, et al., 1982; Kehrl, et al. ,  
1 984; Maruyama, e t  aI., 1985; Symons, et al., 1985; Chen, 1988; Calvert, e t  al., 1990; 
Flores-Romo, et aI . ,  1990] . The experimental model system used in these studies 
involved the effects of TCDD on both background and lipopolysaccharide (LPS)-induced 
proliferation and differentiation (i .e., IgM and IgO) of purified splenic resting and cycling 
B cells derived from Ah-high responder B6C3Fl female mice. The relative purities and 
functional capacities of these two populations of cells were carefully and extensively 
characterized as was described in the methods and results. This was important in 
validating the use of purified B cell populations in mechanistic studies related to the actions 
of TCDD on lymphocyte function in particular, and in in...Yilm immunotoxicity studies in 
general. LPS was selected as the immunological probe in these studies based on its ability 
to stimulate both proliferation and differentiation of purified B cells in the absence of either 
macrophages or T cells or their respective B cell modulatory cytokines. This was 
important in allowing the determination of the direct effects of TCDD on B lymphocyte 
proliferation and differentiation without the interference of secondary effects through 
macrophages or T cells. The second objective was related to the first, in that the studies to 
determine the actions of TCDD on different populations of B cells were carried out in the 
presence of two separate serum environments; one which selectively inhibited suppression 
of in vitro antibody responses to SRBC (i.e. , 10% FBS) and one which selectively 
supported suppression in a significant and dose-related fashion (i.e. , 5% NBCS).  This 
added condition was to enable the determination of the direct modulatory role of serum­
derived growth factors in the effects of TCDD on B lymphocyte function. Specifically, 
these studies were performed to determine if, in addition to a differential pattern of effects 
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of TCDD on splenic B cell populations, serum-born growth factors could be partially 
responsible for the dual behavior of B cells when directly exposed to TCDD. Moreover, T 
cell proliferation in these two serum environments was also compared to determine the 
relative sensitivities between B cells and T cells in suppression of whole lymphocyte 
antibody responses. In a similar manner to the B cell, both background and Con A­
stimulated proliferation were monitored. The third objective of this investigation was to 
determine the potential role, and/or relationship, between the dual effects of TCDD on B 
lymphocyte function and the Ah-gene locus. These studies were conducted in a two-fold 
manner. The fIrst series of studies were conducted to determine the modulatory effect of 
the various sera (i.e., fetal and newborn bovine sera and normal mouse sera from Ah-high 
responder - B6C3Fl - and Ah-Iow responder - DBA/2 - mouse strains) on the ability of 
TCDD to cause induction of P450 1 A l  (ethoxyresorufin-O-deethylase; EROD) activity in 
primary hepatocyte cultures derived from Ah-high responder, B6C3Fl ,  mice. These 
studies were designed to determine if enhancements and/or no-effect responses of 
lymphocytes derived from Ah-high responder animals, to direct in vitro exposure to TCDD 
in the presence of the various sera, would correlate with the levels of P450 activity 
obtained in hepatocytes cultured under the same serum-supplemented conditions. The 
second series of experiments consisted of cross-over studies in which hepatocytes and 
splenocytes from both Ah-high responder (B6C3Fl )  and Ah-Iow responder (DBA/2) mice 
were directly exposed to TCDD under various serum-supplemented conditions, including 
their own natural sera environment (i.e., normal mouse serum) . These studies were 
conducted to determine if natural components within the sera of Ah-high responder and 
Ah-Iow responder mouse strains could confer the phenotypic patterns of P450 activity and 
immunosuppression that is typically seen in these two strains of mice following acute 
exposures in vivo. The findings of these experiments are discussed individually, but in a 
manner which relates to the effects of TCDD on whole lymphocyte responses. 
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Results of the studies conducted using purified B cell subpopulations demonstrate 
that the dual nature of the effects of TCDD on antibody responses is a function of both the 
state of in vivo activation (i.e., stage of the cell cycle) and the presence of serum-derived 
hormones, each being required in the production of either effect. These actions are 
i l lustrated in Figure 36 and are modeled after the proposed actions of SAC on B 
lymphocyte responses as described above (Figure 35). For resting B cells, TCDD appears 
to induce an "activation-like" signal which can cause at least a proportion of these cells to 
proliferate and differentiate into immunoglobulin-secreting cells in the absence of any 
exogenously added B cell stimulus. This effect however, only occurs in the presence of 
fetal bovine serum (FBS;  i .e., conditions which do not support suppression of in vitro 
antibody responses) and at TCDD concentrations of �30 nM. TCDD did not affect either 
response when resting B cells were stimulated by LPS . In cycling B cells a more 
generalized pattern of suppression was seen, which occurred more prevalently in the 
presence of the NBCS. TCDD caused a dose-related decrease in both background and 
LPS-stimulated proliferation, with significant effects at concentrations as low as 300 pM. 
Similarly, TCDD was found to inhibit differentiation of these cells by decreasing both 
background and LPS-stimulated IgM and IgG secretion in a dose-related manner, and 
across the same dose range shown to inhibit B cell proliferation. Most interestingly, there 
was a serum dependency for the effects of TCDD on LPS-stimulated cycling B cells which 
closely paralleled the effects seen on whole splenocyte responses to SRBC; thus 
confirming a major effect on the cycling B lymphocyte in  suppression of humoral 
immunity by TCDD. Therefore, enhancements in immune function by TCDD are at least 
partially due to the direct activating effects of TCDD on the resting B cell . Conversely, the 
effects of TCDD on the background proliferation of cycling B cells are characterized as a 
generalized suppression; with a more consistent suppression occurring in the presence of 
the NBCS . These observations are therefore important in demonstrating the relationship 
between enhancements and suppression of humoral immune function, as related to both the 
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LPS-I nduced 
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Figure 36. Model of the Actions of TCDD on Resting (Go) (Figure A) and Cycling 
(G 1) (Figure B) B Cell Proliferation and Differentiation in the Absence and Presence of a 
B Cell Stimulus. 
1 7 4 
stage in the B cell cycle and the modulation of serum-derived growth factors. From these 
studies it can be concluded that the enhancements in resting B cell proliferation and 
differentiation has no consequence in either suppressing or enhancing the proliferative or 
differentiative effects of a B cell stimulus and would suggest that this population of cells is 
less sensitive to the suppressive effects of TCDD on B cell function. However, in contrast 
to this suggestion, it should be reemphasized that the direct enhancements in resting B cell 
proliferation results in the complete depletion of these cells following antigen stimulation of 
exposed mice, thereby contributing as much to the overall immunotoxicity in the whole 
animal as the direct functional suppression of B cell responses as described below for the 
cycling B cell population. As indicated, additional studies were key to determining that 
TCDD can interfere with both the proliferation and differentiation of both unstimulated and 
LPS-stimulated cycling B cells and that the same serum-dependent phenomena is observed 
in these cells as was found for the in vitro T-dependent antibody response (i.e., there were 
more dramatic effects in  the presence of NBCS).  Moreover, this latter finding further 
establishes this population of B cells as the sensitive cells to functional suppression by 
TCDD and that proliferation is significantly affected. In comparative studies using purified 
T cells, no significant suppression of either background or Con A-stimulated proliferation 
was detected regardless of the serum used. Interestingly however, significant and dose­
related enhancements in Con A-stimulated cycling B cell proliferation were seen in the 
presence of FBS .  This finding suggests that in addition to enhancement of resting B cell 
proliferation and differentiation, increases in antigen stimulated T cell proliferation may 
contribute to the enhancements seen in the in  vitro, and even in vivo at low TCDD 
concentrations, antibody responses. In terms of relative sensitivities for suppression 
however, the T cell appears to be less affected by TCDD exposure. However, this data 
does not rule out the possibility that there is not an indirect influence by the T cell to 
suppress B cell responses. The potential role of T cell cytokines in modulation of either 
enhanced activation or proliferation of both resting and cycling B cells, as well as the 
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whole lymphocyte anti-SRBC response, is illustrated in Figure 15 .  These results suggest 
that enhancements in  the AFC response under serum-free culture conditions requires 
antigen stimulation and the release of T cell-derived cytokines. In addition, Figures 21 and 
23 demonstrate that both gamma-interferon (G-IFN) and IL-2 (both secretory products of 
the inflammatory Th l T cell subtype) can modulate the direct effects of TCDD on B cell 
proliferative responses in the absence of antigen challenge. The effects of G-IFN in 
enhancing the activation of resting B cells by TCDD is especially noteworthy given the 
many reports which have characterized the actions of this cytokine as having properties of 
a B cell growth and differentiation factor following stimulation by a number of B cell 
activating stimuli, including SRBC [Leibson, et aI . ,  1 984; Nakamura, et al . ,  1 984; 
Sidman, et aI., 1 984; Brunswick and Lake, 1985; Defrance, et al. ,  1986; Romagnani, et 
aI., 1986; Boyd, et al. ,  1987; Karray, et al . ,  1987; Morikawa, et aI., 1987; Xia and Choi, 
1988; Punnonen and Viljanen, 1989a; Punnonen and Viljanen, 1989b]. 
Results of experiments used to address the third objective have added the most 
compelling evidence that enhancements and suppression of both whole lymphocyte AFC 
and isolated B cell antibody responses is regulated in an Ah-dependent manner. In these 
studies it was determined that the influence of the serum on the ability of TCDD to either 
inhibit (and/or enhance) or suppress whole lymphocyte and purified cycling B cell 
antibody responses has a direct correlation with the modulation of TCDD-induced 
P450 1 A l  activity in primary hepatocytes. When comparing the direct effects of TCDD on 
the lymphocyte with the induction of ethoxyresorufin-O-deethylase (EROD; P450 1 A l )  
activity in primary hepatocytes it was found that calf serum conditions which inhibit and/or 
enhance antibody responses in the presence of TCDD (i.e., 10% FBS) support a lower 
induction of enzyme activity in the hepatocyte (as compared to a BSA protein control). 
Conversely, NBCS supports a more pronounced and dose-dependent suppression of 
antibody responses and a higher induction of P450 activity in the hepatocyte. It should be 
pointed out however, that NBCS does express a concentration dependency for the effects 
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of TCDD on whole lymphocyte responses (see Figure 26) in which concentrations below 
4% were not found to support suppression, thus suggesting that the active component in 
the serum must be at appropriate concentrations in order to potentiate the effects of TCDD 
on lymphocyte function. In contrast to the effects seen in the presence of calf sera, 
immune responses and induction of hepatocyte P450 enzyme activity in the presence of 
normal mouse sera display a more direct correlation to effects mediated through the Ah­
gene locus and the Ah-receptor. In particular, antibody responses to SRB C  mediated by 
the A h-high responder B6C3Fl splenocyte are suppressed in a dose-related manner by 
TCDD in the presence of normal mouse serum whereas responses by the A h- Iow 
responder DBA/2 splenocyte are not. In contrast, responses by DBA/2 splenocytes were 
actually enhanced in the presence of normal mouse serum, at TCDD concentrations of 0.3 
and 3 nM (much like what is  seen in B6C3Fl splenocyte responses in the presence of 
FBS). Coordinately, TCDD-induced EROD activity in the presence of normal mouse 
serum is selectively enhanced in the B6C3Fl hepatocyte, and not in the DBN2 hepatocyte, 
as compared to the BSA protein control. Moreover, crossover studies determined that the 
responses of splenocytes and hepatocytes of either strain were no different in the presence 
of serum from either of the two strains and demonstrates that the Ah-dependency of the 
effects of TCDD are not related to the compositions of serum derived from these two 
strains of mice. These latter findings help to explain the dual pattern of effects of TCDD 
on lymphocyte function and correlate with several reports that have described the factors 
which can influence the induction of P4501 A l  activity in human leukocytes [Busbee, et 
aI., 1 972; Kouri, et al. ,  1 974; Kouri, et aI. ,  1 979] . In these reports, it has been described 
that both the serum and the activation state are important in inducing P4501 A l  activity. 
More specifically, the higher the proliferative capacity of the cell the higher the inductive 
capacity. This in tum is related to the serum in support of cellular growth in in vitro 
culture systems. These earlier fmdings again correlate with the observations in the present 
study, in which differential effects were seen between resting and cycling B cells in 
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response to TCDD. Collectively, these results, combined with these earlier reports, would 
indicate that the dual nature of the effects of TCDD on lymphocyte function is related to the 
capacity of the cell to respond to the TCDD through Ah-receptor mediated cellular events. 
Resting B cells, which have a lower capacity for responses mediated through the Ah­
receptor, demonstrate an enhancement or "activation-like" response, whereas cycling B 
cells, which have a higher capacity for Ah-mediated responses, demonstrate a generalized 
suppressive response following TCDD exposure. 
To summarize the effects of TCDD on the B lymphocyte, Figure 37 illustrates the 
proposed actions of TCDD on the two major populations of B lymphocytes as related to 
the manifestation of effects on the whole lymphocyte T-dependent antibody response. As 
modeled from the proposed actions of SAC on antibody responses, TCDD has opposing, 
but equally toxic effects on the resting and cycling B cell. Each of these actions can disrupt 
lymphocyte responses to a T-dependent antigen and are influenced by hormonal factors. 
However, given the fact that TCDD causes the activation of cellular kinases within minutes 
of exposure [Kramer, et al . ,  1987] and the similarity in actions to SAC, these responses 
are most likely mediated by both Ah-receptor-dependent and Ah-receptor-independent 
mechanisms. Moreover, in keeping with a lower sensitivity to suppression of T cell 
function as previously reported [Dooley, et aI., 1990] , cycling T cells demonstrate only 
enhanced behavior following TCDD exposure and would be indicative of a lower capacity 
for direct suppressive effects on this cell in suppression of immune function. Therefore, it 
is not just the response that is mediated through the Ah-receptor, but also the level of the 
response, which is important in producing the ultimate effect - either enhancements or 
suppression; both however, being toxic responses that are mediated at different theshold 
levels of TCDD exposure within the cell. 
In summary, the present studies demonstrate several key observations in the 
understanding of the actions of TCDD on B lymphocyte function. Experiments conducted 
using purified B cell subpopulations demonstrate that the dual effects of TCDD on humoral 
178 
Figure 37. Proposed Actions of TCDD on B Cell Activation and Differentiation 
in the In Vitro T-Dependent Antibody Response. 
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immune responses are a function of both the stage of the cell cycle and the serum 
environment in which the cells are exposed. Cycling B cells appear to be the primary 
target for suppression by TCDD whereas resting B cells appear to be associated with 
immune enhancements that are seen following low dose exposures in the whole animal. 
Based on studies conducted on the modulatory role of sera on both hepatocyte P450 1 A l  
activity and suppression of both in vitro APC responses to SRBC and purified B cells to 
LPS, the effects of TCDD on lymphocyte responses are consistent with a role by the Ah­
gene locus. Interestingly, lower levels of induction as seen in the presence of FBS, or the 
lower levels of P450 activity expected in resting B cells, appear to result in immune 
enhancements, whereas higher levels of induction as seen in the presence of NBCS, or 
previously shown in activated lymphocytes, appear to result in a more generalized 
suppressive activity on humoral immunity. 
Lastly, experiments were conducted to investigate the immunotoxic effects of TCDD 
following either acute or subchronic exposures in mice. Acute exposure of mice to TCDD 
traditionally leads to changes in organ weights (i .e. , specifically liver and thymus, 
reflecting hepatomegaly and involution, respectively) and a suppression of humoral and 
cell-mediated immunity that is consistent with a role by the A h-Iocus [Sharma and 
Gehring, 1 979; Vecchi, et aI., 1 983;  Kerkvliet, et al . ,  1 990b] . However, while these 
fmdings are fairly descriptive of acute dosing regimens, several reports have indicated that 
differences may exist in the toxicities produced by TCDD, and closely related congeners, 
depending on the dose [Clark, et aI ., 198 1 ;  Clark, et al.,  1983] , route [Pohjanvirta, et al . ,  
1989] and length of exposure [Holsapple, et al. ,  1986b] used by various investigators. Of 
particular interest is this latter phenomena, in which a report from this laboratory has 
shown that subchronic exposure of B6C3F l mice to the low affinity Ah-receptor ligand, 
2,7-dichlorodibenzo-p-dioxin (2,7-DCDD), caused suppression of the in vivo antibody 
forming cell (AFC) response to SRBC which was comparable to that seen with TCDD; 
even in the absence of significant induction of liver P450 activity (i.e., aryl hydrocarbon 
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hydroxylase activity; AHH) [Holsapple, et al . ,  1 986b] . This finding was one of the first 
to demonstrate that low affmity agonists for the Ah-receptor, while having little or no effect 
on immunity when given acutely, could have dramatic effects on these immune parameters 
when administered sequentially over a longer period of time. 
Results of this investigation demonstrate that the conditions of exposure are 
important in determining the immunotoxicological potential of TCDD in vivo. This 
conclusion is based on the finding that subchronic exposure in DBA/2 mice leads to an 
enhanced suppression of both the background IgM and stimulated (day 4 anti-SRBC) AFC 
responses in the absence of significant changes in hepatomegaly or liver P4501Al  (EROD) 
activity. These findings are consistent with previous reports which have demonstrated that 
subchronic exposure of mice (i.e., B6C3Fl)  to either 2,7-DCDD [Holsapple, et aI., 
1 986b] or any of several polycyclic aromatic hydrocarbons (PAHs) [White, et al. ,  1985a] 
can produce suppression of the anti -SRBC AFC response that is comparable to that 
produced following acute exposures to TCDD. This latter study is especially noteworthy 
with respect to the current investigation because of the differential effects that were seen in 
DBA/2 mice, as opposed to the B6C3Fl  strain. In particular, these results indicated that 
subchronic exposure to either 3-methylcholanthrene or 7, 1 2-dimethylbenz(a)anthracene 
resulted in a higher degree of suppression of the day 4 antibody response in DBA/2 mice 
than was seen in B6C3Fl  mice. Similar results were observed in one of several trials with 
DBA/2 mice in the present study. This finding is important from the standpoint that the 
PAHs are also thought to induce their immunosuppressive effects, at least in part, through 
A h-receptor mediated mechanisms. Conversely, these findings instead suggest the 
involvement of additional, non-Ah-receptor mediated, mechanisms in suppression of 
humoral immunity by both the polycyclic and polyhalogenated aromatic hydrocarbon 
compounds. However, it is important to note that there was a small, but significant, 
enhancement in splenic P450 I A 1 activity in both strains following the subchronic 
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exposure regimen, and that our results cannot rule out the involvement of Ah-receptor­
mediated responses in these effects. This finding is further discussed below. 
Additionally, flow cytometric analyses of splenocyte subpopulations demonstrated 
that subchronic exposures resulted in the significant loss of a non-B/non-T lymphocyte 
which may be associated with the enhanced suppression of humoral immunity observed in 
these animals. Interestingly, there was a coordinated loss of splenic P450 activity with the 
loss of the non-B/non-T population. It is therefore likely that the non-B/non-T cell is of 
the macrophage/monocyte lineage, as based on the work of Ladics, et al. ( 1 99 1 )  who have 
determined that the primary cell type associated with the induction of P450 activity by 
benzo(a)pyrene in the spleens of B6C3Fl mice is the macrophage [Ladics, et al. ,  199 1b] . 
In terms of a mechanism which can account for the differential effects that are 
mediated by TCDD in the DBA/2 strain, there are no readily available explanations. For 
example, Curtis, et aI. ( 1 990) have determined that repeated exposures of C57BU6J mice 
to TCDD can alter its distribution within the liver and other tissues of these mice (i.e., 
spleen, fat, etc .)  [Curtis, et aI., 1 990] . This phenomena was attributable to an inducible, 
high affinity, low capacity system which affected the pharmacokinetics of TCDD. This 
observation is similar to the earlier findings of Leung, et al. ( 1 988) who established that 
the greater accumulation of TCDD in the liver of C57BU6J mice, as compared to DBA/2J 
mice, was not due to the higher fat content in DBA!2J mice or to cytosolic TCDD binding, 
but was more dependent on the presence and affinity of microsomal TCDD binding 
proteins [Leung, et aI., 1 988]. Therefore, while these findings may help to explain the 
enhanced toxic effects of repeated exposure in B6C3FI mice, as demonstrated in the 
studies outlined in the results, they are insufficient in explaining the findings in the DBA/2 
strain. This is in light of the fact that the redistribution of TCDD following repeated 
exposures, as identified by Curtis and co-workers, was accompanied by an increase in 
liver weight in the C57BU6J mice, an effect that is clearly not seen in the DBA/2 strain in 
the present study. However, as indicated above, an enhancement in splenic EROD activity 
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was identified in the DBN2 strain, thereby suggesting the involvement of Ah-receptor 
mediated effects in the enhanced suppression of humoral immunity in the DBA/2 strain. 
The enhancement in turn, may be the result of a selective redistribution of TCDD into the 
spleens of these animals. This effect is currently being investigated and may be the result 
of physiological differences which contribute to differences in the toxicokinetics of TCDD 
within these two strains. 
In relation to the role of the Ah-Iocus in the mediation of effects on immunity by 
TCDD, Kerkvliet, et ai. ( 1 990) have recently demonstrated that Ah-receptor-independent 
mechanisms are likely to play some role in suppression of humoral immunity by TCDD 
[Kerkvliet, et aI . ,  1 990c]. This conclusion is based on the observation that a biphasic 
dose-response relationship for suppression of the anti-SRBC AFC response was produced 
in response to TCDD treatment in Ahdd (low responsive) congenic mice, as opposed to 
Ahbb (high responsive) mice, which did not correlate with induction of AHH activity in the 
liver. However, these results were obtained using acute exposure regimens which again 
are unlikely to represent an adequate comparison in explaining the differences identified 
within the present study. Therefore, further experimentation is necessary in order to 
uncover the differential mechanisms involved with humoral suppression in DBA/2 and 
B6C3Fl  mice following subchronic exposures to TCDD. Moreover, this study, in present 
fonn, raises additional questions concerning the relevancy of subchronic exposures in 
immunotoxicity evaluations of TCDD. Previous investigators have demonstrated that a 
subchronic exposure regimen based on dosing once per week for several weeks produces a 
greater suppression in C57BL/6 mice than is observed in the DBA/2 strain [Vecchi, et aI., 
1 983] .  A comparison of these results with those obtained in the present study indicates 
that a subchronic regimen based on weekly exposures produces a profile of 
immunotoxicity that is more like the one associated with an acute (single) exposure [Clark, 
et aI . ,  1 98 1 ;  Vecchi, et al . ,  1 983] . Therefore, when considering human exposures 
specifically, a supposed A h-low responder population, subchronic studies in low-
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responsive animal models (i.e., DBA/2 mice) may better depict the dose regimen and body 
burden attained following repeated low level environmental exposures as would have 
occurred, for example, in Times Beach, Missouri [Knutson, 1984] . This is in contrast to 
exposures that have taken place following large scale industrial accidents as in Seve so, 
Italy [Pocchiari, et ai. , 1979; Tognoni and Bonaccorsi, 1982], in which acute exposures to 
large doses of TCDD may be more appropriately applied. In this regard, human 
populations exposed to low doses over an extended period of time (i.e. , months to years) 
may be at increased risk to immunotoxic effects by these chemicals through presently 
unidentified Ah-receptor-independent mechanisms. 
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